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ABSTRACT:  Gonadal  hormones exert  a  critical  influence  over  
the architecture of specific brain areas affecting the formation 
of  neuronal contacts. Cellular mechanisms mediating gonadal  
hormone actions on synapses have been studied extensively in 
the rat arcuate  nucleus, a hypothalamic center  involved in the 
feed-back regulation of gonadotropins. Gonadal steroids exert 
organizational and activational effects on arcuate nucleus syn-
aptic  connectivity.  Perinatal testosterone  induces a  sexual di-
morphic pattern of synaptic contacts. Furthermore, during the 
preovulatory and ovulatory phases of the estrous cycle there is 
a  transient  disconnection  of  inhibitory  synaptic  inputs to  the  
somas of arcuate neurons. This synaptic remodeling is induced 
by  estradiol,  blocked  by  progesterone,  and  begins  with  the  
onset of puberty in females. Astroglia appear to play a signifi-
cant  role  in the  organizational  and  the  activational  hormone  
effects  on  neuronal  connectivity  by regulating  the  amount  of  
neuronal membrane available for the formation of synaptic con-
tacts  and  by  releasing  soluble  factors,  such  as  insulin-like  
growth  factor  I  (IGF-I),  which  promote  the  differentiation  of  
neural processes. Recent evidence indicates that gonadal ste-
roids  and  IGF-I  may  interact  in  their  trophic  effects  on  the  
neuroendocrine hypothalamus. Estradiol and IGF-I promote the 
survival and morphological differentiation  of  rat  hypothalamic  
-neurons in primary cultures. The effect of estradiol depends on 
IGF-I,  while the effects of  both estradiol  and IGF-I  depend on 
estrogen receptors. Furthermore, estrogen activation of astro-
glia in hypothalamic tissue fragments depends on IGF-I recep-
tors.  These findings indicate that  IGF-I  may mediate  some of 
the developmental and activational effects of gonadal steroids 
on the brain and suggest that IGF-I may activate the estrogen 
receptor  to  induce  its  neurotrophic  effects  on  hypothalamic  
cells. In addition, IGF-I levels in the neuroendocrine hypothala-
mus are regulated by gonadal steroids. IGF-I levels in tanycytes, 
a specific astroglia cell type present in the arcuate nucleus and 
median eminence, increase at puberty, are affected by neonatal 
androgen levels, show sex differences, and fluctuate in accor-
dance to the natural variations in plasma levels of ovarian ste-
roids that are associated with the estrous cycle. These changes 
appear to be mediated by hormonal regulation of IGF-I uptake 
from  blood or  cerebrospinal fluid  by tanycytes.  These  results  
suggest  that  tanycytes  may  be  involved  in the  regulation  of  
neuroendocrine events in adult rats by regulating the availability 
of IGF-I to hypothalamic neurons. In summary, IGF-I and differ-
ent  forms  of  neuron-astroglia  communication  are  involved  in  
the  effects  of  estradiol  on  synaptic  plasticity  in the  hypotha-
lamic arcuate nucleus.  © 1997 Elsevier Science Inc. 
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INTRODUCTION 
Gonadal  hormones  exert  profound  influences  on  neural  develop-
ment and function, mainly, although not exclusively,  in brain areas 
related to neuroendocrine control and sexual behavior. Sex steroids 
exert organizational  effects on brain development  and  activational  
effects  on  the  adult  brain.  Indeed,  the  sexual  dimorphism  that  
exists in the adult brain is induced by androgen effects on  neuronal  
differentiation,  with  part  of  these  effects  being  subsequent  to  the  
intracerebral  aromatization  of  androgens  to estrogens  [50].  Estra-
diol  promotes  the survival  of  neurons  and  the  growth  of  neuronal  
processes,  regulating  the  formation  of  neuronal  connectivity  
[20,43], and therefore, the function of  neuronal  networks.  Further-
more,  recent  evidence  indicates  that  glial  cells  arc  affected  by  
gonadal  steroids  and  are  actively  involved  in  the  organizational  
and  activational  effects of  these  hormones  [9,19,27.40.44,57].  
Cellular  mechanisms  mediating  gonadal  hormone  actions  on  
synapses  and  glial  cells  have  been  extensively  studied  in  the  rat  
arcuate  nucleus,  a  hypothalamic  center  involved  in  the  feed-back  
regulation of gonadotropins.  Perinatal androgens induce the sexual 
differentiation  of  synaptic  connectivity  in  the  arcuate  nucleus  
[21,43].  Furthermore,  in postpuberal  females, there  is an estrogen-
induced transient disconnection of GABAcrgic  inputs to the somas 
of arcuate neurons during the preovulatory  and ovulatory phases of 
the estrous cycle. This  synaptic remodelling  is blocked  by  proges-
terone and begins with the onset of female puberty  |2()|.  Astrocytes 
appear to play  a significant role  in these synaptic changes  [20,22].  
In  the  afternoon  of  proestrus,  estradiol  induces  synthesis  of  glial  
fibrillary  acidic  protein  (GFAP),  a specific component  of  astroglia  
cytoskeleton  [20,22,34], Synthesis of GFAP is accompanied  by the 
growth  of  glial  processes  that  ensheathc  the  neuronal  membrane  
and  displace  the  synaptic  terminals.  Glial  processes  retract  and  
synapses  reform in the afternoon of estrus  120.22]. Glial cells  also  
appear  to be  involved  in the organizational  effects of  sex  steroids  
on  arcuate  neurons  [9,21].  Testosterone  appears  to  regulate  the  
number  of  synaptic  inputs  to  arcuate  neurons  by  affecting  the  
amount  of  neuronal  membrane  covered  by  glial  processes  and.  
therefore,  the amount  of  membrane  available  for the  formation  of  
synaptic  contacts  [21].  
The  signaling  mechanisms  involved  in  these  hormonal  ef-
1 To  whom requests  for reprints should  be addressed. 
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Ice is  on  neurons  and  glia  have  been  investigated  in  hypotha-
lamic  cultures.  The  estradiol-induced  growth  of  astrocyte  pro-
cesses  in  vitro  is dependent  on the  preexisting  direct  contact  of  
glial  cells  with  living neurons and  on  specific  neuron-astrocyte  
inicractions.  because  it  is  not  observed  in  cocultures  of  hypo-
thalamic  neurons with astrocytes from other brain areas [ 18,20]. 
The expression  of a polysialic acid-enriched  embryonic  form of 
the  neural cell  adhesion  molecule  in the neuronal  membranes  is  
essential  for the  glial  plastic  changes  induced  by  estradiol,  but  
not  for those induced  by signals such as  fibroblast  growth factor 
that  act directly  on astrocytes [18,20]. This  finding suggests  that  
a  neuron  to  astrocyte  signaling  pathway  participates  in  the  
plastic  effects  of  gonadal  hormones.  In  addition,  glial  cells  
release different soluble  factors that  alter neuronal  function and 
thai  may  he  involved  in  the  regulation  of  synaptic  connectivity  
and  neuroendocrine  function  [11,40,46].  One  such  factors  is  
insulin-like  growth  factor-I  (IGF-I),  a  cytokine  with  paracrine  
trophic cffects on neural cells and that acts as a hormonal  signal  
involved  in the  regulation  of  hypothalamic  hormone  secretion.  
Here,  we  review  recent  evidence  indicating  that  IGF-I  is  in-
volved  in some of  the effects induced  by  gonadal  hormones  on  
hypothalamic  neurons.  
IGF-I  AND  ESTROGEN  SIGNALING  INTERACT  IN  
DEVELOPING  HYPOTHALAMIC  NEURONS  
IGF-I  is  locally  synthesized  by  glia  and  neurons  of  the  hypo-
thalamus as  well  as  of other  brain  areas  [5,23] and has  prominent  
trophic  actions,  stimulating  survival,  proliferation, and differenti-
ation  of  specific  neural  cell  populations  [37,63],  IGF-I  may  also  
participate  in  neuroendocrine  events  at  the  level  of  the  hypothal-
amus  because  it  has  been  shown  to  be  involved  in  the feed-back 
regulation  of  growth  hormone  by  affecting  the  synthesis  or  the  
release of growth hormone-releasing hormone and somatostatin by 
hypothalamic  neurons  [3,60].  IGF-I  may  also affect the  reproduc-
tive  axis  by  modulating  the  release  of  gonadotropin  releasing  
hormone  by  hypothalamic  cells  and,  therefore,  the  release  of  
gonadotropins  [6,25].  
In  several  tissues,  such  as  rodent  uterus  and  pituitary,  and  in  
several  cell  types,  such  as  human  breast  cancer  cells,  estrogen  
upregulates IGF-I gene expression [17,28,47,49,58] and modulates 
IGF-I  action  by  affecting the  levels  of  IGF-I  receptors  [67]  and  
IGF  binding  proteins  (IGFBPs)  [36,48,53,69].  Likewise,  IGF-I  
may  regulate  steroid  hormone  action  by  stimulating  the  synthesis  
of  steroid  hormones  [10,13,24]  and  steroid  hormone  receptors  
[ 1.8.31 ].  In  addition,  estrogen  and  antiestrogens  regulate  several  
cellular  responses  induced  by  IGF-I  [1,16,61,68],  As  in other cell 
types.  IGF-I  and  estrogen  may  also  have  interactive  effects  on  
neurons.  The first evidence  was  provided  by Toran-Allerand  and  
co-workers  [62],  showing  that  in  explant  cultures  of  fetal  rodent  
hypothalamus,  estrogen  and  insulin  have  synergistic  effects  on  
neurite  growth,  an  effect  probably  mediated  by  IGF-I  receptors.  
More recent  data from our laboratory indicates  that estrogen  mod-
ulates  IGF-1 receptors and binding proteins in monolayer  hypotha-
lamic  cultures  [56].  
We  have  also  recently  studied  whether  the  effects of  estro-
gen  on  hypothalamic  neuronal  survival  and  neurite  growth  are  
mediated  by  IGF-I  [12].  To  assess  the  effect  of  17j3-estradiol  
and  IGF-1  on  the  survival  and  differentiation  of  hypothalamic  
neurons,  the  hormone  and/or  peptide  were  added  to  rat  hypo-
thalamic  monolayer  cultures  every  2  days  for  6  days  at  a  final  
concentration  of  10_v  M.  Neuronal  survival  and  growth  of  
microtubule  associated  protein-2  (MAP-2)  immunoreactive  
processes  was  then  assessed.  Neurons  exposed  to  estradiol  or  
IGF-I  showed  a significant  increase  in  neuronal  survival  and  in  
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FIG.  1. Extension  of  microtubule  associated  protein-2  (MAP-2)  Immuno-
reactive  processes  from hypothalamic  neurons  in  monolayer  culture.  The  
extension  of MAP-2 immunoreactive  processes was evaluated  by  counting  
their  intersections  with  a  morphometric  grid  (see  [I2|).  Both  IGF-I  (10  ''  
M)  and  estradiol  (I0~9  M),  either  alone  or  in  combination,  induced  the  
growth  of  MAP-2  immunoreactive  processes  (upper  panel).  Inhibition  of  
IGF-1  synthesis  by  incubating  the cultures  with  an  antisense  oligonucleo-
tide to  IGF-1  (33 /ig/ml) resulted  in the inhibition  of  the effect of  estradiol  
(lower  panel).  A  sense  control  sequence  was  without  effect.  Asterisks  
indicate significant differences (p  <  0.01) vs cultures  incubatcd  in  control  
medium. 
the  growth  of  MAP-2  immunoreactive  processes  (Fig.  I).  The  
simultaneous  incubation  of the  cultures  with  17J3-estradiol  and  
IGF-I  also  resulted  in  increased  neuronal  survival  and  differ-
entiation. The  effect of  estradiol  and  IGF-1 acting  together  was  
similar  to  that  observed  when  cultures  were  treated  separately  
with  either  factor  (Fig.  1). Therefore,  the  effects of  17j3-estra-
diol  and  IGF-I  were  not  additive,  suggesting  that  both  factors  
may  be  acting  through  a  common  mechanism.  Wc  decided,  
therefore,  to test  whether  the effect of  estradiol  was  dependent  
on  IGF-I  synthesis.  The  cultures  were  thus  exposed  for 2  days  
to an  antisense  oligonucleotide  to  IGF-I  [12],  Incubation  of  the  
cultures  with  the  antisense  sequence  resulted  in  a  significant  
decrease  in  the  stimulatory  effects  of  17/3-estradiol  on  the  
number  of  neurons  and  the  extension  of  neuronal  processus  
(Fig.  1).  Incubation  of  the  cultures  with  the  sense  oligonucle-
otide  did  not  significantly  affect these  parameters  [12].  
These  results  indicate  that  IGF-I  synthesis  in  the  cultures  is  
necessary  for manifestation  of the sex steroid effect, suggesting 
that  estradiol  may  induce  neuronal  survival  and differentiation 
by  the  activation  of  IGF-I  signaling  cascades.  Several  mecha-
nisms  may  be  envisaged  to  explain  the  interaction  of  estradiol  
and  IGF-I.  For  instance,  it  has  been  shown  that  estradiol  may  
increase  transcription  of  the  IGF-I  gene  by  enhancing  Fos-Jun  
binding to the AP-1 motif  [64]. However, this hormone does not 
appear  to  significantly  affect  IGF-I  synthesis  in  hypothalamic  
cultures  [56],  Alternatively, estrogen  may regulate  IGF-I  recep-
tors or IGFBPs  [56],  In addition,  the interaction  of estradiol  and  
IGF-I  is complicated  by the fact that trophic effects of  IGF-I  on  
hypothalamic  neurons  may  also  be  dependent  on  estrogen  re-
ceptor. 
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FIG.  2.  Effect  of  the  pure  estrogen  receptor  antagonist  ICI  182,780  on  the  
growth  of  MAP-2  immunoreactive  processes  from  hypothalamic  neurons  
in  monolayer  culture.  The  presence  of  ICI  182,780  (10  nM)  in  the  culture  
medium  resulted  in  the  inhibition  of  the  effects  of  estradiol  (10~9  M)  and  
IGF-I  G O - ' '  M).  Asterisks  indicate  significant  differences  (p  <  0.01)  vs.  
cultures  incubated  in  control  medium.  
IGF-I  MAY  ACTIVATE  ESTROGEN  RECEPTORS  IN  
HYPOTHALAMIC  NEURONS  
Recent  studies  indicate  that  IGF-I  [2,26,30,41.51,54]  and  other  
trophic  factors  may  activate  the  estrogen  receptor  in different  cell  
types.  Activation  of  the  estrogen  receptor  appears  to  be  essential  
for  the  mitogenic  effect  of  IGF-I  on  the  prolactin  secreting  pitu-
itary  tumor  cell  line  GH3  [51]  and  for  the  IGF-I-induced  growth  
and  differentiation  of  the  human  neuroblastoma  cell  line  SK-ER3  
[41].  In  uterine  cell  cultures  transfected  with  a  simple  estrogen-
responsive  reporter  gene,  not  only  estrogen,  but  also  IGF-I  is  able  
to  stimulate  estrogen  receptor-mediated  transactivation  and  estro-
gen  receptor  phosphorylation,  suggesting  that  IGF-I  could  be  act-
ing  to  stimulate  estrogen  receptor-mediated  transcription  in  these  
cells  through  direct  modification  of  the  estrogen  receptor  protein  
[2],  Activation  of  the  estrogen  receptor  occurs  in  the  absence  of  
hormone  [2.26,30,41,51,54],  is  mediated  by  the  membrane-asso-
ciated  receptor  tyrosine  kinase-Ras-Raf-mitogen-activated  protein  
kinase  cascade  [30,54],  and  involves  the  activation  function  2  
domain  of  the estrogen  receptor  in neuroblastoma cells  [54], or the 
activation  function  1 domain  in  other  cell  types  [26,30].  
Based  on  these studies,  we decided  to determine  if  the effect of 
IGF-I  on  the  survival  and  differentiation of  hypothalamic  neurons  
was  dependent  on  the  estrogen  receptor.  Hypothalamic  cultures  
were grown for 4 days and then  incubated  with  IGF-I (10 - 9  M) for 
48  h  in  the  presence  of  the  pure  estrogen  receptor  antagonist  ICI  
182.780  (Fig.  2)  or  an  antisense  oligodeoxynucleotide  to  the  es-
trogen  receptor  [12], The estrogen  receptor  antagonist  ICI  182,780  
blocked  the  effects  of  both  estradiol  and  IGF-I  on  neuronal  sur-
vival  and  neuritic  growth  (Fig.  2).  Similar  effects  were  observed  
when  using  an  antisense  oligonucleotide  to  the  estrogen  receptor  
[12],  These  parameters  were  not  significantly  affected,  however,  
by  a  nonsense  control  sequence  [12].  These  results  indicate  that  
estrogen  receptors  are  necessary  for  the  action  of  IGF-I  on  hypo-
thalamic  survival  and  neuritic  growth  [12].  A possible  explanation  
of  these  results  is  that  IGF-I  may  activate,  either  directly  or  
indirectly,  estrogen  receptors  in  hypothalamic  neurons.  
ESTROGEN  ACTIVATION  OF  HYPOTHALAMIC  
ASTROGLIA  DEPENDS  ON  IGF-I  RECEPTORS  
One  of  the  most  prominent  effects of  estradiol  on  the  arcuate  
nucleus  of  adult  rats  is  the  increase  in GFAP  levels  that  occurs  in  
the  afternoon  of  proestrus  |2(),22.34|.  The  estrogen-induced  in-
crease  in GFAP  protein  and  niRNA  levels  during  the afternoon of 
proestrus  is associated  with the redistribution  of astroglia  cytoskel-
etal  components,  the  growth  of  astrocyte  processes,  the  enshealh-
ing of  neuronal  somas  by  glial  processes,  and  the  transient  discon-
nection  of  inhibitory  GABAergic  synapses  from  neuronal  somas  
by  the  interposed  glial  processes  [22],  These  changes  are  also  
elicited  by  the  administration  of  estradiol  to  adult  ovariectomizcd  
rats  [22].  
We  have  recently  tested  whether  astrocyte  activation  by  estro-
gen  in  the  arcuate  nucleus  is dependent  on  IGF-I  (Gareia-Segura  
et  al„  unpublished).  Hypothalamic  tissue  fragments  front ovaricc-
tomized  rats,  which  contained  the  arcuate  nucleus  and  the  median  
eminence,  were  incubated  in  ¡in artificial cerebrospinal  fluid lor 6 h 
in  the  presence  or absence  of  10  12  M estradiol.  Surprisingly,  the  
hormone  did  not  induce  a  significant  increase  in  GI'AP  immuno-
reactive  levels,  which  is  in  contrast  to  what  is  observed  in  vivo  
(Fig.  3). The effect of  the  hormone  was observed,  however,  in  the  
presence  of  insulin (I0~''  M), although  insulin  alone  had  no effect 
on  GFAP  immunoreactivity  (Fig.  3).  Furthermore,  the  effect  of  
estradiol  in  the  presence  of  insulin  was  abolished  when  the  frag-
ments  were  incubated  with  the  specific  IGF-I  receptor  antagonist  
peptide JB1  [55] (1  jug/ml) (Fig. 3). This suggests  that  the effect of 
estradiol  on  arcuate  nucleus  astrocytes,  in  the  presence  of  insulin,  
depends  on  the  activation  of  IGF-I  receptors.  Because  insulin,  at  
concentrations  that act  on  IGF-I  receptors,  was unable  to induce an 
increase  in  GFAP  immunoreactive  levels,  the  activation  of  IGF-I  
receptors  by  itself  is  not  enough  to  stimulate  glial  cells.  This  is  
further support  for the  existence  of  a coordinated  crosstalk  mech-
anism  between  the  IGF-1  and  estradiol  signaling  pathways  in  the  
hypothalamus. 
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FIG.  3. Effect of  estradiol  (E).  insulin  (I) and  the  IGF-1  receptor  antagonist  
JBI  on  GFAP  immunoreactive  levels  in  the  arcuate  nucleus  ofovariecto-
mized  rats  in  vitro.  The  asterisk  indicates  a  significant  difference  vs.  
control  values  (/>  <  0.01).  
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GONADAL  STEROIDS  REGULATE  IGF-I  LEVELS  IN  
HYPOTHALAMIC  ASTROGLIA  
Studies  in  vivo  also  suggest  an  interaction  between  IGF-I  and  
gonadal  steroids  and  that  glial  cells  actively  participate  in  this  
interaction.  Tanycytes,  a  specific  glial  cell  type  present  in  the  
arcuate  nucleus  and  median  eminence,  are  IGF-I  immunoreactive  
11 11.  IGF-I  immunoreactive  levels  in  tanycytes  show  sex  differ-
ences  in  the  rat  arcuate  nucleus,  with  adult  females  showing  
significantly  lower  IGF-I  levels  than  males  of  the  same  age.  This  
sex  difference  is  abolished  by  early  postnatal  androgenization  of  
females  11  I  ], suggesting  that  it  may  be  dependent  on  the  burst  of  
androgen  production  by  the  testis  of  developing  male  rats  that  
occurs  perinatally.  Furthermore,  IGF-I  levels  in tanycytes  increase  
in  both  male  and  female rats  at the time  of  puberty.  Females  show  
an  abrupt  increase  in  IGF-I  immunoreactive  levels  in  tanycytes  
between  the  morning  and  the  afternoon  of  the  first  proestrus.  
Henceforth.  IGF-1  immunoreactivity  fluctuates  according  to  the  
different  stages  of  the  estrus  cycle.  IGF-I  immunoreactive  levels  
are  high  in  the afternoon of proestrus,  after the peak  of  estrogen  in  
plasma,  remain  increased  in the  morning  of  the following day,  and  
then decrease  to basal conditions  by the morning  of metestrus  [11].  
In  addition.  IGF-I  levels  decrease  in  tanycytes  when  gonadal  
steroid  levels  are  reduced  by  ovariectomy  and  increase  in  a  dose-
dependent  manner  when  ovariectomized  rats  are  injected  with  
l7(i-estradiol  [II].  The  changes  in  IGF-I  levels  in  tanycytes  may  
be  related  to  the  endocrine  effects of  IGF-I,  in  particular,  with  its  
effects on  LHRH  secretion  [6.25].  
throughout  the  CNS.  including  tanycytes.  specifically  accumulate  
the  labeled  IGF-I  (Fernandez-Galaz  et  al.,  unpublished).  The  ac-
cumulation  of  IGF-I  was  specific  because  it  was  substantially  
decreased  by  the  administration  of  unlabeled  IGF-I  or  unlabeled  
insulin,  which  also  acts  on  IGF-I  receptors  [38J,  and  was  blocked  
by  the  specific  IGF-I  receptor  antagonist  JB1.  The  distribution  of  
IGF-I  accumulating  cells  varied,  depending  on  the  time  after  the  
intravenous  administration  of  labeled  IGF-I.  By  5  min.  IGF-I  
accumulation  was  observed  in  the  choroid  plexus,  median  emi-
nence, and area postrema, structures  with high  local  levels of  IGF-I  
receptors  [29,39,42,65,66].  By 90  min,  IGF-1 was accumulated  by  
cells  located  in  different  CNS  areas  such  as  the  olfactory  bulb,  
cerebral  cortex,  striatum,  islands  of  Calleja,  hippocampal  forma-
tion,  habenula,  hypothalamus,  midbrain,  cerebellum,  pons,  me-
dulla  oblongata,  and  spinal  cord.  The  time  elapsed  between  the  
intravenous  injection of the peptide  and the  labeling  of  many  brain  
areas  suggest  that  the  peptide  is  first  taken  up  by  areas  devoid  of  
blood-brain  barrier  and  then  released  to  the  cerebral  ventricles.  
IGF-I  may  then  be  accumulated  from  cerebrospinal  fluid  by  spe-
cialized  cells  such  as  tanycytes.  
THE  ACCUMULATION  OF  IGF-I  BY  TANYCYTES  
FLUCTUATES  DURING  THE  ESTROUS  CYCLE  
In  1974, Brawer  et al.  [7] reported  ultrastructural  modifications  
in  the  ventricular  surface  of  tanycytes  in  the  arcuate  nucleus  of  
female rats  at different stages  of  the estrous  cycle.  The  number  of  
TANYCYTES  ARE  INVOLVED  IN  IGF-I  UPTAKE  
FROM  BLOOD  AND  CEREBROSPINAL  FLUID  
Tanycytes  are  specialized  ependymal  cells  that  are  considered  
a  phylogcnetically  primitive  form  of  astroglia  [59],  These  cells  
have  many  ultrastructural  and  immunological  similarities  with  
astrocytes  while  preserving  a  radial  shape  characteristic  of  the  
asimglia  of  submammalian  vertebrates  [15.59].  It  has  been  pro-
posed  that  tanycytes  of  the  arcuate  nucleus  and  median  eminence  
may  be  involved  in endocrine  regulation  [15.19,40,44].  This func-
tion  may  be  mediated  in  part  by  tanycyte  accumulation  of  sub-
stances  from the  cerebrospinal  fluid  or  from the  capillaries  of  the  
median  eminence.  In  agreement  with  this  possibility,  previous  
studies  have  shown  that  tanycytes  are able  to  take  up  /3-endorphin  
from  the  cerebrospinal  fluid  [4],  Furthermore,  tanycyte  processes  
are closely  associated  with  neurosecretory  terminals  in  the  median  
eminence  [35.52].  Encapsulation  of  neurosecretory  terminals  by  
tanycyte  endfeet  may  regulate  neuronal  contact  with  portal  capil-
laries  [32.33.35.45]  and  may  also result  in  a focal concentration  of  
factors,  such  as  IGF-I,  that  may  affect  neurohormone  release.  In  
addition  to  IGF-I,  other  factors  may  be  involved  in  the  endocrine  
effects  of  tanycytes.  For  instance.  Ma  et  al.  [40]  have  reported  a  
marked  increase  in  transforming  growth  factor  (TGF)-a  gene  
expression  in  tanycytes  during  the  initiation  of  puberty  in  the  rat.  
TGI'-a  mRNA  levels  increase  gradually  after the  anestrous  phase  
of  puberty,  reaching  peak  values  on  the  afternoon  of  the  first  
proestrus.  Thus. TGF-a  gene  expression  in  tanycytes  fluctuates  in  
parallel  to the  modifications  of  IGF-I  levels,  suggesting  a  possible  
interdependence  of  these  changes.  
An  interesting  question  in  regard  to  the  hormonal-induced  
changes  in  IGF-I  immunoreactivity  in  tanycytes  is  the  source  of  
this  IGF-I, because tanycytes do not express mRNA for IGF-I  [11].  
The  modifications  in  IGF-I  levels  may  be  the  result  of  the  hor-
monal  modulation  of  its  uptake  from blood  or cerebrospinal  fluid.  
To test for this possibility,  IGF-I  was labeled  with digoxigenin  and  
injected  intravenously  or  in  the  lateral  cerebral  ventricle.  In  both  
cases  we  found  that  various  subsets  of  neurons  and  glial  cells  
FIG. 4. Labeling of tanycytes (arrowheads)  in the arcuate  nucleus of  female 
rats  after the  injection  of  digoxigenin-IGF-1  in  the  lateral  cerebral  ventri-
cle.  (A)  Afternoon  of  proestrus  (B).  Afternoon  of  estrus.  v—Third  ventri-
cle.  Scale  bar.  25  pan.  
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microvilli  increased  during  proestrus  remained  elevated  during  
estrus  and  decreased  in  metestrus.  The  significance  of  these  
changes  is  still  unknown,  but  may  well  be  related  to  the  uptake  of  
substances  from  the  cerebrospinal  fluid.  By  using  colloidal  gold  
ultrastructural  immunolocalization  techniques,  we  have  recently  
observed  that  IGF-I  receptors  are  enriched  in  the  microvilli  of  
tanycytes  (Garcia-Segura  et  al„  unpublished).  Therefore,  changes  
in  the  extension  of  microvilli  may  be  related  to  changes  in  the  
number  of  IGF-I  receptors  exposed  to  the  lumen  of  the  third  
ventricle,  and  this,  in  turn,  may  influence  the  uptake  of  IGF-I  by  
tanycytes.  To  test  whether  IGF-I  uptake  by  tanycytes  fluctuates  
during  the  different  stages  of  the  estrous  cycle,  we  injected  IGF-I  
labeled  with  digoxigenin  in the lateral  cerebral  ventricle  of  cycling  
female  rats.  Six  animals  were  injected for each  day  of  the  estrous  
cycle,  three  of  them  in  the  morning  and  the  other  three  in  the  
afternoon.  Animals  were  killed  1  h  after  the  injection  and  the  
number  of  digoxigenin  labeled  tanycytes  was  counted  [14].  
The  number  of  tanycytes  labeled  with  digoxigenin  showed  
prominent  changes  associated  with  the  different  phases  of  the  
estrous  cycle  (Figs.  4  and  5). Compared  to diestrus  and  metestrus,  
there  was a significant decrease  in the number  of  labeled  tanycytes  
in  the  afternoon  of  proestrus.  A  recovery  was  observed  by  the  
morning  of  estrus  that  was  followed  by  a  significant  increase  by  
the  afternoon  of  estrus.  The  decrease  in  the  number  of  tanycytes  
that  accumulate  digoxigenin-labeled  IGF-I  in  the  afternoon  of  
proestrus was unexpected,  because at this stage of the estrous cycle 
there  is  a  significant  increase  in  IGF-I  immunoreactivity  in  these  
cells [II]. The apparent  discrepancy  may be due to the  competition  
of exogenous  IGF-I  with  increased  endogenous  IGF-I  levels  in  the  
afternoon of  proestrus.  Further  studies  are  necessary  to  determine  
the  cause  of  the  differences observed  in  the  number  of  tanycytes  
that  accumulate  IGF-I  after  its  intracerebroventricular  injection.  
Nevertheless,  these  findings  suggest  that  tanycytes  may  regulate  
the  availability  of  IGF-I  to  hypothalamic  cells.  
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FIG.  5.  Number  of  tanycytes  labeled  with  digoxigenin-IGF-l  during  the  
different  stages  of  the  estrous  cycle.  Data  are  the  number  of  stained  cells  
per  mm  of  the  ependymal  cell  layer  at  the  level  of  the  arcuate  nucleus  in  
the morning  (am)  and afternoon (pm) of  proestrus (P), estrus (E).  metestrus  
(M), and diestrus (D). Asterisks  indicate significant differences (p  <  0.001)  
vs.  the  other  stages  of  the  estrous  cycle.  
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FIG.  6.  Diagram  depicting  the  effects  of  estrogen  and  IGF-1  on  synaptic  
plasticity  in  the  arcuate  nucleus  and  the  interactions  between  tanycytes.  
neurons,  and  astroglia.  According  to this  model, estrogen  may affect  IGF-1  
availability  to  arcuate  neurons  by  regulating  the accumulation  of  IGF-1  by  
tanycytes.  Estrogen  and  IGF-1,  acting  probably  on  neurons,  may  regulate  
neuron  to  astroglia  interactions  involved  in  synaptic  plasticity.  
CONCLUSIONS 
The  data  examined  in this  review  indicate  that  growth  factors,  
such  as  IGF-I,  participate  in  the  effects  of  sex  hormones  in  the  
central  nervous  system.  Gonadal  steroids  regulate  the  levels  of  
IGF-I  in  the  mediobasal  hypothalamus  and  the  signaling  mecha-
nisms  of  estradiol  and  IGF-I  interact  to  induce  trophic  and  devel-
opmental  actions  on  hypothalamic  neurons.  Moreover.  IGF-I  is  
also  involved  in  activational  effects  of  estradiol  on  astrocytes  of  
the  hypothalamic  arcuate  nucleus  of  adult  rats.  Because  activation  
of  astrocytes  by  estradiol  in  the  arcuate  nucleus  is  linked  to  
modifications  in  synaptic  connectivity,  these  findings  suggest  that  
IGF-I  may  be  involved  in  estrogen  effects  on  synaptic  plasticity.  
This  is further supported by the fact that the modifications in  IGF-I  
levels  in  the  arcuate  nucleus  of  adult  females  during  the  estrous  
cycle  correlate  with  plastic  changes  in  synaptic  connectivity.  
Moreover.  IGF-I  in  the  arcuate  nucleus  of  adult  rats  appears  to  be  
originated,  at  least  in  part,  in extrahypothalamic  areas.  Tanycytes.  
a  specialized  form  of  hypothalamic  astroglia,  may  play  a  crucial  
role  in  the  local  effects of  this  factor  by  regulating  its  availability  
to  hypothalamic  cells.  In  summary,  IGF-I  and  different  forms  of  
glia  to  neuron  communication  appear  to  be  involved  in  the effects 
of  gonadal  hormones  on  the  neuroendocrine  hypothalamus.  A  
diagram  depicting  the  interactions  between  these  various  compo-
nents  is  shown  in  Fig.  6.  According  to  this  model,  estrogen  will  
regulate  IGF-I  levels  in the arcuate  nucleus  by acting on  tanycytes.  
IGF-I  may  then  affect  estrogen-induced  neuron  to  astrocyte  sig-
naling  mechanisms  involved  in  synaptic  plasticity.  
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Abstract 
The actions of nitric oxide (NO) on gastrointestinal plasma loss, assessed by the leakage of [l23I)huntan serum albumin, provoked by 
intraabdominal surgery and organ manipulation has been investigated  in pentobarbitone-anaesthesized  ruts. Gentle manipulation (3  min)  
of  the stomach or the  small  intestine  following laparotomy leads  to  an  increase  in  albumin extravasation  in  the  stomach,  riwytenum,  
jejunum and colon over  1  h.  Administration  of  the  NO synthase inhibitors,  /Vc-imro-L-arginine  methyl  ester (1-5  mg kg"'.  s.c.) and 
<Vc-monomethyl-L-arginine (12.5-50 mg kg'1, s.c.). provoked a further substantial elevation of gastrointestinal albumin extravasation in 
the surgically manipulated rat. but not in  control rats. This effect could be prevented by the pretreatment (15 min) with L-arginine (300 
mg kg'1.  s.c.) or by the concunent  infusion of  the NO donor.  5-nitroso-glutathione (5 |ig kg"'  min'"1,  I.v.).  Endogenous NO, most 
likely formed by endothelial NO synthase, thus appears to maintain microvascular integrity during surgery and organ manipnlntjnn of the 
gastrointestinal tract. ©1999 Elsevier Science B.V.  All rights reserved. 
Keywords:  Nitric oxide (NO) endothelial; Vascular permeability; Gastrointestinal tract; Surgery; Plasma lost; Microcirculation 
1. Introduction 
Experimental  and  clinical  studies  have  shown  that  a  
reduction in circulating plasma volume can occur during or 
following  major  surgical  intervention  (Jamum,  1961;  
Krakelund,  1971; Robarts,  1979; Akerstrom and Lisander, 
1991).  However,  there  is  no  clear  understanding  of  the  
mechanism  of  such  plasma  extravasation  associated  with  
surgical  manipulation  or  the  processes  that  regulate  it  
'Akerstrom and Lisander,  1991).  
Nitric oxide (NO), formed continuously  in the vascular  
Endothelium and  in  neuronal  elements  by  the  constitutive  
40  synthase  (endothelial  NO  synthase  and  neuronal  NO  
synthase, respectively), plays a key role in the maintenance 
if  microvascular  integrity  under  physiological  circum-
sances (Moncada et al..  1991; Moncada and Higgs,  1995).  
lowever, under pathological conditions (such as following 
ndotoxin  or cytokine administration),  the  widespread  ex-
ression  of  the  inducible  NO synthase  can  be  detected  in  
Corresponding  author.  Fax:  +1-44-171-982-6177;  E-mail:  
j.whittle@mds.qmw.ac.uk 
many  cell  types  including  the  vascular  endothelium,  neu-
trophils,  macrophages  and  intestinal  epithelial  cells  which  
leads  to the  overproduction of  NO (Moncada et al.,  1991;  
Moncada and Higgs,  1995).  
The  expression  of  inducible  NO  synthase  provokes  
microvascular  leakage of albumin  into  gastrointestinal  tis-
sues  following  endotoxin  administration  (Boughton-Smith  
et  al.,  1993).  Moreover,  the  selective  inhibition  of  in-
ducible NO synthase by the bislsothiourea derivative,  1400  
W, protects  the microvasculature  against  such plasma loss 
(László and Whittle,  1997). Thus, the uncontrolled produc-
tion  of  NO  under  pathological  conditions  is  detrimental  
towards  the  vascular  endothelium,  which  may  involve the 
generation  of  such  tissue  damaging  radicals  as  the  hy-
droxyl  and  peroxynitrite  (Beckman  et  al.,  1990;  Hogg  et  
al..  1992; Lipton et al.,  1993).  
In  contrast,  the  physiological  generation  of  NO  by  
endothelial  NO  synthase  has  beneficial  microcirculatory  
effects. Thus,  inhibition of endothelial  NO synthase by the 
administration  of  the  nonselective  NO  synthase  inhibitor,  
N°-nitro-L-arginine  methyl ester  (L-NAME) or N°-mono-  x ,  
methyl-L-arginine  (L-NMMA), provokes intestinal albumin 
leakage  following challenge  with  low  doses of  endotoxin.  
114-2999/99/$ - see front matter ©  1999 Elsevier Science B.V. All rights reserved. • 
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under conditions where neither endotoxin nor NO synthase 
inhibitors alone affected microvascular albumin  extravasa-
tion  (László  et  al..  1994a).  Furthermore,  L-NMMA  aug-
mented  gastrointestinal  microvascular  damage  induced  by  
high doses of endotoxin (Hutcheson et al..  1990). Constitu-
tive NO synthase has a beneficial role during the  initiation 
of  intestinal  inflammation, since  its  inhibition  in  the early 
phase  of  various inflammatory  bowel  disease  models  pro-
vokes  or  augments  microvascular  leakage  (Kiss  et  al..  
1997; László and Whittle,  1998).  
Endogenous NO attenuates the adherence and immigra-
tion of  leukocytes  in  the  vascular  endothelium  (Kubes  et  
al.,  1991). actions that have key importance in the genera-
tion of  vascular permeability  and inflammation (Wedmore 
and  Williams.  1981).  Indeed,  administration  of  inhibitors  
or  antagonists  of  such  neutrophil-derived  mediators  as  
platelet-activating factor, thromboxanes and Ieukotrines at-
tenuated  intestinal  microvascular  injury  provoked  by  the  
inhibition of endothelial NO synthase in the early phase of 
experimental  sepsis and  intestinal  inflammation (László et 
al..  1994b: László and Whittle.  1998).  
In  a  recent  study,  following  the  administration  of  the  
N O  synthase inhibitors. L-NAME  or L-NMMA.  abdominal  
laparotomy produced a significant elevation in microvascu-
lar leakage in the jejunum and colon over  1 h (László and 
Whittle,  1999). These NO synthase inhibitors had no such 
effect  in  conscious,  anasthesized  or  skin-incised  rats.  In  
addition, no significant difference in  albumin  leakage  and 
accumulation  was  observed  in  tissues  from  unoperated  
conscious  or  anaesthesized  rats,  or  in  anaesthesized  rats  
with a skin-incision or abdominal laparotomy under resting 
conditions, showing that these minor surgical interventions 
alone do not provoke changes in microvascular permeabil-
ity to albumin. 
In  many  studies  on  the  microcirculation,  the  tissues  
under investigation are exposed by laparotomy.  Moreover,  
in  such  studies,  the  organs  such  as  those  of  the  gut,  are  
further  manipulated  or  exteriorised,  to  expose  a  suitable  
region for the observation. Thus,  in the present  study,  we  
have now extended the findings with laparotomy  alone, to 
evaluate  the  effects  of  abdominal  surgery  with  gentle  
manipulation  of  the  gastrointestinal  organs  on  vascular  
permeability,  and to study  the effects of  inhibitors  of  NO  
synthase. 
2. Materials and  methods  
2.1. Surgical manipulation 
Male  Wistar  rats  (225-275  g)  were  fasted  overnight,  
but  allowed  for  free  access  to  water.  The  animals  were  
separated into two groups: 
In  the control  group,  the  animals  were  deemed  to  be  
conscious  for the  majority  of  the  experimentation  period,  
since  the  treatments  were  performed  under  transient  
halothane  anaesthesia  from  which  the  animals  had  com-
pletely recovered within 2 nun.  Autopsy  in this group \ 
performed under haiotlianr  anaesthesia  within  1  min.  
In the laparotomy and oigun manipulated groups (tern 
surgical  manipulation),  the  animals  received  pentobai  
tone  (60  mg  kg~':  i.p.)  t** induce  anaesthesia  and  wc  
tracheotomized.  A  .5-cin-long  midline  laparotomy  in  i  
abdominal  wall  was petforined,  without  significant blec 
ing. In the manipulated  group, part  of  the small bowel w; 
exteriorised  and  gently  handled  for 3  min  in  a  5 X 5 ci 
gauze pad moistened in  37°C- saline. The bowel was placi 
back  into  the  abdominal  cavity,  and  n  gauze  moistene  
with saline was placed over the  incision for the protectio 
against evaporation. Those rats  who had  significant bleec 
ing  were  excluded  from  the  siudy.  In  all  of  the  anaes  
thetised  groups,  the  body  temperature  was  maintained  oi  
36.5-37°C  using a  homeothermic  control  unit  and under  
blanket (Harvard  Instruments).  
[>3SI]human  serom  albumin  (2  p.Ci  kg"1,  i.v.)  war  
administered  via  a  needle  inserted  into  the  tail  vein,  am 
autopsy  was  performed  1 h  later,  he.,  the  time-interval  
between  the  start  of  surgical  procedures  and  autopsy  was  
60  min.  The  1  h  maximum  timepoint  was  chosen  to  
exclude  the  involvement  of  inducible  NO  synthase,  that  
requires 2-3  h  following  challenge  for  expression,  since  
this  could  modify  vascular  leakage  and  hence  confound  
interpretation of the findings (Doughton-Smith et al.. 1993). 
2.2. Plasma leakage 
As a measure of vascular endothelial permeability, leak-
age  of  [i:sI]human  serum  albumin  into  tissue  was  deter-
mined  in  segments  of  the  stomach,  duodenum,  jejunum 
and colon.  Blood  was collected  from the  abdominal  aorta  
into syringes containing  trisodium  citrate (final concentra-
tion 0.318%)  and  centrifuged (10,000 Xg,  10  min.  4°C>.  
The [i:5I]human serum albumin content  of  the plasma and 
segments  of  tissues  was  determined  in  a  gamma-spec-
trometer  (Nuclear  Enterprises  NE  1600) and  the  albumin  
content  in  tissues  was  calculated.  The  control  value  for  
albumin accumulation was taken as the mean of the data of 
a  group  of  control  unanaesthesized  animals,  which  re-
ceived  albumin  only,  which reflect» basal  albumin  move-
ment  into  tissues.  This  basal  control  mean  value  was  
calculated  and subtracted  from the  value from each  of  the 
animals  in  each  experimental  group.  The  data  were  ex-
pressed  as  changes  in  albumin  accumulation  (A  plasma  
leakage,  p.1 plasma g~'  tissue), corrected for intravascular 
volume  as  described  previously  (Boughton-Smith  et  al..  
1993; László et  al.,  1994a).  
2.3.  Effect  of  L-NAME  and  t.-NMMA  on  gastrointestinal  
plasma leakage 
In a set  of rats from each  of  the groups, L-NAME  (1-5 
m g  k g " 1 ,  s.c.)  or  L-NMMA  ( 1 - 5 0  mg  k g " ' ,  s.c.)  was  
injected  concurrently  with  l,25I]human  serum  albumin.  
Plasma  leakage  in  the  jejunum  and  colon  was  evaluated  
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after  1  h.  In  a  separate  group,  rats  were  pretreated  with  
L-arginine  (300  mg k g - 1 ,  s.c.)  15  min  before  L-NAME  (5  
mg kg"1 ,  s.c.)  administration,  and  gastric,  duodenal,  jeju-
nal  and  colonic  plasma  leakage  was  determined  1  h  after  
L - N A M E . 
2.4.  Effect  of  S-nitroso-glutathione  on  gastrointestinal  
plasma  leakage  
In surgically  manipulated  rats,  infusion  of  the NO  donor  
5-nitroso-glutathione  (5  p.g kg"1  min" ' )  into  the  tail  vein  
was  commenced  concurrently  with  the  administration  of  
L-NAME  (5  mg  kg"1 ,  s.c.).  Plasma  leakage  in  the  stom-
ach. duodenum, jejunum and colon  was  measured  1 h  later.  
2.5.  Chemicals  
['"Ijhuman  serum  albumin  was  obtained  from  Amer-
sham International (UK) and IZINTA (Budapest,  Hungary).  
All  the  other  compounds  were  from Sigma  (Poole,  Dorset,  
UK). 
2.6.  Statistics  
The  data  are  expressed  as  mean  ±  S.E.M.  from  (n)  rats  
per experimental  group.  For  statistical  comparisons,  analy-
sis  of  variance  with  the  Bonferroni  test  was  utilised,  where  
P  <  0.05  was  taken  as  significant  
3.  Results  
3.1.  Effect  of  surgical  manipulation  on  gastrointestinal  
plasma  leakage  
Abdominal  surgery  and  gentle  manipulation  of  the  or-
gans  provoked  significant  albumin  leakage  into  the  gastric  
and  duodenal  tissue  (Fig.  1),  and  jejunal  and  colonic  
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Fig.  1.  leakage  of  radiolabeled  albumin  (expressed  as  A  albumin  
leakage,  p.1 g"1  tissue) provoked  by intraabdominal  surgery and manipu-
lation  in  the  stomach  and  duodenum  of  the  rat,  and  its  aggravation  by  
iV°-Qitro-L-arginine  methyl  ester  (l-NAME,  5  rag kg"',  s.c.).  Data  are  
shown  as  the  mean ± SiLM.,  where  (n)  is  8-12  for  each  group,  and  
where  statistical  significance  is  given  as  *P  < 0.05  compared  to  con-
scious untreated  groups.  
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Fig.  2.  Leakage  of  rodiolabelled  albumin  (expressed  as  A  albumin  
leakage.  g" '  tissue) provoked  by  intraabdominal  surgery and manipu-
lation  in  the  jejunum  and  colon  of  the  rat,  and  its  aggravation  by  
Nc-nitro-L-arginine  methyl  ester  (L-NAME,  5  mg kg"' ,  s.c.).  Data  are  
shown  as  the  mcan±S.EA1„  where  (n)  is  8-12  for  each  group,  and  
where  statistical  significance  is  given  as  * P < 0.05  compared  to  con-
scious  untreated  groups.  
tissues  (Fig.  2)  over  1  h.  compared  with  the  control  
(resting)  albumin  extravasation  in  the  stomach,  duodenum,  
jejunum  and  colon  of  the  conscious  rat. The  control  values  
of  plasma leakage  are 51  ±  3.  118  ±  5,  136  ±  8 and 52  ±  7  
| i l  g"1  tissue,  respectively,  over  this  1 h  period.  
3.2.  Effect  of  L-NAME  or  L-NMMA  on  gastrointestinal  
plasma  leakage  following  surgical  manipulation  
In  conscious  unoperated  control  rats,  administration  of  
the  NO  synthase  inhibitor,  L-NAME  (5  mg  kg" 1 ,  s.c.)  did  
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Fig.  3.  Leakage  of  radiolabeled  albumin  (expressed  as  A  albumin  
leakage,  p.1 g"1  tissue) provoked  by  Intraabdominal  surgery  and manipu-
lation  in  the  colon  of  the  rat,  and  Its  dose-dependent  aggravation  by  
Nc-nitro-L-arginine  methyl  ester  (l-NAME.  1-5 rag kg"' ,  s.c.)  and by 
Nc-monomethyl-L-arginine  (i.-NMMA.  12.5-50  mg kg - 1 ,  s.c.).  Data are t  j  
shown  as  the  mean ± S . E . M . ,  where  (n)  is  6-12  for  each  group,  and  
where  statistical  significance  is  given  as  * P < 0.05  compared  to  the  
surgically  manipulated  control  (Cont.) groups. 
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Fig.  4.  Leakage  of  radiolabeled  albumin  (expressed  as  A  albumin  
leakage,  p.1 g "1  tissue) provoked by intraabdominal  surgery  and manipu-
lation  in  the  stomach,  duodenum, jejunum  and  colon  of  the rat  (opened  
columns),  and  its  aggravation  by  /Vc-nitro-L-arginine  methyl  ester  (L-
N A M E ,  5  mg kg - 1 ,  sx.,  grey  columns).  Inhibition  of  albumin  leakage  
provoked by L - N A M E  in the surgically manipulated rat (hatched columns) 
by  S-nitroso-giutathione  infusion  (5  fig  kg"'  min -1 ,  ¡.v.).  Data  are  
shown as the mean±S.E.M..  where (n)  is 6-9 for each  group, and where 
statistical  significance is given as*P  < 0.05 compared to the intraabdom-
inal  surgery  alone (open  columns)  groups.  
not  affect  plasma  leakage  over  1  h  in  the  gastric  and  
duodenal  tissue  (Fig.  1),  or  in  jejunal  and  colonic  tissues  
(Fig.  2).  
In  surgically  manipulated  rats,  administration  of  NO  
synthase  inhibitors.  L-NAME  ( 1 - 5  mg  k g - 1 ,  s.c.)  or  L-
NMMA  (12 .5 -50  mg  kg" 1 ,  s.c.)  provoked  a  further  dose-
dependent  increase  in  plasma  leakage  over  1  h  in  the  
stomach  and  duodenum  (Fig.  1),  in  the  jejunum  (Fig.  2)  
and  in  the  colon  (Figs.  2  and  3).  This  augmentation  of  
gastrointestinal  plasma  leakage  was  inhibited  near-maxi-
mally  with  L-arginine (300  mg kg"' ,  s.c.)  pretreatment  (15  
min before L-NAME)  by  100  ±  12%, 90  ±  10%,  91  ±  21%  
and  92  ±  19%  in  the  stomach,  duodenum,  jejunum  and  
colon,  respectively  (N  — 4—6,  P  <  0.005).  
3.3.  Effect  of  S-nitroso-giutathione  on  gastrointestinal  
plasma  leakage  
Intravenous  infusion  of  the  NO  donor,  S-nitroso-
glutathione  (5  |xg  kg"1  m i n - 1  for  1  h)  abolished  the  
increase  in  gastric,  duodenal,  jejunal  and  colonic  plasma  
leakage  induced  by  L-NAME  (5  mg  kg" 1 ,  s.c.)  in  surgi-
cally  manipulated  rats,  as  shown  in  Fig.  4.  
4.  Discussion  
In  this  present  study,  an  increase  in  vascular  permeabil-
ity  has  been  observed  in  gastric,  duodenal,  jejunal  and  
colonic  tissues  in  rats  that  had  undergone  intraabdominal  
surgery  and  gentle  manipulation  of  the  gastrointestinal  
tissues.  Our  study  confirms  previous  findings  in  which  it  
has  shown  that  abdominal  surgery  itself  provoked  an  
vation  of  vascular  peimeiibllliy  in  ints  (Akerstrom  
Lisander,  1991).  The  incieuse  ¡n  albumin  extravasa  
under the  current  condition«  is  a consequrnce  of  the  gei  
manipulation  since  il  hu« been  demonstrated  that  the  mi  
surgical  procedures  of  iiacheotomy,  incision  of  the  abdi  
inal  skin  or  abdominal  laparotomy  alone  did  not  prove  
albumin  leakage  in  the  nnnesthr-Uscit  fM (László  and  Wli  
tie,  1999).  Thus,  it is  feasible  that  our model  is  appropn  
for  the  investigation  of  the  mechanisms  of  plasma  I*  
during  surgical  proccduies.  
Administration  of  the  NO  synthase  inhibitor,  L-NAN  
in  conscious  unoperaied  rat«  did  not  uffect  basal  album  
extravasation  within  the  1  h  period,  which  is  consistc  
with  our  previous  findings  (László  et  ul„  1994a,b).  Hoi  
ever,  when  the  NO  synthase  inhibitors  were  administer  
in  rats  with  surgery  and  tissue  manipulation,  a  furtlv  
increase  in  gastrointestinal  vascular  permeability  occurrc  
The  actions  of  L-NAME  could  he  reversed  by  L-arginii  
pretreatmenL  It  is  likely  that  actions  of  endothelial  N  
synthase  involved,  since  previous  studies  have  demoi  
strated  that  a  minimum  of  2  h  am  needed  for  the  expre  
sion  of  the  inducible  NO  synthase  (Doughton-Smith  et  al  
1993),  while  in  our  current  model,  the  experimental  perio  
has  been  only  1  h.  On  the  basis  of  our  present  data,  i  
appears  that  NO  produced  by  endothelial  NO  synthas  
modulates  the  changes  in  vascular  permeability  durin  
surgical  challenge.  Such  events  include  abdominal  laparo  
tomy  itself  (László  and  Whittle,  1999)  and  subsequen  
organ  manipulation.  Thus.  NO  generated  by  endothelia.  
NO  synthase  may  play  a  protective  role  in  the  microcircu  
lation  against  endothelial  dysfunction  and  the  consequent  
plasma  loss  during  and  following  surgical  operations.  
Physiologically  formed  NO  might  protect  the  microcir  
culation  by  preventing  the  deleterious  actions  of  neu  
trophils  towards  the  vascular  endothelium  during  surgical  
procedures.  Polymorphonuclear  leukocytes  are  well-known  
to  play  a  crucial  role  in  the  changes  in  microvascular  
permeability  during  inflammatory  processes  leading  to  tis-
sue  oedema  (Wedmore  and  Williams.  1981).  Administra-
tion  of  L-NAME  enhances  the  adhesion  of  leukocytes  to  
the  vascular  endothelium,  assessed  by  in  vivo  microscopy  
in  surgically  prepared  animals  (Kubes  et  al.,  1991;  Arndt  
et  al.,  1993).  In  a  recent  study,  the  increase  in  plasma  
leakage  by  L-NAME,  in  rats  with  abdominal  laparotomy  
alone,  was  abolished  by  the  pretreatment of  a  rabbit  anti-rat  
neutrophil  serum  suggesting  the  involvement  of  neu-
trophils  in  these  events  (László  and  Whittle,  1999).  Thus,  
endogenous  NO  formed  by  endothelial  NO  synthase  may  
counteract  to  the  effects  of  neutrophil-dcrived  mediators  
which  are  released  in  response  to  surgical  trauma.  
In  our  present  study,  administration  of  the  NO  donor,  
S-nitroso-giutathione  attenuated  plasma  extravasation  pro-v  
voked  by  L-NAME  and  surgical  manipulation.  This  protec-
tion  by  the  NO  donor  may  involve  actions  on  neutrophils,  
since  NO  decreases  neutrophil  function  and  their  adhesion  
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to the vascular endothelium both in vivo and  in vitro (Ma 
et al..  1993;  Moilanen  et  al..  1993;  Granger  and  Kubes.  
1994). 
Our present results thus suggest that the minor surgical 
intervention  of  opening  the abdominal  cavity  and a gentle 
handling  of  the  stomach  or  the  small  intestine  lead  to  
microvascular  changes  in  these  tissues.  This  process  ap-
pears  to  be  modulated  by  NO.  since  inhibition  NO  syn-
thase substantially increased plasma extravasation from the 
gastrointestinal organs under these conditions. The mecha-
nisms underlying this apparent  microvascular  priming  are  
unknown, but may reflect neuronal or humoral  stimulation 
as  a  consequence  of  the  surgical  stress,  as  well  as  the  
activation  of  the neutrophil. The current  data  suggest  that  
should  NO  formation  be  compromised  during  surgical  
procedures,  plasma  and  fluid  loss  would  be  augmented,  
events  which  could  lead  to  hypovolemia,  as  well  as  
oedema formation and a decreased tissue oxygenisation. It 
is  possible  therefore  that  administration  of  NO  donors  
during  major  surgical  interventions  may  be  beneficial  in  
preventing  any  subsequent  vascular  endothelial  dysfunc-
tion  and the consequent plasma loss. 
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Abstract — The actions of the female sex steroid, oestradiol on cysteamine-induced mucosal ulceration has been evaluated  in female 
Wistar  rats.  Administration  of  cysteamine  (400 mg-kg"1,  s.c.)  provoked  macroscopic  gastroduudenal  nuietisal  injury  (assessed  
planimetrically) and an increase in microvascular permeability  (assessed by the extravasation of radiolabeled albumin) in the stomach 
and  duodenum,  determined  24 h  later.  Ovariectomy  (2  weeks  before  cysteamine)  reduced  gastroduoilcnal  macroscopic  injury, and 
albumin  extravasation  following cysteamine  challenge. Administration  of  oestradiol  (1-5 mg-kg-1,  as  an  l-m.  depot  I  week  before  
cysteamine) dose-dependently augmented gastric and duodenal macroscopic mucosal lesions and microvascular pemirabiliiy provoked 
by  cysteamine.  These findings indicate  that  oestradiol  can  exacerbate  gastroduodenal  ulceration  and  miciovasculoi  injury. ©  1999  
Elsevier Science Ltd. Published by Éditions scientifiques et  médicales Elsevier SAS 
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1. Introduction 
On the basis of experimental  and clinical  observa-
tions, it is known that ulceration of the gastroduodenal 
mucosa shows sexual dimoiphism. Thus, in the fertile 
age,  peptic  ulcer  disease  occurs  more  frequently  
among men than women [2]. In experimental  models  
of mucosal damage, this sexual difference  of mucosal 
injury  has  also  been  found.  Oral  administration  of  
ethanol  caused more severe  gastric mucosal  erosions  
in  male rats  than in  females [8, 9]. In  this  model  of  
mucosal damage, gonadectomy protected the stomach 
against ethanol-induced injury in male rats [8]. More-
over,  administration  of  the  testosterone-synthase  in-
hibitor,  cyproterone acetate attenuated gastric hemor-
rhagic  erosions  in  intact  male rats  following ethanol 
challenge [8], and reduced gastric lesions and duode-
nal  ulceration  provoked  by  cysteamine [11].  Such  
findings  suggest that endogenous sex hormones might 
possibly  play  a  role  in  the  development  of  gas-
troduodenal mucosal ulceration. 
The  aim of  the present  study  was to  evaluate  the  
actions  of  the  female  sex  steroid,  oestradiol  on  the  
generation  cysteamine-induced  gastroduodenal  ulcer-
ation in the rat. Thus, in female rats, we examined the 
effects of ovariectomy and oestradiol on the severity of 
macroscopically  detectable  lesions  as  well  as  the  
changes in microvascular permeability in the stomach 
and duodenum provoked by cysteamine. 
* Correspondence and reprints 
2. Materials and methods 
2.1. Experimental protocol 
Female Wistar rats (200-220g)  were injected with 
cysteamine  (400mg kg~,f  s.c.).  TWcnty-four  hours  
after  cysteamine  administration,  tlic  animals  were  
killed by ether overdose, and their stomach and duode-
num were removed. During this 24-h period, rats were 
deprived  of  food, but  received  water  ad  libitum. For 
the determination  of  plasmu  leakage,  ,25Mnbclcd  hu-
man serum albumin ([,25I]-H{SA, 2 pCi kg"1. i.v.) was 
administered 2h  before  autopsy.  In  some  groups  of  
rats, ovariectomy was performed under ether anaesthe-
sia 2  weeks  before any  experimental  procedure.  For  
additional  groups of rats, a  depot  injection of oestra-
diol  (1-5 mg-kg-1,  i.m.)  were  administered  1 week 
before cysteamine challenge. 
2.2 Macroscopic evaluation of lesions 
The area of damage and the total mucosal snrfnee-of 
the stomach and duodenum were measured by a digital 
planimeter  (Sokkia  Planimeter  KT-82-N,  Japan),  and 
the  injured area  was  expressed  as  percentage  of  the  
total mucosal surface. 
2.5. Albumin leakage 
Leakage of [125I]-HSA was-determined in the stom-
ach  and  duodenum  as  an  index  of  microvascular  
damage.  Blood  was  collected  from  the  abdominal  
aorta into syringes  containing  irisodinin  citrate (final 
492 Szepes  et  al.  
concentration  0.318%)  and  centrifuged  (10 000  g,  
10 min,  4  °C).  The  [125I]-HSA  content  of  the  plasma  
and  segments  of  gastric  and  duodenal  tissue  was  
determined  in  a gamma-spectrometer  (Nuclear  Enter-
prises  NE  1600)  and  the  albumin  content  in  the  
stomach and duodenum calculated,  taking into account 
any  changes  in  gastroduodenal  blood  volume  as  de-
scribed  previously  [4],  Values  from  control  tissues  
were  subtracted  from  the  values  of  treated  tissue  and  
the  data  were  expressed  as  plasma  leakage,  pL  
plasma g - 1  wet  tissue.  
2.4.  17-f-oestradiol  plasma  level  
Plasma  17-P-oetradiol  levels  were  determined  after  
ovariectomy  by  a  radioimmuno-assay  method  de-
scribed  previously  [8].  
2.5.  Materials  
[125I]-labeled  human  serum  albumin  was  obtained  
from Izinta  (Budapest,  Hungary).  Oestradiol  benzoate  
was  purchased  from  Intervet  International  (Boxmeer,  
the  Netherlands).  All  other  compounds  were  from  
Sigma  Chemical  Company.  
2.6.  Statistical  evaluation  
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The  data  are expressed  as  mean ±  SE  from  (n)  rats  
per  experimental  group.  For  statistical  comparisons,  
Student's  /-test  test  for  unpaired  data  or  analysis  of  
variance  with  the  Bonferroni  test  were  used,  where  
P  < 0.05  was  taken  as  significant  difference.  
3.  Results  
3.1.  Gastroduodenal  ulceration  provoked  by  
cysteamine 
Administration  of  cysteamine  (400  mg-kg"1,  s.c.)  
provoked macroscopic  injury  in the gastric  and duode-
nal  mucosa  (4.5 ±0.6%  and  12.9+1.0%  of  total  
mucosal  area, respectively;  n  =  7,  P  < 0.001)  as  shown 
in  figure  1.  Cysteamine  challenge  also  increased  mi-
crovascular  permeability  in  the  stomach  
(A57  ±  9  pL-g  tissue,  n  -  7,  P  < 0.001)  and  duode-
num  (A 155 ±  6  pL-g"1  tissue;  n  =  7,  P<  0.001)  after  
24  h,  as  shown  in  figure  2.  
3.2.  Effects  of  ovariectomy  
Ovariectomy  (2  weeks  before  cysteamine  chal-
lenge)  decreased  plasma  17-(3-oestradiol  level  (from  
182 ± 1 0  to  87 ± 5  pmol-L-1,  n  =  6).  Ovariectomy  
significantly  lowered  the  gastric  and  duodenal  macro-
scopic  mucosa]  injury  provoked  by  cysteamine  (by  
Figure  1.  Induction  of  rat  gastric  and  duodenal  mucosal  
macroscopic  injury  by  cysteamine  (Cyst.  400 mg-kg"',  s.c.)  
after 24 h. The  inhibition  of  cystcamine-induced  damage  by  
ovariectomy  (Ovar.,  2  weeks  before  cysteamine  challenge)  
and  the  potentiation  of  cysteamine  provoked  mucosal  le-
sions  by  oestradiol  (1-5 mgkg-'weck - 1 ,  i.m.)  pretreatmcnt  
is  shown.  The  columns  show  the  extent  of  gastric  and  
duodenal  macroscopic  lesions  (expressed  as  lesion  area,  
percentage total  mucosal  area).  Data are given as the mean ± 
SE of 4-7  rats per group; statistical  significance is shown  as  
*P  < 0.05,  inhibition  of  cystcainine-induced  lesion;  
*P  < 0.05,  potentiation  of  cysteamine  induced  lesion.  
62 ± 1 3 %  and  65 ±15%,  respectively;  P<  0.001,  
n  =  5)  as  shown  in  figurr  1.  Ovariectomy  likewise  
attenuated albumin extravasation  in  the gastric  mucosa  
and  duodenum  provoked  by  cysteamine  (by  63 ±  19%  
and 65 ±  7%,  respectively;  P  < 0.001, n  =  5)  as  shown  
in  figure  2.  
3.3.  Effects  of  oestradiol  
Administration  of  oestradiol  (1-5  mgkg _ I week _ 1 ,  
i.m.)  to  unopcrated  rats  dosc-dependently  augmented  
gastric  and  duodenal  macroscopic  mucosal  lesions  
induced  by  cysteamine  (by  138 ±35%  and  by  
114 ±  23%,  respectively;  P  <  0.001,  n  =  4).  This  treat-
ment  also  increased  the  microvascular  injury  in  the  
stomach  and  duodenum  (by  182 ±59%  and  by  
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Figure  2.  Induction  of  rat  gastric  and  duodenal  vascular  
leakage  of  plasma  (determined  using  radiolabeled  albumin)  
by  cysteamine  (Cyst.,  400mg-kg~',  s.c.)  after  24 h.  The  
inhibition of cysteamine-induced plasma leakage by ovariec-
tomy  (Ovar.,  2  weeks  before  cysteamine  challenge)  and  
potentiation  of  cysteamine-provoked  plasma  leakage  by  
oestradiol (1-5 mg-kg-'-week-1, i.m.) pretreatment  is shown. 
The  columns  show  the  leakage  of plasma  (A  pL-g"1  tissue)  
in gastric and duodenal tissues. Data are given as the mean  ±  
SE of  4—7  rats per group;  statistical  significance is shown  as  
*P  < 0.05, inhibition of cysteamine-induced  plasma  leakage;  
*P < 0.05,  potentiation  of  cysteamine-induced  plasma  leak-
age. 
38 ±5%,  respectively;  P  < 0.01,  n  =  4)  provoked  by  
cysteamine  (figures  1  and 2,  respectively).  
4.  Discussion  
This  study  in  female  rats  following  ovariectomy  
extends  the  previous  observations  in  males  that  fol-
lowing  gonadectomy  the  gastroduodenal  mucosa  is  
less  sensitive  to  various  ulcerogenic  stimuli  [8,  11].  
The  reduction  by  ovariectomy  of  cysteamine-induced  
ulcers  of  the  stomach  and  duodenum  could  be  related  
to  the  observed  decrease  of  plasma  oestradiol  levels.  
Indeed,  mucosal  damage  in response  to challenge  was  
increased  by  exogenous  administration  nt  oestradiol  
into  intact  female  rats.  
It  is  known  that  an  increase  <•! gastric  pnrielul  cell  
mass  has  a  beneficial  action  ngainsi  (he  development  
of  mucosal  lesions  following  ulcerogenic  challenge  
and accelerates  ulcer healing  |6, 7|.  Since  ovariectomy  
enhances  gastric  parietal  cell  mass 1 1 t h i s  proccss  
may  contribute  to  the  mcchanisn'  by  which  ovariec-
tomy  protected  the  mucosa  against  cysteamine-
induced  injury.  Other  factois  ate  also  likely  to  be  
involved  in  the  apparent  nggicssive  actions  of  oestra-
diol  towards  the  gastroduodenal  iiiucosu.  Tints  admin-
istration  of  oestrogens  can  lead  to  the  inactivallon  of  
prostaglandins  in  the  stomach  [5],  and  piostuglandins  
are  known  to  have  key  importance  jn  the  defense  
mechanism  of  the  gastroduodenal  mucosa  113,  16].  
Here,  cysteamine  challenge  also  piovokcd  mi-
crovascular  plasma  leakage,  as  a  measure  of  vascular  
endothelial  damage.  This  finding  is  in  agreement  with  
the  previous  suggestion  that  aggressive  vascular  fac-
tors  are  involved  in  the  generation  of  eystcainine-
induced  gastroduodenal  ulcers  13],  It  is  well-
established  that  microcirculatory  injury  and  the  
consequent hypoxia  arc among  those  important  factors  
which  are  considered  to  lead  to  gastroduodenal  mu-
cosal  ulceration  [14,  15].  As  with  the  tuucioscopic  
injury,  in  our  present  work,  the  reduction  in  endog-
enous  oestradiol  synthesis  following  ovariectomy  lead  
to  the  attenuation  of  cysteamine-induced  microvascu-
lar leakage.  In contrast,  augmentation of  microvascular  
leakage  followed  the  administration  of  exogenous  
oestradiol  after  cysteamine  challenge.  Although  fur-
ther  studies  are  needed  to  evaluate  whether  the  ob-
served  microvascular  defects  arc  tire  consrqucncc  or  
the cause  of cysteamine-provoked  mucosal  injury,  it  is  
relevant  that  oestrogens  have  vasoconstrictor  actions  
by  modulating  the  pressor  effect  of  vasopressin  [12].  
The  significant  aggressive  role  of  endogenous  vaso-
pressin  via  its  pressor  receptors  in  the  development  of  
gastroduodenal  mucosal  ulceration  has  heen  described  
previously  [10,  12].  
In  conclusion,  oestradiol  appears  to  exert  a  pro-
ulcerogenic  action  in  the  generation  of  macroscopic  
and  microvascular  injury  in  the  stoniuch  and  duode-
num  following  cysteamine  administration  in  female  
rats.  Thus  inappropriate  levels  of  endogenous  (»estra-
diol  might possibly  be  involved  in  the  pathogenesis  of  
gastroduodenal  mucosal  damage.  
Acknowledgments 
This  work  was  supported  by  the  Hungarian  Ministry  of  
Higher  Education  (FKFP  0045/1997  and  PFI>  21K9/I998)  
and  by  the  Hungarian  Ministry  of  Welfare (T  I12  6-12/1996).  
Ferenc  László  was  sponsored  by  the  Uolyai  Fellowship  of  
the  Hungarian  Academy  of  Sciences.  
494 Szepes et al. 
References 
[1]  Adeniyi K.O., Gastric secretion and parietal cell mass: effect 
of sex hormones, Gastroenterology  101 (1991) 66-69. 
[2]  Aston  N.O.,  Kalaichandran  S.,  Carr  N„  Duodenal  ulcer  
hemorrhage  in  the  puerperum,  Can.  J.  Surg.  34  (1991)  
482-483. 
[3]  Bemardini  M.C.,  Blandizzi  C.,  Morini  G.,  Chiavarini  M.,  
Impicciatore  M,  Del  Tacca  M.,  Pirenzepine  prevents  
cysteamine-induced  formation of  gastroduodenal  ulcers and 
reduction of mesenteric circulation. Arch. Int  Pharmacodyn.  
302 (1989) 242-254. 
[4]  Boughton-Smith N.K., Evans S.M., László F„ Wittie BJ.R., 
Moncada  S„  The  induction  of  nitric  oxide  synthase  and  
intestinal vascular permeability by endotoxin in the rat, Br. J. 
Pharmacol.  110 (1993)  1189-1195.  
[5]  Elegbe R.A., Inactivation of prostaglandin E2 in the stomach 
of pregnant and oestrogen pretreated rats, Biochem. Exp. Biol. 
14 (1978) 69-76. 
[6]  Johnson  LJL,  Thkeuchi  K.,  Pentagastrin  protects  against  
stress ulceration in rats. Gastroenterology 76 (1979) 327-334. 
[7]  Johnson  L.R.,  Takeuchi  K.,  Effect  of  cell  proliferation  on  
healing of  gastric  and duodenal ulcers  in rats. Digestion 33 
(1986) 92-100. 
[8]  László F.. Amani &, Varga Cs., László F.A., Influence of sex 
hormones  on ethanol-induced  gastric haemotrhagic erosions 
in rats. Acta PhysioL Hung. 80 (1992) 289-292. 
[9]  László  F..  Amani  E„  Karácsony  G„  Szabó E,  Rengei  B„  
Varga Cs.. László RA., The modulatory role of endogenous 
vasopressin in  Uic  phenomenon (hat orally  administered etha-
nol  generales  more  severe  gastric  erosions  in  male  than in 
female ralo. Ann.  NY  Avail. Sci. 689 (1993) 623-626. 
[10]  László F, Karávsuny  G.,  Pávó I..  Varga Cs., Rojik L, László 
F.A.,  Aggressive  o'le  of  vasopressin  in  development  of  
different gastric leslims in rata, Bur. J. Pharmacol. 258  (1994)  
15-22. 
[11]  László  F„  Varga  C«-.  Monlimeri  C.,  Drago  F„  Damaging  
actions of testosterone on cysieamine-induccd gastroduodenal 
ulceration and vascular leakage in the rat, Eur. J. Pharmacol. 
337 (1997) 275- 278= 
[12]  László F.A., Lás/Jó P. de Wicil D., Pharmacology and clinical 
perspectives of  vasopressin  antagonists,  Pharmacol.  Rev. 43 
(1991) 73-108. 
[13]  Robert  A.,  Cytoprotoctiou  by  prostaglandins.  Gastroenterol-
ogy 7 (1979) 761-767. 
[14]  Robert A., Kauffman O.L., Stress ulcers, erosions and gastric 
mucosal  injury,  in:  Sleisengei  M.H.,  Fordtran  J.S.  (Eds.),  
Gastrointestinal  Disease,  Pathophysiology,  Diagnosis,  Man-
agement, Saunders Co.. Philadelphia,  1989. pp. 772-792. 
[15]  Whittle  B.J.R.,  Thirteenth  Godilum  Memorial  Lecture. Neu-
ronal and endothelluni-derived mediators in the modulation of 
the gastric microcirculation: integrity  in balance, Br. J. Phar-
macol.  110 (1993) 3-17. 
[16]  Whittle  B.J.R.,  Vane J.R.,  Prostanoids as  regulators  of  gas-
trointestinal  function, in: Johnson  L.R. (Ed.),  Physiology of 
the Gastrointestinal Duct,  Raven Press,  New York,  1987 pp. 
143-180. 
i 
66. 
Morschl É.. Bretus I., Nemesik J., László F., Pávó I. 
Estrogen-mediated  up-regulation of the Ca-dependent constitutive  nitric oxide 
synthase in the rat aorta and heart. 
Life Sci. 2000;68(l):49-55. 
Lift'  Sciences  
Estrogen-mediated  up-regulation  of the  Ca-dependenl  
constitutive nitric oxide  synthase  in the rat aorta and  heart  
Éva Morschl3, Ildikó  B retus3, János Nemcsik\  Ferenc  László1' *,  Imre  Pávóc  
'First  Dept.  of  Medicine,  Medical  Faculty,  Univ. Szeged,  H-6701  Szeged,  P.B  46*J,  Hung, try 
bInstitute  of  Experimental  Medicine,  Hungarian  Academy  of  Sciences,  Budapest,  Hungary  
cLilly  Area  Medical  Center,  A-1031  Vienna,  P£.  114,  Austria  
Received 20  January 2000; accepted 26 June 2000 
Abstract 
The role  of endogenous estrogens  has been  studied  in the regulation  of the Cu-dcpcndcnt  constitu-
tive nitric oxide synthase (cNOS) enzyme  activity  in aortic  and cardiac tissues  of  the rat. The  activity  
of cNOS enzyme was measured by the citrulline  assay  in the abdominal  aorta and  in the left ventricle 
of the heart obtained from male, sham-operated female and ovariectomized female Wistai  rats. Estrogen 
replacement  therapy  (17-0-estradiol,  20-100  (xg/kg/day,  s.c.)  has  been  performed  in  ovariectomized  
rats  over  two  weeks.  We found  that  cNOS  activity  was  higher  in  the  aorta  and  heart  of  female  rats  
compared  to males. Ovariectomy  decreased  cNOS  activity  in both tissues  to  that  level  what  could  be  
observed  in males. Estrogen supplementation  caused a dose-dependent  elevation  of cNOS enzyme ac-
tivity  in cardiac and aortic tissues, where the higher dose (100 |xg) completely  restored cNOS enzyme 
activity to the levels found in females. We concluded  that endogenous estrogens up-regulute  the activity 
of the cNOS isoenzymes  in the rat aorta and heart.  © 2000 Elsevier Science Inc. All  rights reserved. 
Keywords:  Nitric oxide; eNOS enzyme regulation; Estrogen; Cardiovascular protection; Ischemic  heart disease 
Introduction 
In  the  reproductive  years,  the  incidence  of  ischemic  heart disease  among  women  is  lower  
compared  to  men  [1].  This  gender difference  can  also  be  observed  under experimental  con-
ditions,  since  it  was  shown  that  female  rats  were  less  prone  to  coronary  artery  occlusion-
provoked  ventricular  arrhytmias  compared  to  male  [2].  The  sexual  dimorphism  disappears  
after  menopause;  i.e.  the  incidence  of  coronary  heart  disease  dramatically  increases  in  
women following their reproductive  period to those levels  that can be found  in  men of  a sim-
ilar age  [1]. Moreover,  the risk of  ischemic  heart disease  is significantly  higher among  surgi-
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cally  postmenopausal  women  in  comparison  with  pre-menopausal  women  in  the  same  age  
[3].  Population-based  observational  studies  showed  that  estrogen  replacement  therapy  in  
postmenopausal  women reduced  the mortality  due to cardiovascular  disease  |4], These  data  
suggest the cardiovascular protective role of endogenous and exogenous  estrogen.  
The cardiac protective effect of  estrogen, at least in part, relates  to the actions of  the  hor-
mone on blood lipid profiles. Estrogen decreases serum low-density  lipoprotein and  increases  
high-density lipoprotein cholesterol concentration. It is clear that such changes  in serum lipo-
protein concentrations are important factors in the development of coronary  artery and  gener-
alized atherosclerosis. Indeed, direct experimental  findings  showed that estrogen  replacement  
therapy  reduced  the extent  of coronary  artery atherosclerosis  in ovariectomized  monkey  [5].  
In  addition,  it  was  also  shown  that  estrogen  replacement  therapy  increases  cndothelium-
dependent  relaxation  in  the  coronary  artery  under  experimental  and  clinical  circumstances  
[6,7]. On the basis of these observations, it is suspected that the major site of the cardiovascu-
lar protective actions of estrogen is the arterial intima where most likely vuscului' cndothelium-
dependent mechanisms are  involved.  
Nitric oxide (NO) is synthesized  from L-arginine by three distinct  isoenzymes. These  NO 
synthase  (NOS) enzyme  isoforms can  be divided  into two functional  classes  based  on  their  
sensitivity  to  calcium.  The  cytokine-  or  bacterial  endotoxin-inducible  isoenzyme  (iNOS)  
binds calmodulin tightly in a calcium-independent fashion, and expressed  mostly under patho-
logical conditions. The constitutive forms (cNOS), isoenzymes endothelial NOS (eNOS; orig-
inally described in vascular endothelial cells) and neuronal NOS (nNOS; originally  described  
in  neuronal  tissues),  bind  calmodulin  in  a  reversible  and  calcium-dcpendent  fashion. NOS 
enzyme  activities  in  tissues  can  be  determined  by  the  citrulline  assay, what  wc  used  in  our  
present  study,  based  on  the  functional  difference  in  their  enzymatic  parameters  between  
iNOS and cNOS. As the two isoenzymes of the calcium-dependent  constitutive NOS  (eNOS  
and nNOS) can not been differentiated, therefore, we use later the traditional  collective  term 
cNOS.  Under  physiological  circumstances  the  activity  of  cNOS  can  be  detected  continu-
ously, and plays a crucial cardiovascular protective role. However, the mechanisms by  which  
the activity of the cNOS isoenzymes is regulated are poorly understood  [8,9].  
A  number  of  indirect  in  vitro  (vascular endothelial  cell  culture,  isolated  organs, etc.)  ob-
servations have suggested that the liberation of NO might be regulated by sex hormones  [10].  
In our present study, we investigated the actions of endogenous estrogens, dircctly on the reg-
ulation  of  cNOS  enzyme  activity  under  in  vivo  circumstances  in  the  aorta  and  even  in  the  
heart  (since no data still available in this organ) obtained  from  the conscious  surgically  post-
menopausal  (i.e. ovariectomized)  rat.  
Methods 
Study  groups  
10-12  weeks-old  male  and  female Wistar  rats  were  used. Ovariectomy  and  sham  opera-
tion have been performed under ether anesthesia. The  animals  were  allowed  to recover  over  
one month. In separate groups of ovariectomized animals, estrogen replacement  therapy  (17-
(3-estradiol, 20-100  p,g/kg/day, s.c.) was introduced over a two-week  period.  
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Ca-dependent  nitric  oxide  synthase  enzyme  activity  
NOS activity  was determined as the conversion of L-[,4C]-arginine  moiinhydn »chloride  to  
L-[l4C]-citrulline  based  on  the  method  described  previously  [11,12]  with  mint»  modifi-
cations aiming to detect mostly the activity of cNOS [10,13,14]. We sacrificed the animals  by 
decapitation, and immediately after autopsy, we prepared the fresh tissues  lor  NOS  measure-
ments. Cardiac (the left ventricle from an individual rat) and aortic  (pooled  from (lie abdomi-
nal aorta of two rats) tissues were homogenized (15 s, Ultra-Turrax homogenizcr, 5 mm blade)  
in  buffer (250  mg/ml,  4°C,  10  mM  Hepes,  32  mM  sucrose,  1 mM  dithiolhrcilol,  0.1  mM  
EDTA,  10 p-g/ml soybean trypsin inhibitor,  10 |xg/ml of leupeptin, and 2  p-g/ml ol  aproionin,  
pH  7.4), and was  followed by  centrifugation for 20  min  at  10,000  g  at  4  "C,  Samples  were  
mixed  with  Dowex  (AG  50W-8; 200-400,  8%  cross-linked, Na+  form) resin,  and  followed  
by centrifugation for a further  10 min at  10,000 g at 4 °C. Sample supernatant  (40  p-l) was  in-
cubated  for  10  min  at  37°C  in  reaction  buffer  comprising  (final  concentrations)  50  mM  
KH2P04 ,10  (ig/ml calmodulin, 2.5 mM CaCI2 ,50 mM valine,  1 mM dithiolhrcilol,  15.5 nM 
L-arginine,  1 mM  L-citrulline, 0.3 mM NADPH,  3  |xM  flavin  adenine  dinuelcolido  (FAD),  
3  p,M  flavin  mononucleotide  (FMN),  3  p,M  tetrahydrobiopterin  and  0.17  p,M  of  [l4C]L-
arginine.  The  reaction  was  arrested  by  the  addition  (0.5  ml)  of  a  1:1  v/v  suspension  of  
Dowex:water. After addition  of 0.85 ml distilled water and  allowing  the  settling  lor  30  min,  
the  supernatant  was  removed  for  scintillation  counting.  Protein  content  was  estimated  via  
spectrophotometric  assay (Bio-Rad Protein Assay), and NOS activity was expressed  us pmol/ 
min/mg  protein,  where  constant  linear  rates  with  different  amounts  of  extracts  could  be  
found. Total NOS  activity  was defined as citrulline formation that was  abolished  by  incuba-
tion  in vitro with NG-nitro-L-arginine  (L-NNA,  1 mM). Basal L-NNA-sensitivc  activity  that  
was abolished by EGTA was taken as calcium-dependent  cNOS activity. In addition, calcium-
independent  NOS  activity  (iNOS)  was  also  determined  as  the  difference  between  samples  
containing  ImM EGTA and samples containing  1 mM L-NNA. 
Chemicals  and  statistics  
L-[U-14C]arginine  monohydrochloride  was  obtained  from Amersham  International.  All  
other  compounds  were  from the  Sigma  Chemical  Company. The  data  are  expressed  as  the  
mean  ±  SEM of (n) rats per experimental group. Data were analyzed with the  Tukey--Kramer  
Multiple Comparisons test, where p<0.05  was taken as significant. 
Results 
We found that cNOS activity  was higher in the aorta and heart of female rats compared  to  
males  (by  105±10%  and by  104±18%, respectively;  n  =  7-9; p<0.001).  Ovariectomy  de-
creased  cNOS  activity  in  both  tissues  to  that  level  what  could  be  observed  in  mules  (by  
58±6%  in the aorta and by 49±4%  in the heart; n  =  7-9; p<0.001). Estrogen  supplementa-
tion in the ovariectomized rat caused a dose-dependent elevation of cNOS enzyme activity  in  
cardiac and aortic tissues, where the higher dose (100 |xg) completely restored cNOS enzyme 
activity to that level what could be observed in females. Data are shown  in Fig.  1.  
In female and male rats, there was no significant gender difference in  iNOS  activity  in  the  
aorta  (being 0.07±0.04  and 0.09±0.04  pmol/min/mg  protein, respectively;  n  =  7-H)  and  in  
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plasma  concentration  of  estrogen  is high  [21], and  administration  of  estradiol  increased  en-
dothelium-dependent  arterial  relaxation  [22].  Our  results  accord  with  earlier  observations  
where physiological levels of  circulating  17-0-estradiol has been  shown  to elevate  basal  NO  
release from endothelial cells, which amount of NO was sufficient to increase the diameter of 
pressurized  coronary  arteries in rats  [23]. Our observations  are in  agreement  with  the. earlier 
findings  of Weiner et al. [10], where an increase in endogenous estrogen  level  (hy  pregnancy),  
and  administration  of  exogenous  estrogen  to  intact  females  elevated  the  calcium-dependent  
cNOS enzyme  activity  and mRNA expression  in the uterine artery  and  heart  of  guinea  pigs.  
Interestingly, in a recent report of Nuedling et al. [24], it has been demonstrated  that estrogen 
administration provokes the expression  of eNOS protein in rat cardiac  myoeytcs  both  under  
in  vivo  and  in  vitro  circumstances,  which  result may provide  a further insight  for the  better  
understanding  of estrogen-mediated  cardiac.protection. Moreover, NO has been found to be 
involved in the early and delayed cardiac protective effects of preconditioning  induccd by coro-
nary artery occlusion [25], cardiac pacing [26,27] and non-toxic endotoxin  treatment  [27,28] in 
various  species. In  addition, estradiol  supplementation  improved  vasodilatation  in  postmeno-
pausal  women, because  of  augmented NO  production  [29]. Finally, chronically  administered  
estrogen enhanced the release of NO from the vascular endothelium of the rat aortic ring  [30].  
In a large number of studies, it has been demonstrated that NO synthesized  by cNOS has a 
key beneficial importance  in the maintenance  of vascular integrity.  In  summary,  it  is  known  
that  inhibition  of  cNOS  increases  blood  pressure, platelet  aggregation  and  leukocyte  adher-
ence to  the vascular endothelium. On  the basis  of  numerous  observations,  it  is  strongly  be-
lieved  that NO synthesized  in the vascular endothelium  (eNOS) plays the crucial  role  in  the  
beneficial vascular effects of cNOS  [8,9]. However, recent studies have shown that NO  syn-
thesized in neuronal elements by nNOS might have similar vascular protective uctions  [9,10]  
whose activity is also included in cNOS. It seems that further studies are needed to clarify the 
role of nNOS in cardiovascular  protection.  
In  contrast, NO  donors, because  of  their  smooth  muscle relaxing  effect, are  well-known  
arterial  and venous vasodilators. Furthermore, they inhibit leukocyte adherence  to the  vascu-
lar endothelium and platelet aggregation, processes that have crucial role in vascular conges-
tion. It is also well established that NO donors are used worldwide as cardiac drugs, because 
of their direct coronary dilatory effects (high conductance big vessels), which  putative  mech-
anism  plays  an  additional  role  in  their  protective  action  against  myocardial  ischcmia  [31].  
Thus,  NO  synthesized  by  cNOS  preserves  normal  vascular  tone,  leukocyte  deposition  and  
platelet aggregation  [8,9].  
Taking the results together, it is strongly suggested, that the endogenous estrogens  up-reg-
ulate cNOS enzyme activity in the rat aorta and heart. This estrogen-mediated  increase of NO 
production by cNOS might possibly be an explanation of the sexual dimorphism  of  ischemic  
heart disease; i.e. women are less sensitive than men are in the fertile age. 
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Abstract 
The  actions  of  ovariectomy  on  nitric  oxide  synthase  (assessed  by  the citrullin  assay),  mucus  secretion  (assessed  by  the  Alcyan  blue  
technique) and ulcerogenic  response (indomethacin (30  mg kg"1,  s.c., 4 h) or cysteamine (400 mg kg - 1 ,  s.c., 24 h)) were studied in  the  
female  rat  stomach.  Ovariectomy  increased  nitric  oxide  synthase  and  mucus  secretion,  and  decreased  the  severity  of  lesions,  effects  
reversed by the nitric oxide synthase inhibitor,  NG-nitro-L-arginine  methyl ester (L-NAME,  10 mg kg"1 ,  s.c.,  4 h before measurements). 
Therefore, estrogen-deficiency protects the gastric mucosa by nitric oxide (NO)-mediated mucus hypersecretion.  © 2000 Elsevier  Science 
B.V. All  rights  reserved.  
Keywords:  Nitric  oxide (NO); Gastric mucus;  Estrogen  
The  sexual  dimorphism  of  gastric  o r / a n d  duodenal  
ulceration  is  well  known.  Clinical  and  experimental  obser-
vations  suggest  that  sexual  steroids  have  a key  importance  
in  the  regulation  of  the  defensive  mechanisms  of  the  
gastroduodenal  mucosa  (Robert  and  Kauffman,  1989;  
László  et  al„  1997;  Drago  et  al.,  1999).  In  earlier  studies,  
gonadectomy  decreased  the  severity  of  gastric  mucosal  
injury  in various  models  of  ulceration  (László  et  al.,  1997;  
Drago  et  al.,  1999).  It  is  also  well  established  that  numer-
ous  aggressive  and  protective  factors affect the  gastroduo-
denal  mucosa,  and  an  imbalance  between  them  is  
pathogenic  in  the  development  of  mucosal  injury  (Robert  
and  Kauffman,  1989).  Among  the  protective  factors,  gas-
troduodenal  mucus  plays  a crucial  role  (Robert  and  Kauff-
man,  1989).  Administration  of  nitric  oxide  (NO)  donors  
stimulates  mucus  release  from  isolated  gastric  mucus-cell  
fraction  (but  not  in  parietal  cells),  and  it  has  also  been  
demonstrated  that  NO  synthase  is  presented  in  these  cells  
(Brown  et  al.,  1992,  1993).  Moreover,  an  increase  in  
endogenous  NO  synthase  activity  in  the  gastric  mucosa  
protected  the  stomach  against  damage  (Tepperman  et  al.,  
" Corresponding  author.  Tel.:  +36-1-210-0819;  fax:  +36-1-210-0813.  
E-mail  address:  laszlof@koki.hu (F.  László).  
1993).  In the present  study,  the action  of  the  estrogen-defi-
cient  state  (i.e. ovariectomy)  on  gastric NO  synthase  activ-
ity,  mucus  secretion  and  on  the  susceptibility  of  the  mu-
cosa  towards  various  ulcerogenic  stimuli  has  been  exam-
ined. 
We  used  female Wistar  rats  (200-220  g).  Sham  opera-
tion  or  ovariectomy  has  been  performed  1  month  before  
the experiments. For provocation  of gastric mucosal injury, 
indomethacin  (30  mg  k g - 1 ,  s.c.)  or  cysteamine  (400  mg  
kg" 1 ,  s.c.)  were  administered,  and  the  measurement  
(planimetry)  of  lesions  has  been  performed 4  or 24  h  later,  
respectively.  The  animals  were  starved  for  24  h  before  
(indomethacin)  or  during  (cysteamine)  lesion  induction.  
For the evaluation  of gastric mucosal NO synthase  activity,  
we used the citrulline assay. The detailed description  of  the  
method  can  be  found  in  the  paper  of  Brown  et  al.  (1992).  
For  the  measurement  of  gastric  mucus  level,  we  used  the  
Alcyan  blue  technique,  which  methodological  description  
can be found  in  details  in the paper  of  Drago  et al.  (1999).  
For  the  investigation  of  the  role  of  NO  in  our  model,  the  
NO  synthase  inhibitor,  N°-nitro-L-arginine  methyl  ester  
(L-NAME,  10  mg  kg" 1 ,  s.c.)  was  administered  into  
ovariectomized  rats  4  h  before  any  measurement.  For  the  
citrulline  assay,  L-[U-l4C]arginine  monohydrochloride  was  
obtained  from  Amersham  International.  All  other  com-
0014-2999/00/$  -  see  front  matter  ©  2000 Elsevier Science  B.V.  All  rights  reserved.  
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Fig.  I.  Actions  of  ovariectomy  (Ovar.,  grey  columns)  on  mucus  secretion  
(expressed  as  p.g  dye  g ~1  tissue),  nitric  oxide  synthase  activity  (NOS,  
expressed  as  pM  inin ~1  m g ~ '  protein)  and  lesion  formation  (expressed  
as  extent  of  lesions  in  percent)  provoked  by  indomethacin  or  cysteamine  
in  the  stomach  of  the  female  rat  (Cont.,  open  columns),  and  their  reversal  
by  the  administration  of  the  nitric  oxide  synthase  inhibitor,  V°-nitro-L-
arginine  methyl  ester  (L-NAME,  hatched  columns).  Data  are  expressed  as  
means + S.E.M.,  where  n  = 4 - 6  rats  in  a group.  * P  < 0.05  between  Cont.  
and  Ovar.  groups:  *P  <  0.05 between Ovar.  and Ovar. + L - N A M E  groups.  
pounds  were  from  Sigma.  Data  were  analyzed  with  the  
Turkey-Kramer  multiple  comparisons  test,  where P  <  0.05 
was  taken  as  significant.  
We  found  that  ovariectomy  increased  gastric  NO  syn-
thase  activity  (by  96  ±  11%,  n  =  6,  P  <  0.005)  and  mucus  
secretion  (by  57  +  8%,  n  =  5,  P < 0 . 0 1 ) ,  and  decreased  
the  severity  of  lesions  (by  63  ±  10%  or  by  61  ±  6%  fol-
lowing  indomethacin  or  cysteamine  challenge,  respec-
tively;  n  = 4 -5 ,  P<  0.001).  All  these  effects  of  ovariec-
tomy  were  reversed  by  the  administration  of  the  NO  
synthase  inhibitor,  L - N A M E  (Fig.  1 ) .  
Our  present  findings  confirm  that  gonadectomy  im-
proves  the  defensive  mechanism  of  the  stomach  (László  et  
al..  1997;  Drago  et  al.,  1999).  Female  sexual  steroids  have  
dual  actions  on  the  gastric  mucosa.  Progesterone  prevents  
injury,  since  during  early  pregnancy  (when  progesterone  
level  is  high),  a  lower  susceptibility  of  the  stomach  has  
been  found  (Montoneri  and  Drago,  1997).  In  contrast,  
estrogens  augment  damage,  because  of  the  gastric  protec-
tion  by  ovariectomy  and  lactation,  when  the  level  of  
estrogens  is low (Robert  and  Kauffman,  1989; Drago et  al.,  
1999).  These  observations  are  apparently  conflicting  with  
the  well-known  experience,  i.e.  males  are  more  prone  to  
gastric  ulceration  than  females,  although  their  estrogen  
level  is  low.  However,  orchidectomy  or  testosterone  antag-
onist  revealed  to  protect  against  injury.  This  shows  that  in  
males,  instead  of  harmful  estrogens,  testosterone  plays  an  
aggressive  role  towards  the  gastric  mucosa  (László  et  al.,  
1997).  Testosterone  may  generate  more  severe  gastric  
damage  in  males  compared  to  females,  since  in  males  the  
protective  progesterone  level  is  also  low.  
In  our  study,  an  increased  gastric  mucosal  NO  synthase  
activity  has  been  shown  after  ovariectomy.  This  elevated  
gastric  NO  production  might  have  an  important  role  in  the  
protection  against  ulcerogenic  challenge,  since  the  admin-
istration  of  the  N O  synthase  inhibitor,  L - N A M E  restored  
mucosal  damage  in  the  ovariectomized  rat  to  that  level  
what  could  be  observed  in  control  females.  An  increased  
generation  of  NO  may  play  a role  among  gastric  protective  
mechanisms  by  its  ability  to  maintain  microvascular  in-
tegrity  (Whittle,  1993),  which  is  also  known  to  be  an  
important  factor  in  the  development  of  mucosal  injury  
(Robert  and  Kauffman,  1989).  In  the  case  of  indo-
methacin-induced  gastric  mucosal  injury,  this  NO-media-
ted  microcirculatory  mechanism  is  more  likely  to  be  in-
volved,  since  in  this  model,  vascular  factors  are  known  to  
have  crucial  pathogenic  role  (Robert  and  Kauffman.  1989;  
Whittle,  1993).  Indeed,  in  a time-response  study,  we  found  
that  microvascular  injury  preceded  mucosal  damage  fol-
lowing  indomethacin  administration,  while  the  opposite  
could  be  observed  with  cysteamine  (our  unpublished  re-
sults).  In  our  present  study,  we  found  that  in  ovariec-
tomized  rats  the  mucus  secretion  in  the  stomach  has  been  
increased,  an  effect reversed  by L - N A M E .  Thus, N O  medi-
ates  mucus  overproduction  in  the  ovariectomized  rat.  This  
mucus  hypersecretion  may  be  the  common  pathway,  which  
explains  why  the  estrogen-deficient  state  protects  the  gas-
tric  mucosa  against  different ulcerogenic  stimuli.  
In  conclusion,  estrogen-deficiency  provokes  a  NO-
mediated  gastric  mucus  hypersecretion,  which  improves  
mucosal  defence.  
Acknowledgements 
Ferenc  László  was  supported  by  the  Széchenyi  Profes-
sor  Fellowship  of  the  Hungarian  Ministry  of  Education.  
References 
Brown,  J.F.,  Keates,  A.C.,  Hanson,  P.J.,  Whittle,  B.J.R.,  1993.  Nitric  
oxide  generators  and  cGMP  stimulate  mucus  secretion  by  rat  gastric  
mucosal  cells.  Am.  J.  Physiol.  265,  G418-G422.  
Brown,  J.F.,  Tepperman,  B.L.,  Hanson,  P.J.,  Whittle.  B.J.R..  Moncada,  
S.,  1992.  Differential distribution  of  nitric oxide synthase  between  cell  
fractions  from  the  rat  gastric  mucosa.  Biochem.  Biophys.  Res.  Com-
mun.  30,  680-685.  
Drago.  F„  Montoneri,  C.,  Varga,  Cs„  László,  F.,  1999.  Dual  effects  of  
female  sex  steroids  on  drug-induced  gastroduodenal  ulcers  in  the  rat.  
Life  Sci.  64,  2341-2350.  
László,  F.,  Varga,  Cs.,  Montoneri,  C.,  Drago,  F..  1997.  Damaging  actions  
of  testosterone  on  cysteamine-induced  gastroduodenal  ulceration  and  
vascular  leakage  in  the  rat.  Eur.  J.  Pharmacol.  337.  275-278.  
Montoneri,  C„  Drago,  F.,  1997.  Effects  of  pregnancy  in  rats  on  cys-
É. Morschl  et al./European  Journal  of Pharmacology  392 (2000)  R5-R7  R7 
teamine-induced  peptic ulcers: role of progesterone.  Dig.  Dis. Sci. 42, 
2572-2575. 
Robert,  A.,  Kauffman,  G.L.,  1989.  Stress  ulcers,  erosions,  and  gastric  
mucosal  injury.  In:  Sleisenger,  M.H.,  Fordtran,  J.S.  (Eds.),  Gastroin-
testinal  Disease,  Pathophysiology,  Diagnosis,  Management.  Saunders,  
Philadelphia,  pp.  772-792.  
Tepperman,  B.L.,  Vozzolo,  B.L.,  Soper,  B.D.,  1993.  Effect of  neutrope-
nia  on gastric  mucosal  integrity  and  mucosal  nitric oxide  synthesis  in 
the rat.  Dig. Dis.  Sci.  38,  2056-2061.  
Whittle, B.J.R.,  1993. Neuronal and endothelium-derived  mediators in the 
modulation  of  the  gastric  microcirculation:  integrity  in  the  balance.  
Br. J.  Pharmacol.  110,  3-17.  
Pávó I., László F., Morschl É.. Nemesik J., Berkó A., Cox D.A., László F.A. 
Raloxifene, an estrogen-receptor  modulator, prevents decreased constitutive  
nitric oxide and vasoconstriction in ovariectomized  rats.  
Eur. J. Pharmacol.  2000;410(1):101-104.  
ELSEVIER European Journal  of Pharmacology 410 (2000)  101-104  
ww» r|,Pvier.|||/|ucatr/ej|>hBi 
Short  communication  
Raloxifene, an oestrogen-receptor  modulator, prevents  decreased  
constitutive nitric oxide and vasoconstriction  in ovariectomized  rats  
Imre Pávóa,  Ferenc László  b'*,  Éva Morschlb,  János Nemesik  b,  Anikó  Rcrkóe,  
David A.  Cox  d,  Ferenc A.  Lászlóc  
*  Lilly  Area  Medical  Center,  Vienna,  Austria  
b  Institute  of  Experimental  Medicine.  Hungarian  Academy  of  Sciences.  H-1083  Budapest.  Szlgonv  u.  41,  Hungun  
c  Department  of  Comparative  Physiology,  University  of  Szeged.  Szeged.  Hungary  
d  Eli  Lilly  Research  Laboratories,  Indianapolis,  IN,  USA  
Received 4 September 2000: received  in revised form 3 November 2000: accepted  10  November 2000 
Abstract 
Administration  of  graded  doses  of  [Arg8]vasopressin  (0.06-0.18  p-g k g - 1 ,  i.v.)  induced  a  dose-dependent  increase  in  ancrial  blood  
pressure  in the catecholamine-depleted  (phentolamine;  10 mg kg - 1 ,  i.p.)  intact  and  ovariectomized  female rat,  with  the elevation  of  blood  
pressure  more  marked  following ovariectomy.  In addition,  ovariectomy  caused  the  down-regulation  of  aortic CaJ 4  dependent  constitutive  
nitric  oxide  synthase (assessed  by  the citrulline  assay). The  down-regulation  of  the  Ca2+-dependent  constitutive  nitric  oxide  synthase  and  
augmentation  of  vasopressin-induced  blood pressure  responses were  prevented  by the  therapy (1 month, p.o.)  with  the  selective  oestrogen  
receptor  modulator,  raloxifene  (0.3-1.0  mg  kg"1  day - 1 ) ,  or  with  17(3-oestradiol  (0.3  mg  kg  '  day" ' )  in  ovarlectonibed  tats.  Thus,  
oestrogen  deficiency  down-regulates  vascular  constitutive  nitric  oxide  synthase,  which  appears  to  be  involved  in  the  increased  sensitivity  
of  the  vasculature  to  vasopressin,  since  both  effects  can  be  reversed  by  the  exogenous  administration  of  the  natural  ocsirogcn  
17p-oestradiol  or  the  selective  oestrogen-receptor  modulator  raloxifene.  ©2000  Elsevier  Science  B.V,  All  rights  icsetvcd  
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1.  Introduction  
In  the  reproductive  years,  the  incidence  of  cardio-
vascular  disease  is  lower  among  women  than  among  men.  
This  gender  difference  disappears  following  either  natural  
or  surgical  menopause,  suggesting  a  protective  role  of  
endogenous  estrogens  in  the  cardiovascular  system  (Clark-
son  et  al.,  1997).  
Under  experimental  conditions,  endogenous  estrogen  or  
administration  of  natural  estrogens  has  been  demonstrated  
to  increase  Ca2+-dependent  constitutive  nitric  oxide  (NO)  
synthase (cNOS)  activity  in  vascular  tissues  (Weiner  et  al„  
1994;  Morschl  et  aL,  2000).  Selective  oestrogen-receptor  
modulators  have  tissue-specific  oestrogen  agonist  effects,  
e.g.  on  bone  and  lipid  metabolism,  and  antagonist  effects,  
e.g.  on  breast (Clarkson  et  al„  1997).  In  addition,  increased  
'  Corresponding  author.  Tel.:  +36-1-210-0819:  fax:  +36-1-210-0813.  
E-mail  address:  laszlof@koki.hu  (F.  László).  
NO  release  has  been  observed  front  the  isolated  rat  aorta  
following  the  administration  of  selective  oestrogen-rccep-
tor  modulators  such  as  raloxifene  (Rahiiniau  cl  al..  1997).  
It  is  known  that  NO.  formed  continuously  |>y cNOS  in  
the  vascular  endothelium  and  neuronal  elements,  plays  a  
significant  protective  role  in  the  maintenance  of  vascular  
integrity.  The  inhibition  of  cNOS  provokes  Mood  pressure  
elevation,  platelet  aggregation  and  adhesion  of  neutrophils  
to  the  vascular  endothelium  (Moncada  and  Uiggs.  1995).  
Moreover,  it  has  recently  been  demonstrated  i|)Ut  oestrogen  
can  modulate  the  action  of  vasopressin  on  lite  barorcllex  
control  of  sympathetic  outflow,  and  thereby  participate  in  
cardiovascular  regulation  (He  et a l .  1999).  
In  the  present  study,  we  investigated  the  va-.opressin-in-
duced  blood  pressure  response  in  catecholamine  depicted  
ovariectomized  rats,  by  determining  the  changes  of  aortic  
cNOS  enzyme  activity  in  conjunction  with  the  vaso-
pressin-provoked  blood  pressure  response  following  ralox-
ifene  or  oestrogen  supplementation  in  the  oestrogen  defi-
cient  state.  
>014-2999/00/$ -  see  front matter  ©2000  Elsevier  Sciencc  B.V.  All rights reserved. 
MI: S001 4-2999(00)00865-7 
102 /.  Pávó  ei  al. /European  Journal  of  Pharmacology  41012000)  IOl_ilti  
2.  Materials  and  methods  
2.1.  Experimental  protocol  
We  used  sham-operated  and  ovariectomized  female  
Wistar  rats (200-220  g).  Operations  were  performed  under  
transient  ether  anaesthesia,  followed  by  a  1-month  recov-
ery  period.  In  ovariectomized  rats,  raloxifene  (0 .3-1  mg  
kg"1 ,  p.o.,  once  daily)  or  173-oestradiol  (0.3  mg  kg"1 ,  
p.o.,  once  daily)  were  administered  for  1  month.  The  
procedures,  doses  of  compounds,  and  route  of  administra-
tion  have  been  established  in previous  studies  (Rahimian  et  
al.,  1997;  Morschl  et  al.,  2000).  Control  animals  received  
the  vehicle  at  the  same  time,  in  the  same  volume  and  by  
the  same  route.  
2.2.  Car  * -dependent  aortic  nitric  oxide  synthase  enzyme  
activity 
NOS  activity  was  determined  as  the  conversion  of  
L-[uC]arginine  monohydrochloride  to  L-[l4C]citrulline  
based  on  the  method  described  previously  (Salter  et  al.,  
1991).  with minor modifications  aiming  to  detect  the  activ-
ity  of  cNOS  (Weiner  et  al,  1994;  Garvey  et  al.,  1997).  We  
sacrificed  the  animals  by  decapitation,  and  immediately  
after  autopsy  prepared  fresh  tissues  for  NOS  measure-
ments.  Aortic  tissues  were  pooled  from  the  abdominal  
aorta  of  two  rats.  Tissues  were  homogenized  (15  s,  Ultra-
Turrax homogenizer,  5  mm  blade)  in buffer (250 mg  ml"1 ,  
4°C,  10 mM  HEPES,  32  mM  sucrose,  1 mM  dithiothreitol,  
0.1  mM  EDTA,  10  p.g ml"1  soybean  trypsin  inhibitor,  10  
p.g  m l - 1  leupeptin,  2  |xg  m l - 1  aprotonin,  pH  7.4).  This  
was  followed  by  centrifugation  (20  min,  10,000  X  g,  4°C).  
Samples  were  mixed  with  Dowex  (AG  50W-8:  200-400,  
8% cross-linked,  Na"  form) resin.  After further centrifuga-
tion  (10  min.  10.000  X  g,  4°C),  the  supernatant  (40  p. I) 
was  incubated  for  10  min  at  37°C  in  reaction  buffer  
comprising  (final  concentrations):  50  mM K H 2 P 0 4 ,  10  p.g  
m l - 1  calmodulin,  2.5  mM  CaCI2,  50  mM  valine,  1  mM  
dithiothreitol,  15.5  nM  L-arginine,  1  mM  L-citrulIine,  0.3  
mM  NADPH,  3  p.M  flavin  adenine  dinucleotide  (FAD),  3  
p.M  flavin  mononucleotide  (FMN),  3  p.M  tetrahydro-
biopterin  and  0.17  p.M  of  [l4C]L-arginine.  The  reaction  
was  terminated  by  the  addition  (0.5  ml)  of  a  1:1  v / v  
suspension  of  Dowex:water.  After  addition  of  0.85  ml  
distilled  water  and  settling  for 30  min,  the  supernatant  was  
removed  for  scintillation  counting.  Protein  content  was  
estimated  by  spectrophotometric  assay  (Bio-Rad  Protein  
Assay),  and NOS  activity  expressed  as  pmol  min"1  m g - 1  
protein,  with  constant  linear  rates  for  different  amounts  of  
extracts. 
Total  NOS  activity  was  defined  as  citrulline  formation  
abolished  by  incubation  in  vitro  with  Nc-nitro-L-arginine  
(L-NNA,  1 mM).  Basal  L-NNA-sensitive  activity  that  was  
abolished  by  EGTA  was  taken  as  Ca2+-dependent  cNOS  
activity.  In  addition.  (Jn3'-independent  NOS  activity  
(iNOS)  was  also  detcrtiiiiiHl  f»s  the  difference  between  
samples  containing  1 mM  CHTA  and  samples  containing  1  
mM  L-NNA.  
2.3.  Blood  pressure  response  to  vasopressin  
Animals  were  anaesthetised  with  urethane (1.25  g  kg"1 ,  
i.p.).  and  then  pre  treated  with  phentolamine  (10  mg  kg"1,  
i.p.).  A  single  bolus  injection  of  arginine-vasopressin  
(0.06-0.18  pg  kg"1 ,  i.v.)  Was  administered  into  the  tail  
vein  following  the  stabilisation  of  blood  pressure.  The  
procedure  in  details  has  liccit  described  previously  (László  
et  al.,  1991).  Btiefly,  the  elevation  of  blood  pressure  
(expressed  as  a  % maximal  increase  compared  to  the  basal  
value)  was  measured  in  the  right  carotid  artery  through  a  
blood  pressure  transducer  connected  to  the  HAEMOSYS  
computerised  complcx  haemodynamic  analysis  system  
(Experimetria  UK.  London)  The  core  temperature  of  rats  
was  maintained  at  37"C  with  a  homeothermic  control  unit  
(Harvard  Instrument,  UK).  
2.4.  Chemicals  
L-[uC]arginine  monohydrochloride,  raloxifene,  argi-
nine-vasopressin  and  phentolamine  were  purchased  from  
Amersham  International  (UK),  Eli  Lilly  and  Company  
(USA),  Organon  OSS  (The  Netherlands)  and  Ciba-Geigy  
(Switzerland),  respectively.  All  non-specified  agents  were  
from  Sigma.  
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Fig.  1. Ovariectomy-provokcd  decrease  in  constitutive  aortic  nitric  oxide 
synthase  (cNOS)  enzyme  activity  (expressed  as  pmol  min"1  mg"1  
tissue). Actions  of  raloxifene  (ralox.;  1  mg  kg"1)  or  17ß-oestradiol  
(oestr.: 0.3  mg kg - 1)  supplementation  (1  month, p.o.)  on cNOS enzyme 
activity  in  the  aorta  of  ovariectomized  rats.  Data  are  expressed  as  
mean + S.E.M.  of  five  measurements  in  each  group;  ' P < 0.001  means  
significant  difference between  the  intact  female  and  the  ovariectomized  
group. 
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2.5.  Statistics  3.2.  Blood  pressure  response  '«  vasi'prvssin  
The  data  are expressed  as  the  mean  ±  S.E.M.  of  (n)  rats  
per  experimental  group.  Data  were  analyzed  by  the  
Tukey-Kramer  Multiple  Comparisons  test,  with  P  <  0.05  
taken  as  significant.  
3.  Results  
3.1.  Ca2  + -dependent  aortic  nitric  oxide  synthase  enzyme  
activity 
As  shown  in  Fig.  1,  ovariectomy  significantly  decreases  
aortic  cNOS  activity,  i.e.  it  falls  to  37  ±  2%  of  the  intact  
rat  (n  =  5;  P  <  0.001).  In  the  aorta  of  the  ovariectotnized  
rat,  173-oestradiol  (0.3  mg  k g - 1 )  or  raloxifene  (1  mg  
k g - 1 )  supplementation  (1  month,  p.o.)  completely  restored  
cNOS.  enzyme  activity  to  levels  seen  in  intact  females.  
In  female  rats.  iNOS  activity  in  the  aorta  was  0.08  ±  
0.05  pmol  min"1  m g - 1  protein  (n  =  5).  Neither  ovariec-
tomy  nor  administration  of  173-oestradiol  or  raloxifene  
changed  aortic  iNOS  activities  compared  to  the  intact  basal  
values  (n  =  5,  data  not  shown).  
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Fig.  2.  Increase  of  arterial  blood  pressure  (expressed  as  9c  change,  
measured  in  the  right  carotid  artery)  by  intravenous  administration  of  
arginine-vasopressin (0.06-0.18  p.g kg"1 ) in the catecholamine-depleted 
(phentolamine.  10  mg kg"1,  i.p.)  sham-operated  and  ovariectotnized  (1  
month)  female rat.  Effect  of  supplementation  (1  month,  p.o.)  with  I7P-
oestradiol  (0.3  mg  kg"1  day"')  or  the  selective  ocstrogen-receptor  
modulator,  raloxifene  (0.3-1  mg  kg"1  day"1)  on  vasopressin-induced  
blood  pressure elevation  in the ovariectomized  rat.  Data are expressed as 
mean±S.E.M..  where  n = 8-12 rats  in a group.  " P < 0.05  means signif-
icant  blood  pressure  increase  compared  to  the  vasoprcssin-treated  intact  
female group:  *P < 0.05 means significant blood  pressure  decrease com-
pared  to the vasoprcssin-treated  ovariectomized  female group. 
As  shown  in Fig.  2.  udminloiruiion  of  vasopressin  caused  
a  dose-dependent  increase  0f  uorial  blood  pressure  botl  
in  the  ovary-intact  and  ovariectomized  leniale  rat.  How-
ever,  in  the  ovariectontizeii  animals,  vasopressin  induced  a  
significantly  higher  elevation  of  bit tod  prrssure  than  in  
ovary-intact  females.  Oestrogen  replacement  abolished  the  
increased  blood  pressuie  response  observed,  and  raloxifene  
supplementation  caused  a dose  dependent  dcerease  in blood 
pressure  enhancement  provoked  by  vasopressin  in  ovariec-
tomized  rats.  
4.  Discussion  
The  present  findings  arr  in  agreement  with  recent  ob-
servations  that  vasoconstrictor  tone  is  Increased  in  various  
vascular  beds  following  ovariectomy,  an effect  that  can  be  
mitigated  by  oestrogen  or  raloxifene  therapy  (He  et  al.,  
1999;  Zoma  et  al„  2000).  This  impaired  vasodilatation  
most  likely  originates  from  the  down-regulation  of  cNOS  
in  the  oestrogen-deficient  state.  
Under  in  vitro  circumstances,  a  reduction  of  the  basal  
release  of  NO,  as  detected  by  augmented  catecholamine-
induced  contractile  response  in  the  presence  of  an  NO  
synthase  inhibitor,  was  found  in  aortic  rings  from  ovariec-
tomized  animals,  an effect  blocked  by  raloxifene  or  oestra-
diol  treatment  (Rahimian  et  aL  1997).  Under  in  vivo  
conditions,  reduced  cNOS  activity  lias  been  demonstrated  
in  the  aortic  tissue  of  ovariectomized  rats  compared  with  
normal  females,  and  administration  of  173-oestradiol  
dose-dependently  increased  aortic  cNOS  activity  in  
ovariectomized  rats  to  normal  female  levels  (Morschl  et  
al.,  2000).  Our  present  findings  give  further  support  to  the  
proposition  that  vascular  cNOS  uctivity  is  regulated  by  
estrogen,  and  that  under  in  vivo  circumstances  raloxifene  
has  oestrogen  agonist  properties  with  respect  to  vascular  
cNOS  activity.  
Finally,  there  are  pathological  circumstances  in  which  
release  of  NO  by  cNOS  from  an  intact  endothelium  pro-
tects  the  vascular  tissue  against  the  potentially  injurious  
effects  of  endogenous  vasoconstrictors  such  as  vaso-
pressin.  For  example,  in  the  early  compensated  phase  of  
endotoxaemia,  severe  vasculai  dysfunction  can  occur  fol-
lowing  endotoxin  challenge  when  cNOS  is  inhibited,  
whereas  neither  endotoxin  nor  cNOS  inhibitor  alone  cause  
dysfunction,  and  this  injury  is  reversed  by  u  vasopressin  
antagonist  (László  and  Whittle,  199-1).  Moreover,  in  the  
operating  theatre,  cNOS  has  been  demonstrated  to  main-
tain  vascular  integrity  (László  and  Whittle.  1999):  it  effec-
tively  counteracts  the  increase  in  vascular  permeability  
provoked  by  vasopressin  which  is  known  to  be  released  
during  major  surgical  operations  (Melville  ct  al.,  1985;  
Pávó  et  al.,  2000).  Thus,  in  the  ovaricctoinized  state,  
impaired  expression  or/and  activity  of  cNOS  tnay  explain  
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the increased  blood pressure response to vasopressin  in the 
absence  of oestrogen. 
In  conclusion,  our results  suggest  that  in  oestrogen-de-
ficiency  aortic  cNOS  is  down-regulated,  which  strongly  
suggests  its involvement  in the increased  sensitivity  of the 
vasculature  to  the  vasoconstrictor  effect  of  vasopressin.  
Both  actions  can  be  reversed  by  the  therapy  with  the  
natural  oestrogen  17(J-oestradiol,  or  the  selective  oestro-
gen-receptor  modulator  raloxifene.  Thus,  raloxifene  be-
haves as an oestrogen receptor agonist with regards to both 
regulation  of  vascular  cNOS  and  vasopressin-provoked  
increases  in blood pressure in  vivo.  
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Vasopressin deficiency decreases the frequency 
of gastroduodenal  ulceration in humans 
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Abstract—Vasopressin is a stress hormone released from the posterior pituitary. In humans suffering liront central diabetes insipidus, 
this release of vasopressin is diminished. It was shown previously that the congenutally vasopressiii-deticiein  Dratllobom homozygous 
rat  is  less  sensitive  to  various  ulcerogenic  stimuli.  In  this  study,  we  investigated  the  incidence  of  gatnnxlmxlonul  ulceration  in  
vasopressin deficient patients. Data on patients aged 20-70, hospitalized in Hungary between  1992 und 1995 wctf  compared with those 
on the total population in this age group (6 681020 in  1994). Subjects with central diabetes insipidus  wete  selected  separately  (815  
cases). Gastroduodenal ulceration was compared in subjects with an intact vasopressin release and vasoprattsln-tlehcicnl  patients. The 
frequencies  of  gastroduodenal  ulceration  were  also  examined  separately  in  male  and  female  subject*,  hi  the  mini  population,  the  
frequency  of  gastroduodenal  ulceration  was  lower  in  vasopressin-deficient  cases  (2.22%  versus  0.til%;  Pk  0.005).  Among  
normal-vasopressin  subjects, males have a higher risk of gastroduodenal  ulceration  than females (3.04%  versu«  Mo%,  respectively;  
P< 0.001). Among vasopressin-deficient subjects, a  similar male:female ratio was observed, but  it  was no) significant (P = 0.36). In 
comparison to the normal-vasopressin population, the incidence of gastroduodenal ulceration was reduced among VHSuprcssin-dcfifient 
males and females by 77% (P < 0.01) and by  82% (P < 0.05), respectively. In conclusion,  endogenous  vasopressin  has a significant 
harmful action towards the human  gastroduodenal  mucosa. Peptide  and non-peptide vasopressin  reccptor  antagonists  might  have a 
potential therapeutic benefit in the treatment (as an adjuvant) and prevention of gastroduodenal ulceration, © '¿000 Wsavicr Science Ltd. 
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1. Introduction 
Gastroduodenal  ulceration is a common disease. It 
is known that aggressive (e.g„ gastric acid, pepsin) and 
protective  (e.g.,  mucosal  blood flow, prostaglandins) 
factors  act  in  the  development  of  acute  or  chronic  
mucosal lesions, and an imbalance between them plays 
a key role in the occurrence of the disease [15]. 
In animals, endogenous vasopressin has been dem-
onstrated  to  act  as  an  aggressive  factor towards  the  
gastroduodenal  mucosa,  since  the  vasopressin-
deficient Brattleboro homozygous rat [16] is less sen-
sitive to various ulcerogenic  stimuli than the rat with 
normal-vasopressin  secretion [5, 6, 8]. 
In  humans,  suffering from central  diabetes  insipi-
dus,  the  secretion/release  of  vasopressin  from  die  
hypothalamus/posterior  pituitary  is  impaired.  These  
patients  are  ideal  subjects of  the investigation  of  the 
role of endogenous vasopressin in generation of vari-
ous  diseases,  in  which  this  stress  hormone  might  
possibly  have a pathogenetic  action. Accordingly  the  
aim of the present study was to evaluate the incidence 
of  gastroduodenal  ulceration  among  vasopressin-
* Correspondence  and reprints 
deficient human subjects in comparison  to the normal-
vasopressin population. 
2. Materials and methods 
2.1.  Study groups 
Two groups of human subjects ngrd between 20 und 
70 years  were  selected:  the  vasoprcsKiti-dclicienl  und 
the  non-deficient  groups.  The  vasopressin-deficient  
cases  suffered from central  diabetes  insipidus,  while  
the non-deficients were taken as the normal population 
in  Hungary in  1994 (data  on 01.01,1995).  All ccniral 
diabetes  insipidus  cases  hospitalized  in  Hungary  lie-
tween 01.01.1992 and 01.10.1995  were selected. Ad-
ditionally, the subjects in the two groups were exam-
ined on the basis  of their sex. 
2.2. Cases with gastroduodenal ulceration 
All patients aged 20-70 years  hospitalized  in Hun-
gary  between  01.01.1992  and  01.10.1995  with  gas-
troduodenal  ulceration  (including  nculc  or  chronic  
gastric  and/or  duodenal  ulceration  with  or  without  
Vasopressin  deficiency  and  the  frequency  of  gastroduodenal  nlcpration  65 
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Figure  1.  Incidence  (per  1 000 subjects)  of  gastroduodenal  ulceration  (including  acutc  and  chronic  gastric  and/or  duodenal  
ulceration  with  or  without  complication,  such  as  bleeding  and/or  perforation)  among  the  normal  Hungarian  population  aged  
20-70 years  (males,  females  and  total  population)  with  an  intact  vasopressin  release  (gray  column)  or  with  a  vasopressin  
deficiency (hatched column).  Statistical  significance: * P < 0.05;  ** P < 0.01;  and  ***  P < 0.005 for normal  vasopressin  versus  
vasopressin-deficient  cases,  and  **** P < 0.001  for males  versus  females.  
12], may  generate  vasoconstriction  and platelet  aggre-
gation  (via  its  Vj  receptors),  and  release  coagulant  
factors  (via  its  antidiuretic  V2  receptors),  leading  to  a  
reduced  blood  flow  and  a  consequent  hypoxia  in  the  
gastroduodenal  mucosa.  The  reduction  of  mucosal  
oxigenation  might  attenuate  the  protective  mecha-
nisms of  the gut and sensitize  it to the damaging effect  
of other well-known  aggressive  factors, such as gastric  
acid  and  pepsin  [15].  Indeed,  administration  of  vaso-
pressin Vj  receptor antagonists  elevates  blood  flow  in  
the superior mesenteric  artery  [14] and protects  against  
various  ulcerogenic  challenge  [5,  6,  8,  9]. Although  in  
a previous  study, a selective V2  receptor antagonist  has  
been  reported to be ineffective against  ethanol-induced  
gastric  hemorrhagic  erosions  in  the  rat [6],  but  the  
involvement of  this type of vasopressin  receptor  seems  
not  to  be  excluded  in  generation  of  gastroduodenal  
ulceration,  since  a  nou-sclcclive  vasopressin  receptor  
antagonist  (V,/V2  antagonist)  was  shown  to  be  more  
potent  in  the  ethanol  model  than  the  selective  V,  
receptor  antagonist  alone  (our  unpublished  result).  
In  conclusion,  endogenous  vasopressin  seems  to  
have  a  significant  harmful  action  towards  the  human  
mucosa  in  generation  of  gastroduodenal  ulceration.  
Peptide  and  orally  effective  non-peptide  vasopressin  
receptor  antagonists  may  have  a  potential  therapeutic  
benefit in the prevention  and treatment  (as an adjuvant) 
of  gastroduodenal  ulceration.  
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Abstract 
Inhibition  of  constitutive  nitric  oxide  (NO)  synthases  by  administration  of  NG-nitro-L-arginine  methyl  ester  (l.-NAME)  during  
abdominal  laparotomy provokes extensive  vascular  leakage in  the rat  gastrointestinal  tract,  assessed  by  the  extrnvaNUlifin of  [mI]human  
scrum  albumin.  In  the present  study,  the  role  of  vasoactive  or  neutrophil-derived  pro-inflammatory  mediators  in  this  process  has  been  
investigated.  Administration  of the thromboxane synthase inhibitor,  1 -benzyI-imidazole (BZI, 25-50  mg kg - 1 ,  s.c.),  the  platelet-activat-
ing  factor  (PAF)  receptor  antagonist,  3-[4-(2-chlorophenyl)-9-methyl-6ff-thienol-[3,2-f][l,2,4]-triazolo-[4.3-aJ[|.4]  clia7cpine-2-yl]-l-(4-
morpholynilH-propionate  (WEB  2086;  0.5-1  mg  kg" ' ,  s.c.),  the  5-lipoxygenase  synthase  inhibitor,  /V-(4-benzyloxybenzyO-
acetohydroxamic  acid (BW A137C; 4 - 2 0  mg kg"1 ,  s.c.) or the vasopressin pressor  receptor  antagonist  ([Mca1 .TyriMe)3.Arg8]vasopres-
sin/Manning  peptide;  0.01-0.2  |ig  k g - 1 ,  s.c.)  dose-dependently  reduced  the  intestinal  plasma  leakage  provoked  by  l-NAME  (5  mg  
kg" ' ,  s.c.), following a 5-cm abdominal laparotomy in anaesthetised rats. These findings suggest that constitutive NO synthase effectively 
counteracts  the  damaging  actions  on  microvascular  integrity  of  mediators,  including  thromboxanes,  PAF,  leukotricnes  and  vasopressin,  
released  during  surgical  intervention.  ©2000  Elsevier  Science B.V. All  rights  reserved.  
Keywords:  Nitric  oxide  (NO);  Vascular  permeability;  Vascular  endothelium; Neutrophil  granulocytes:  Platelet-activating  factor (PAP);  Thromboxanes;  
Leukotricnes; Vasopressin: Surgery 
1. Introduction 
During major surgical  operations,  a  reduction  in  circu-
lating  plasma  volume  can  occur,  following  increased  
plasma  extravasation,  which  develops  without  significant  
bleeding (Krakelund, 1971; Akerström and Lisander, 1991). 
However,  few  experimental  or  clinical 'studies  have  ex-
plored  the  mechanism  underlying  this  phenomenon  
(Akerström and Lisander,  1991; László and Whittle,  1999;  
László et al..  1999).  
Nitric oxide (NO), formed continuously  in the vascular 
endothelium by the constitutive NO synthase, eNOS, plays 
" Corresponding  author.  TeL:  444-20-7882-6176;  fax:  444-20-7882-
6177. 
E-mail address:  b.j.whittle@mds.qmw.ac.uk (BJ.R.  Whittle).  
a  key  role  in  the  maintenance  of  vascular  integrity  
(Moncada and Higgs,  1995).  NO attenuates  the adherence 
and immigration of leukocytes in the vascular endothelium 
(Kubes  et  al.,  1991),  a  process  of  key  importance  in  the  
generation  of  vascular  endothelial  dysfunction,  vascular  
congestion  and  inflammation  (Wedmote  and  Williams,  
1981).  Indeed,  inhibition  of  the  constitutive  NO synthase, 
eNOS,  leads  to  neutrophil  adhesion  and  the  elevation  of  
vascular  permeability,  particularly  in  surgically  prepared  
models  (Kubes  et  al.,  1991;  Kubes  and  Granger,  1992;  
Arndt et al.,  1993).  
In  recent  studies,  constitutively  formed  NO  has  been  
suggested  to  play  a  beneficial  role  against  widespread  
plasma  loss,  observed  during  surgical  operation,  through  
the  maintenance  of  microvascular  integrity  (László  and  
Whittle.  1999; László et al.,  1999). Thus, midline abdomi-
nal laparotomy  and anaesthesia alone, or administration of 
0014-2999/00/S - see front matter ©2000 Elsevier Science  B.V. All rights reserved. 
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the  NO synthase inhibitor,  Nc-nitro-L-arginine  methyl  es-
ter  (L-NAME),  to  anaesthetised  animals  alone,  did  not  
affect  vascular  permeability.  In  contrast,  when  L-NAME  
was  administered  to  laparotomized  animals,  a  generalised  
increase  of albumin leakage developed  in intestinal  organs  
as  well  as  in  the  lungs  and  kidneys  (László  and  Whittle,  
1999). A reduction in the number of circulating neutrophils 
attenuated this vascular leakage provoked by L-NAME  and  
laparotomy  in  all  of  the  organs  investigated,  which  sug-
gests  an  involvement  of  neutrophil-derived pro-inflamma-
tory mediators in this surgical plasma extravasation (László 
and Whittle,  1999).  
In  previous  studies,  a  role  for  the  neutrophil-derived  
pro-inflammatory  mediators  thromboxanes,  platelet-acti-
vating  factor  (PAF)  and  leukotrienes,  on  the  develop-
ment  of  vascular  leakage  provoked  by  die  acute  admini-
stration  of  L-NAME  following  bacterial  endotoxin  
challenge, has been established (László and Whitde,  1995;  
László et al.,  1994).  In the present  work,  the  involvement  
of  such  mediators  in  responding  to  L-NAME  following  
midline  abdominal  laparotomy  has  been  explored  using  
specific  antagonists  and  synthase  inhibitors.  In  addition,  
using  a  specific  vasopressin  pressor  receptor  antagonist,  
the actions of  endogenous vasopressin,  which is known to 
be  released  during  surgical  interventions  (Melville  et  al„  
1985), have been evaluated. 
2. Materials and  methods  
2.1. Surgical manipulation 
Male  Wistar rats  (225-275  g)  were  starved  overnight,  
but were allowed free access to water. In the basal control 
group,  the  treatments  were  performed  under  transient  
halothane  anaesthesia  from  which  the  animals  had  com-
pletely recovered  within 2  min.  Autopsy  in  this  surgically  
unoperated  group  was  performed  under  halothane  anaes-
thesia. In all other groups (using  pentobarbitone-anaesthe-
tised  animals),  a  5-cm  long  midline  laparotomy  in  the  
abdominal  wall  was  performed without  significant bleed-
ing. Rats were tracheotomized  and a gauze pad moistened 
with saline was placed over the incision. At the beginning 
of  the  experiment,  all  groups  were  administered  [  I]hu-
man  serum  albumin  (2  p.Ci  kg -1 ,  i.v.)  via  a  needle  
inserted  into  the  tail  vein  for 3-4  s.  Autopsy  was  per-
formed 1  h later.  
2.2. Plasma leakage 
As a measure of vascular endothelial permeability, leak-
age  of  [,25l]human  serum  albumin  into  tissue  was  deter-
mined in segments  of  the jejunum  and  colon.  Blood  were  
collected from the  abdominal  aorta  into  syringes  contain-
ing trisodium citrate (final concentration 0.318%) and were 
centrifuged  (10.000 *  10  min.  4°C).  The  [,3SI]human  
serum  albumin  content  of  llir  plasma  and  of  segments  of  
tissues  was  detected  in  a  gumma  spectrometer  (Nuclear  
Enterprises  NE  1600).  and  the  albumin  content  in  tissues  
was calculated. 
The  resting  value  fot  albumin  accumulation  was taken 
as the mean of the data  of a group of basal control animals. 
In  each  experiment,  and  (or  each  procedure,  this  basal  
control mean value was calculated  and subtracted from the 
value from  each  of  the  nnimuls,  in  each  treatment  group.  
The data were expressed  as changes  in  albumin  accumula-
tion  (Aplasma  leakage,  in  microliter  plasma  per  gram  
tissue)  corrected  for  intravascular  volume  (László  et  al.,  
1994). 
2.2.1.  Intravascular volume 
Changes  in  intravascular  volume  in jejunal  and colonic  
tissues  were  determined  in  additional  groups  of  rats  by  
administering  [IIAI]human  serum  albumin  (2  p.Ci  kg -1)  
intravenously via the tail  vein 2 min before tissue removal, 
in all groups investigated. The tissue and plasma content of 
radiolabel  were  determined  and  the  intravascular  volume  
was expressed  as microliter  per  gram  tissue  (László et al.,  
1994). 
2.3.  Effect of L-NAME  and laparotomy on intestinal plasma 
leakage 
In  groups  of  rats,  L-NAME  (5  mg  kg'1 ,  s.c.)  was  
injected  concurrently  with  [l2Sl]human  scrum  albumin.  
Plasma  leakage  in  the  jejunum  and  colon  was  evaluated  
after  1  h.  The  dose  of  L-NAME  and  the  timing  of  the  
experiment were based  on the results of our previous study 
(László and Whittle.  1999).  
2.4. Effect of pro-inflammatory and vasoactive  mediators  
on plasma  leakage provoked  by  L-NAME  and laparotomy 
In laparotomized and L-NAME (5  mg kg"1,  s.c.)-treated 
rats,  the  thromboxane  synthase  inhibitor,  1-benzyl-imi-
dazole  (BZX;-25-50  mg kg'1),  the  PAF receptor  antago-
nist,  (3-[4-(2-chlorophcnyl)-9-mcthyl-6  N-thienol-[3,  
2-f][l,2,4] - triazolo- [4,3 - n] [1,4]-diazcpine-2- yl]-l-(4-mor-
pholynil)-1-propionate  ( W E B  2086;  0 . 5 - 1  mg  kg"1),  
the  5-lipoxygenase  inhibitor,  N-(4-benzyloxybenzyl)-ace-
tohydroxamic  acid  ( B W  A137C;  4 - 2 0  mg kg"1)  or  the  
vasopressin  pressor  receptor  antagonist  ([Mca',Tyr(Me)2,  
Arg8]vasopressin/Manning  peptide;  0 . 01 -0 .2  fig  kg'1)  
was injected s.c.,  15  min  before laparotomy  and  L-NAME  
administration.  Plasma  leakage  in jejuna]  and  colonic  tis-
sues  was  determined  1  h  after  laparotomy.  All  the  com-
pounds  were  dissolved  in  saline  immediately  before  the  
experimentation. The  doses,  timing  and  route  of  adminis-
tration  of  drugs  were  established  in  our  previous  studies  
A 
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(László  et  al.,  1991,  1994;  László  and  Whittle,  1995,  
1999). 
2.5.  Chemicals  
[125I]human  serum  albumin  was  obtained  from  Amer-
sham  International  (UK).  BZI  and  BW  A137C  originated  
from  the  Wellcome  Research  Laboratories,  Beckenham,  
UK.  WEB  2086  was  supplied  by  the  Boehringer  Ingel-
heim,  Germany.  The  vasopressin  antagonist  was  acquired  
from  Bachem,  Germany.  All  the  other  compounds  were  
from  Sigma  (Poole,  Dorset,  UK).  
2.6.  Statistics  
The  data  are  expressed  as  mean  ±  SEM  from  (n)  rats  
per  experimental  group.  For  statistical  comparisons,  analy-
sis  of  variance  with  the  Bonferroni  test  was  utilised,  where  
P  <  0.05  was  taken  as  significant.  
3.  Results  
3.1.  Intestinal  albumin  leakage  provoked  by  L-NAME  dur-
ing  laparotomy  
No  significant  intestinal  albumin  leakage  could  be  ob-
served  when  L-NAME (5  mg  kg"1 ,  s.c.)  was  administered  
alone  into  the  anaesthesized  non-laparotomized  rat  after  1  
h  (A2  ±  4  and  A6  ±  3  p.1 g"1  tissue  in  the  jejunum  and  
[JEJUNUM  I  
20,mg  kg'1  
laparotomy + L-NAME (5 mg  kg"1)  
Fig.  1.  Jejunal and colonic albumin leakage provoked  by L - N A M E  (5 mg 
kg"1,  s.c.) in  the laparotomized  rat over  1  h. The effects of  pretreatment  
(15  min) with  a  thromboxane  synthase  inhibitor  (BZI, 25-50  mg kg"1,  
s.c.).  with  a  PAF  receptor  antagonist.  WEB  2086  (WEB,  0.5-1.0  mg  
kg"1,  s.c.),  or  with a  leukotriene  synthase  inhibitor,  BW A137C (137C, 
4-20  mg kg"1,  s.c.) are  shown.  Data are  expressed  as  the  mean±SEM,  
where  (n)  is  minimum  five  rats  for  each  group,  and  where  statistical  
significance  is  given  as  *P < 0.05  compared  to  conscious  untreated  
animals;  ' P  < 0.05  compared  to  L - N A M E  plus  laparotomy  (control)  
groups. 
laparotomy •  L-hAMh (6 mg  kg')  
Fig.  2.  Dose-dependent  attenuation  of  l/NAMF  (5  mg  kg"1,  s,c./pro-
voked rat jejunal and colonic  albumin  leakage  in laparoti'mizcd uts  over  
1  h.  by  the  pretreatment  (15  min)  with  llu-  vasopressin  pressor  receptor  
antagonist  (VP  antagonist.  0.01-0.2  pg  kg"1,  s.c.)  Dare  Mr  expressed  
as  the mean±SEM,  where (n)  is  minimum five rats  for each  group, and 
where  statistical  significance  is  given  as  *P  «. 0.0'  compared  to  con-
scious  untreated  animals; ' P  < 0,05  compared  to I  NAME plus  laparo-
tomy (control) groups. 
colon,  respectively;  n  •= 7).  Laparotomy  alone  did  not  
provoke  significant  jejunal  or  colonic  albumin  leakage  
over  the  1-h  study  period  (A5  ±  7  mid  Al  ± 7  p.1  g"1  
tissue  in  the  jejunum  and  colon,  respectively;  n  —  8).  In  
contrast,  when  L-NAME  was  administered  concurrently  
with  the  laparotomy  procedures,  significant  albumin  leak-
age  occurred  in  jejunal  and  colonic  tissues  (A82  ±  3  and  
A61  ±  5  p.1 g - 1  tissue,  respectively;  n -  U,  /'  <  0.005),  as  
demonstrated  in  Fig.  1.  
3.2.  Role  of pro-inflammatory  and  vasoactive  mediators  in  
intestinal  plasma  leakage  provoked  by  l  NAME  and  la-
parotomy 
Pretreatment  (15  min)  with  the  thromboxane  synthase  
inhibitor  (BZI,  2 5 - 5 0  mg  kg"1,  s.c.),  the  PAF  receptor  
antagonist  (WEB  2086,  0 .5-1  mg  kg"',  s.c.)  or  a  5-lipo-
xygenase  inhibitor  (BW  A137C,  4 - 2 0  mg  kg"1 ,  s.c.)  
dose-dependently  attenuated  the  subsequent  jejunal  and  
colonic  plasma  leakage  provoked  by  laparotomy  and  L-
NAME,  with  a maximum reduction  of  K8 ±  15%, 97  ±  2%  
or  87  ±  6%  respectively  in  the  jejunum  (n  -  5 - 7 ;  P  <  
0.001),  as  shown  in  Fig.  1.  
Administration  of  the  vasopressin  pressor  receptor  an-
tagonist,  [Mca1 ,TyKMe):,Arg8Jvasoprcssiti  (0.01-0.2  p-g  
kg"1 ,  s.c.,  15  min  before  laparotomy  anil  L-NAME),  de-
creased  jejunal  and  colonic  albumin  extravasation  induced  
by  L-NAME  in  the  laparotomized  rat,  with  a  maximum  
reduction  of  98  ±  1%  in  the  jejunum  (n  -  6;  P  <  0.001),  
as  shown  in  Fig.  2.  
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4. Discussion 
In the present  study, administration  of  the NO synthase 
inhibitor,  L-NAME  provoked  albumin extravasation  in  the  
rat intestinal  tract following laparotomy, confirming previ-
ous observations  (László  and  Whittle,  1999; László et  al.,  
1999).  Other  workers  had  earlier  demonstrated  that  L-
NAME  could  induce  an  increase  in  vascular  permeability  
in  surgically  manipulated  models  (Kubes  and  Granger,  
1992; Filep and Földes-Filep,  1993). These data show that 
constitutive  NO  plays  a  significant  beneficial  role  in  the  
maintenance of microvascular integrity  during  and follow-
ing  such surgical  operations.  
Inhibition  of  NO  synthase  enhances  the  adhesion  of  
leukocytes  to  the  vascular  endothelium  in  surgically  pre-
pared  vascular  beds  (Kubes  et  al.,  1991;  Amdt  et  al.,  
1993).  Adhesion  of  polymorphonuclear  leukocytes  to  the  
vascular  endothelium is  well-established  to play  a  crucial  
role  in  the  increase  of  microvascular  permeability  
(Wedmore  and  Williams,  1981; Bone,  1991),  most  likely  
by  releasing  neutrophil-derived  pro-inflammatory  media-
tors,  such  as thromboxanes,  PAF and  leukotrienes  (Bone,  
1991).  Indeed,  previous  studies  have  demonstrated  that  
administration  of  PAF  receptor  antagonists  decreased  L-
NAME-induced vascular permeability in the post-operative 
period  (Filep  and  Földes-Filep,  1993). Furthermore,  treat-
ment  with  5-lipoxygenase  inhibitors  or  PAF receptor  an-
tagonists  attenuated  L-NAME-provoked  enhancement  of  
adhesion  of  neutrophils  to  the  vascular  endothelium  fol-
lowing surgical preparation  (Arndt et al.,  1993).  
In  previous  studies, L-NAME  has  also  been  shown  to  
enhance  substantially  the  vascular  leakage  following  the  
acute  administration  of  bacterial  endotoxin  (László  et  al.,  
1994). This acute response was attenuated by PAF receptor 
antagonists,  thromboxane  synthase  inhibitors  or  a  5-lipo-
xygenase inhibitor, BW A137C, suggesting a role for these 
neutrophil-derived  mediators in this process (László et al.,  
1994; László and Whittle,  1995). Likewise,  in  the present 
study, the PAF receptor antagonist, WEB 2086, the throm-
boxane  synthase  inhibitor,  BZL  or  the 5-lipoxygenase in-
hibitor,  BW A137C,  significantly  attenuated  albumin  ex-
travasation.  Thus,  the  release  of  the  neutrophil-derived  
pro-inflammatory  mediators  PAF,  thromboxanes  and  
leukotrienes  appears  to  participate  in  the  increase  of  in-
testinal  vascular  permeability  observed  as  a  consequence  
of  acute  abdominal  surgery  following  administration  of  
L-NAME...  .  ...  
The  release  of  the  pituitary  nonapeptide,  vasopressin,  
into die  general  circulation  during  surgical  operations  has  
been  described (Melville et  aL,  1985). It  has  been known 
that vasopressin can be released from the vascular endothe-
lium (Bumstock,  1991). In  addition, pathological levels of 
vasopressin  can  provoke  vascular  endothelial  dysfunction 
via its pressor receptors (László et al.,  1991). In the present 
study,  administration  of  the  vasopressin  pressor  receptor  
antagonist  dose-dependently  attenuated  albumin  leakage  
provoked  by  L-NAME  in  tiro  Iftpaiotomized  rat.  Thus,  
endogenous vasopressin  nifty also  play a role in  the devel-
opment of the enhanced tnlProvasi'ular permeability during 
surgical  intervention.  
Our  current  studies  suggest  thai  the  regulation  of  the  
maintenance of  microvascular  Integrity  during surgical  op-
erations  involves  complex  interactions  between  endothe-
lium- and neutrophil-depcnilent  mechanisms. Thus, consti-
tutively  formed  NO,  most  likely  of  endothelial  origin,  
appears  to  play  a  significant  pathophysiological  role  in  
preventing  albumin  extravasation  in  response  to  surgical  
challenge.  Injurious  mediators,  such  as  the  neutrophil-de-
rived  pro-inflammatory  thromboxanes,  PAF  and  leuko-
trienes,  appear  to  be  released  following  laparotomy,  as  
does  vasopressin;  the  lattci  of  which  may  originate from 
the  posterior  pituitary  or  from  the  vascular  endothelium.  
The  present  findings  suggest  that  such  mediators  may  
interact  either  synergistically  or  in a sequential  cascade to 
provoke the eventual  microvascular  dysfunction. The pro-
cesses  that  stimulate  such  mediator  release  following mi-
nor surgery are as yet  unknown, although the present work 
suggests that  the release  or actions  of  these factors can be 
modulated by endogenous NO. 
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30  The  actions  of a  purified  Helicobacter pylori  lipopolysaccharide  (3  mg kg - 1 ,  i.v.)  on  rat  gastric  antral  and  duodenal  microvascular  
31  integrity (determined as radiolabeled  albumin leakage) and the expression  of the inducible nitric oxide (NO) synthase (iNOS; assessed by 
32  the citrulline assay) were investigated 4 h after challenge.  Significant increases  of albumin  leakage and expression  of  iNOS  in  both antral 
33  and  duodenal  tissues  were  observed  following  challenge.  Concurrent  administration  of  the  selective  iNOS  inhibitor,  I400W  ( IV-(H-
34  (aminomethyl)benzyO-acetamidine;  0.2-1  mg kg - 1 ,  s.c.), with lipopolysaccharide,  caused a dosc-depcndcnt  attenuation of the gastric anil 
3 5  duodenal  albumin  leakage.  Thus,  H.  pylori  lipopolysaccharide  can  initiate  the  expression  of  iNOS  in  the  stomach  and  duodenum  
36  following systemic challenge, which can provoke gastroduodenal  microvascular  dysfunction. © 2 0 0 1  Published  by  Elsevier  Scicncc  H . V .  
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43  1.  Introduction  1999).  One  such  potential  mechanism  involves  lite  ittap-  69  
44  propriate production  of  nitric  oxide (NO),  sincc the cxprcs-  70  
45  The  acid-resistant  Gram-negative bacterium,  Helicobac-  sion  of  the  inducible  NO  synthase  enzyme  (iNOS)  can  be  71  
46  ter pylori,  grows  predominantly  in  the  antral  region  of  the  triggered  by  the  lipopolysaccharide  component  of  bacterial  72  
47  stomach  and  at  sites  of gastric  metaplasia  in  the  duodenum  endotoxins,  as  well  as  the  cytokines  produced  by  lipopoly-  73  
48  (Blaser,  1990).  The pathological  involvement  of  H.  pylori  saccharide  challenge  (Moneada  and  Iliggs,  1995,  Perez-  74  
49  is  recognized  in  gastric  mucosal  inflammation  and  in  Perez  et  al.,  1995).  This  overproduction  of  NO  has  cvto-  75  
so  gastroduodenal  peptic  ulceration  (NIH,  1994).  To  under-  toxic  potential  and  provokes  witlespreatl  microvascular  76  
51  stand  the  mechanisms  that  are  in  involved  in  such  gastro-  inflammatory  reactions  with  albumin  leakage  into  the  in-  77  
52  duodenal  tissue  inflammation  and  injury,  it  is  important  to  terstitium  (László  et  al.,  1995).  Recent  studies  have  shown  70  
53  evaluate  the  effects of  the  soluble  mediators  produced  by  that  the  purified  lipopolysaccharide  from  H.  pylori  can  79  
54  H.  pylori  and  their  actions  in  promoting  cytotoxicity.  cause cytotoxicity  in  rat  duodenal  epithelial  cells  following  ao  
55  The  purification  of  lipopolysaccharide  from  H.  pylori  in  vivo challenge (Lamarque  et al.,  2000).  Pharmacological  BI  
56  has  provided  an  important  tool  for  exploring  the  cytotoxic  studies  indicate  that  this  cytotoxic  action  involves  the  82  
processes related  to the bacterium  and  its products  (Moran,  expression  of  iNOS  in  the  epithelial  cells  and  the  produc-  83  
57  tion  of  superoxide  (Lamarque  et  al.,  2000),  thus  iinplical-  84  
58  ing  a role  of the  cytotoxic  species,  peroxynitritc  (Bcckman  BS  
IS  et  al  1990)  
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91  leads  to  the  expression  of  iNOS,  determined  by  the  cit-
92  rullinc assay,  and  the production  of microvascular  dysfunc-
93  tion,  determined  as  the  leakage  of  radiolabelled  albumin,  
94  in  both  the  gastric  antrum  and  duodenum  of  the  rat.  The  
95  association  of  such  microvascular  injury  with  iNOS  ex-
96  pression  was  explored  by  the  use  of  the  bisisothiourea  
97  derivative,  1400W  (Garvey  et  al.,  1997;  László  and  Whit-
98  tie,  1997),  a  potent  and  selective  inhibitor  of  the  iNOS  
isoform. 
2.  Materials  and  methods  
101 
102 
103  2.1.  Experimental  procedures  
1 0 4 
105  Male  Wistar  rats (230-250  g) were  fasted overnight  but  
106  were  allowed  free  access  to  water.  Under  transient  ether  
107  anaesthesia,  purified  H.  pylori  lipopolysaccharide  (3  mg  
108  k g - 1 )  was  administered  into  the  tail  vein,  and  the  gastric  
antrum  and  the  duodenum  were  removed  4  h  later.  
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2.2.  Albumin  leakage  
For  the  measurement  of  vascular  permeability,  [125I]hu-
man  serum  albumin  was  administered  (2  pCi  k g - 1 ,  i.v.)  
and  its  leakage  into  the  tissue  determined  in  segments  of  
the  gastric  antrum  and  duodenum,  4  h  after  lipopoly-
saccharide  administration.  Blood  was  collected  from  the  
abdominal  aorta  into  syringes  containing  trisodium  citrate  
(final  concentration  0.318%)  and  centrifuged  (10,000  X g ,  
10  min,  4°C).  The  [125I]human  serum  albumin  in  the  
plasma  and  segments  of  tissues  was  detected  using  a  
gamma-spectrometer  (Nuclear  Enterprises  NE  1600).  Sub-
sequently,  the  tissues  were  dried  at  80°C over  48  h  and  the  
albumin  content  on  a  weight  basis  was  calculated.  
The  resting  value  for  albumin  leakage  was  taken  as  the  
mean  of  the  data  of  untreated  control  animals.  In  each  
experiment  and for each procedure,  this basal  control  mean  
value  was  subtracted  from  the  values  of  treatment  groups.  
The  data  were  expressed  as  changes  in  albumin  accumula-
tion  (A  plasma  leakage,  p i  plasma  g"1  dry  tissue)  as  
described  previously  (László  et  al.,  1994,  1995).  
2.3.  Nitric  oxide  synthase  enzyme  activity  
NO  synthase  (NOS)  activity  was  determined  as  the  
conversion  of  L-[14C]arginine  monohydrochloride  to  L-
[l4C]citrulline  (László  et  al.,  1995).  After  lipopolysaccha-
ride  administration  (4  h),  gastric  antral  and  duodenal  tis-
sues  were  homogenized  (15  s)  in  buffer  (250  mg  m l - 1 ,  
4°C)  containing  HEPES  (10  mM),  sucrose  (32  mM),  
dithiothreitol  (1  mM),  EDTA  (0.1  mM),  soybean  trypsin  
inhibitor  (10  p g  m l - 1 ) ,  leupeptin  (10  p g  m l - 1 )  and  
aprotonin  (2  p g  m l - 1 ) .  This  tissue-containing  buffer,  ad-
justed  to pH  7.4,  was centrifuged  at  10,000  X g  for 20  min  
at  4°C.  A  40-pi  sample  of  supernatant  was  incubatcd  for  
10  min  at  37°C  in  110  pi  of  reaction  buffer  comprising  
(final  concentrations):  50  mM  K l l 2 P 0 4 ,  1  mM  MgCl2,  
0.2  mM  CaCI2,  50  mM  valine,  I  mM  dithiothreitol,  15  
nM  L-arginine,  1 mM  l.-citrullinc,  0.3  mM  NADPH,  3  pM  
FAD,  3 p M  FMN  and  157  pM  [l'1C]L-arginine.  The  reac-
tion  was  arrested  by  the  addition  (0.5  ml)  of  a  1:1  suspen-
sion  of  Dowex  (AG  50W-8)  in  water.  The  mixture  was  
dispersed  and  diluted  with  0.85  ml  of  distilled  water,  and  
allowed  to  settle  for 30 min. The  supernatant  was  removed  
for estimation  of  the  radiolabelled  products by  scintillation  
counting  (2  ml  Pico-Fluor).  Sample  protein  content  was  
estimated  via  spectrophotomctric  assay  (Bio-Rad  Protein  
Assay),  and  NOS  activity  was  expressed  as  pmol  min - 1  
mg" '  protein.  
Total  NOS  activity  was  defined  as  citrulline  formation  
that  was  abolished  by  incubation  in  vitro  with  Ac-mono-
methyl-L-arginine  (i-NMMA,  700  pM).  The  L - N M M A -
sensitive  NOS  activity  that  was  not  inhibited  by  E G T A  ( 1  
MM)  incubation  was taken  as  iNOS  activity  (László  et  al.,  
1995). 
2.4.  Effect  of  selective  inhibition  of  inducible  nitric  oxide  
synthase  on  gastric  and  duodenal  albumin  leakage  
In  a  separate  experiment,  the  selective  iNOS  inhibitor,  
A-(8-(aminomethyl)benzyl)-acetamidine  (1400W;  0.2-1  
mg  kg" 1 ,  s.c.)  was  administered  concurrently  with  H.  
pylori  lipopolysaccharide.  The  dose,  timing  and  route  of  
administration  of  1400W have been  established  in  previous  
studies  (Garvey  et  al.,  1997;  Lamarque  et  al.,  2000).  The  
gastric  antrum  and  the  duodenum  were  removed  4  h  
following  treatment.  
2.5.  Chemicals  
Purified  H.  pylori  lipopolysaccharide  was  prepared  as  
previously  described  (Nielsen  et  al.,  1994;  Moran,  1999).  
1400W  (A-(8-(aminomethyl)benzyl)-acetamidine)  was  ob-
tained  from  GlaxoWellcome  (Stevenage,  UK).  L-[U-
14C]arginine  monohydrochloride  was  obtained  from  Amcr-
sham  International  (UK).  [125l]Human  serum  albumin  was  
purchased  from  IZINTA  (Budapest,  Hungary).  All  other  
compounds  were  from  Sigma.  
2.6.  Statistics  
The  data  are  expressed  as  mean  ±  S.E.M.  from  n  rats  
per  experimental  group.  For  statistical  comparisons,  the  
Mann-Whitney  non-parallel  (/-test  and  the One-way  Anal-
ysis  of  Variance  followed  by  the  Tukcy-Kramer  Multiple  
Comparisons  Test  were  utilised,  where  appropriate.  P  <  
0.05  was  taken  as  a  significant  difference.  
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3.  Results  
3.1.  Induction  of  nitric  oxide  synthase  and  albumin  leak-
age 
Administration  of purified  H. pylori  lipopolysaccharide  
(3  mg kg - 1 ,  i-v.)  led  to  the  expression  of  iNOS  activity  in  
the  whole  tissue  of  the  gastric  antrum  (Fig.  1)  and  duo-
denum  (Fig.  2)  when  determined  4  h  later.  The  activity  of  
iNOS  following  challenge  was  significantly  higher  in  the  
duodenum  than  in  the  antrum  (144  ±  58  and  9 ±  5  pmol  
min"1  mg" '  protein,  respectively;  n  — 4,  P  <  0.05).  
The  albumin  accumulation  of  non-challenged  control  
rats  was  217 ±  11  and  383 ±  10  p.1 g"1  dry  tissue  in  the  
gastric  antrum  and  duodenum,  respectively  (n  =  6).  In  a  
separate  group  of  animals,  a  significant  increase  in  gastric  
antral  and duodenal  vascular albumin  leakage  occurred  4 h 
after the  injection of purified  H. pylori  lipopolysaccharide  
(3  mg kg"1 ,  i.v.)  as  shown  in  Figs.  1 and  2,  respectively.  
The  enhancement  of albumin  leakage  after  lipopolysaccha-
ride  challenge  was  significantly  greater  in  the  duodenum  
compared  to the  gastric  antrum  (A  322 ±  27  and  A  201  ±  
22  p.1 g" '  dry  tissue,  respectively;  n =  6,  P  < 0.01). 
Macroscopically  visible  gross  damage  did  not  develop  
either  in  the  gastric  antrum  or  duodenum,  over  the  4  h  
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Fig.  I.  Increase  in inducible nitric oxide synthase  enzyme activity  (iNOS;  
pmol  min"'  mg" '  protein;  left  panel)  and  in  vascular  leakage  (pi  
albumin g" '  dry tissue; right  panel) in the rat gastric  antrum provoked by 
the  intravenous administration  of a purified endotoxin  (LPS) of  H. pylori 
(3  mg  kg"') ,  determined  4  h  later.  The  effects  of  the  concurrent  
administration  of  the  selective  iNOS  inhibitor,  1400  W (1  mg kg ' 1  and  
0.2-1  mg  kg"1,  respectively;  s.c.)  4  h  later  are  also  shown.  Data  are  
expressed  as mean±S.E.M.,  where  n = 4-6  rats  were  in  a  group,  where  
*P  < 0.05  is a  significant  increase  in  iNOS activity  and  albumin  leakage  
following  lipopolysaccharide  administration;  " P <  0.05  is  a  significant  
reduction  of  lipopolysaccharide-provoked  iNOS  expression  and  vascular  
permeability. 
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Fig. 2.  Increase  in inducible  nitric  oxide  synihasc enzyme  nctiviiy (iNOS; 
pmol  min"'  mg"1  protein;  left  panel)  and  in  vascular  leakage  (pi  
albumin g" '  dry tissue;  right  panel)  in  die  rat  duodenum  provoked  hv tlir  
intravenous administration  of  u purified  endotoxin (LPS)  of  II  pvh<ri  (.<  
mg kg"1),  determined 4  h later. The clfecls of the concurrent  utlmuUslru  
tion  of  the  selective  iNOS  inhibitor,  I400W  (I  nig  kg  1  und  0.2-  I  mg  
kg" ' ,  respectively;  s.c.)  4  h  later  arc  also  shown.  Data  ate  expressed  us  
mean±S.E.M.,  where  n = 4  6  rats  wete  in  a group,  where  P  < 0.05  is  
a  significant  increase  in  iNOS  aelivily  und  albumin  leakage  (allowing  
lipopolysaccharide  administration;  * P  -  0.05  is n significant reduction  of  
lipopolysaccharide-provoked  iNOS expression  and  vascular  permeability.  
following  lipopolysaccharide  administration,  nor  was  it  
observed  in  any  other  region  of  the  gastrointestinal  tract.  
3.2.  Effect  of  selective  inhibition  of  inducible  nitric  oside  
synthase  on  gastric  and  duodenal  albumin  leakage  
Administration  of  the  selective  iNOS  inhibitor,  I400W  
(0.2-1  mg  kg"1 ,  s.c.)  concurrently  with  II.  pylori  lipo-
polysaccharide  (3  mg  kg"1 ,  i.v.)  caused  a  significant  and  
dose-dependent  reduction  of  lipopolysaccharide-provoked  
vascular  albumin  leakage  in  the  gastric  antrum  and  duo-
denum  determined  after 4  h (Figs.  I  and  2).  Thus,  I400W  
(1  mg  kg" ' ,  s.c.)  reduced  albumin  leakage  in  the  duo-
denum  and  in the gastric  antrum  by  86 ±  4%  and  68 ±  (t%,  
respectively ( P  <  0.05;  n =  4).  
Likewise,  1400W  (1  mg  kg  ' ,  s.c.)  caused  a  92 ±  (>%  
(n  =  4,  P  < 0.05)  and  98 ±  1% (n  •= 4,  P  <  0.05)  inhibi-
tion  of  iNOS  activity,  determined  4  h  after  challenge,  in  
the  gastric  antrum and  duodenum,  respectively (Figs.  1 and 
2). 
4.  Discussion  
In  the  present  in  vivo  study,  an  increase  in  albumin  
leakage,  a  sensitive  index  of  vascular  cell  injury  and  
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274  inflammation,  in  the  rat  gastric  antrum  and  duodenum  
275  could  be  observed  4  h  following  the  intravenous  adminis-
276  tration  of  H.  pylori  lipopolysaccharide.  These  findings  of  
277  gastroduodenal  microvascular  dysfunction  agree  with  pre-
278  vious  observations,  where  increases  in  microvascular  per-
279  meability  to  protein  in  the  rat  mesenteric  circulation  fol-
280  lowing  local  application  of  a  water-extract  of  H.  pylori  
2Bi  have  been  observed  (Kurose  et  al.,  1994).  In  addition,  
282  administration  of  H.  pylori  extract  or  purified  lipopoly-
283  saccharide  has  been  shown  to  provoke  injury  of  duodenal  
2 84  epithelial  cells  following  intravenous  challenge  (Lamarque  
285  et  al.,  1998;  Lamarque  et  al.,  2000).  
286  The  mechanisms  by  which  soluble  mediators  derived  
287  from  H.  pylori  can  injure  the  gastroduodenal  microvascu-
288  lature  could  involve  a  number  of  pathways.  Early  studies  
289  suggested  that  H.  pylori  extract-induced  microcirculatory  
290  albumin  leakage  could  be  the  consequence  of  interstitial  
291  and  intravascular  cell-cell  interactions  (Kurose  et  al.,  
292  1994).  Thus,  the  lipopolysaccharide  from  H.  pylori  can  
293  activate  polymorphonuclear  cells  (Nielsen  et  al.,  1994).  
294  Administration  of  H.  pylori  extract  can  lead  to  the  expres-
295  sion  of  a  neutrophil-activating  protein,  which  causes  neu-
296  trophils  to  adhere  to  the  vascular  endothelium,  an  event  
297  that  can  initiate  microcirculatory  protein  leakage  (Evans  et  
298  al.,  1995;  Takemura  et  al.,  1996).  Neutrophils  are  known  
299  to release  a number  of pro-inflammatory mediators,  includ-
300  ing platelet-activating  factor and thromboxanes,  which  have  
301  an  important  role  in  promoting  vascular  albumin  leakage  
302  following lipopolysaccharide challenge (László et al.,  1994)  
303  as  well  as  producing  cytotoxic  radicals  such  as  superoxide  
304  and  NO  (Moncada  and  Higgs,  1995).  
305  In  the  present  study,  the  involvement  of  iNOS  in  the  
306  processes  leading  to  microvascular  injury  following  chal-
307  lenge  with  H.  pylori  lipopolysaccharide  was  evaluated  by  
308  using  a highly  selective  iNOS  inhibitor,  1400W (Garvey  et  
309  al.,  1997;  László  and  Whittle,  1997).  Thus,  in  doses  that  
310  reduced  the  iNOS  enzyme  activity  following  lipopoly-
311  saccharide  challenge,  1400W  substantially  attenuated  the  
312  albumin  leakage  in  both  gastric  antrum  and  duodenum.  
313  These  findings  thus  extend  to  the  microvasculature,  the  
314  previous  observations  that  1400W  can  prevent  injury  to  
315  duodenal  epithelial  cells  provoked  by  H.  pylori  lipopoly-
316  saccharide  (Lamarque  et  al.,  2000).  Such  studies  thus  
317  provide  good  evidence  that  iNOS  is  involved  in  both  the  
318  epithelial  cell  cytoxicity  and  the  microcirculatory  injury  
319  brought  about  by  systemic  exposure  to  H. pylori  lipopoly-
320  saccharide,  a  process  that  may  involve  the  production  of  
321  peroxynitrite  through  the  combination  of  superoxide  and  
322  NO  (Lamarque  et  al.,  2000).  Despite  substantially  greater  
323  iNOS  activity  being  detected  in  the  duodenum  compared  
324  to  the  gastric  antrum,  the  relative  expression  of  iNOS  in  
325  these  tissues  appeared  to  contribute  significantly  to  the  
326  microvascular  injury,  as  1400W  prevented  the  leakage  in  
327  both  regions.  The  sites  of  iNOS  expression  that  promote  
328  vascular  leakage  in  the  present  model  are  not  known  but  
may  involve  the  microvascular  endothelium.  In  clinical  
studies  on  gastric  mucosal  biopsies  from  patients  with  330  
gastritis  associated  with  //.  pylori  infection,  increased  331  
antral  mRNA  for  iNOS,  and  iNOS  protein  in  epithelium,  332  
endothelium  and  inflammatory  cells  have  been  reported  333  
(Fu  et  al.,  1999).  334  
The  present  results  thus  suggest  that  the  purified  lipo-  335  
polysaccharide  from  H.  pylori  is  capable  of  inducing  an  336  
iNOS-mediated  microvascular  inflammatory  response  in  337  
the  gastric  antrum  and  duodenum  of  the  rat  following  its  33a  
parenteral  administration.  Thus,  the  local  liberation  of  H.  339  
pylori  lipopolysaccharide  into  the  mucosal  tissue,  or  into  340  
the  systemic  circulation,  may  contribute  to  the  pathogenic  341  
processes  provoked  by  H.  pylori,  through  the  expression  342  
of  iNOS.  
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Gardi,  Miklós Vecsernyés,  Már ta  Gálfi, Éva  Morschl,  
Ferenc  László, and  Gábor B. Makara . Vasopressin  pres-
sor receptor-mediated  activation  of HPA axis by acute etha-
nol stress in rats. Am  J  Physiol  Regulatory  Integrative  Comp  
Physiol  280: R458-R465,  2001.—The plasma  arginine vaso-
pressin  (AVP), ACTH, and  corticosterone  levels and the  hy-
pothalamic  corticotropin-releasing  hormone  (CRH)  content  
were  measured  after  oral  administration  of  1  ml  of  75%  
ethanol  to rats,  a  model known to induce  acute gastric  ero-
sions and stress. Elevated plasma  AVP, ACTH, and  cortico-
sterone levels were detected 1 h after ethanol administration. 
Treatment with the vasopressin pressor (Vj)  receptor antag-
onist  Id(CH2)0Tyr(Me>-AVP]  before  ethanol  administration  
significantly reduced  the ACTH and  corticosterone  level  in-
creases. A higher hypothalamic  CRH content was  measured  
at  30  or  60  min  afteT ethanol  administration.  V]  receptor  
antagonist  injection,  5  min  before  ethanol  administration,  
inhibited the rise in hypothalamic CRH content. The protein 
synthesis blocker cycloheximide prevented the hypothalamic 
CRH content  elevation  after  stress.  The  AVP-,  CRH-,  and  
AVP + CRH-induced in vitro ACTH  release  in normal ante-
rior pituitary  tissue cultures was also prevented by pretreat-
ment with the  receptor  antagonist.  The  results  support  
the  hypothesis  that  stress-induced  AVP  may  not  only  act  
directly  on the ACTH producing anterior pituitary  cells but 
also  indirectly  at  the  hypothalamic  level  via  the  synthesis  
and  release  of CRH. 
adrenocorticotropic  hormone;  corticosterone;  hypothalamic  
corticotropin-releasmg hormone; V, receptor  antagonist  
A  HIGH  DOSE  OF  ORALLY  ADMINISTERED  ethanol  generates  
gastric erosions in rats (61), and such lesions are often 
used  to  evaluate  the  gastric  action  of various  drugs.  
Similar lesions can be observed in the gastric mucosa 
in  animals  exposed to different stress situations  such  
as  cold restraint,  endotoxin injection, or hemorrhagic 
stress  (28).  Adrenal  medullectomy  (66),  endogenous  
vasopressin  [arginine  vasopressin  (AVP)]  deficiency  
(29), administration  of a pressor (Vj) AVP antagonist 
(29), and orchidectomy (27) all protect the gastric mu-
cosa againBt othfinoHnriucod damage. In contrast, ad-
renalectomy  atttmuHteii  gastric  mucosal  protection  
against  ethanol  itijury  (66).  These  data  demonstrate  
that  various  hormones  participate  as  facilitatory  or  
inhibitory mediators in the othanol-induced generation 
of acute gastric  mucosal stress orosionB. 
Among the  Btraen hormones,  ACTH is  one of those 
responding most donditively to various stimuli, and it is 
therefore a useful indicator for the monitoring of stress 
situations. The miyol' physiological regulator  of ACTH 
secretion  following  stress  is  corticotropin-releasing  
hormone  (CRH),  originating  from the  hypothalamus  
(21). 
The  aims  of the  present  study  were  to learn  more  
about hormonal changos following orally administered 
high-dose  ethanol  (known  to  cause  gastric  erosions)  
and  the  involvement,  if  any,  of  AVP in  the  changes  
observed following acute ethanol  challenge.  
MATERIALS  AND  METHODS  
Animals.  Male Wistar rats  (from our breeding farm origi-
nating from different litters) weighing 180-220 g were fasted 
for 24 h, but they received water ad libitum. The animal care 
and  research  protocols  were  in  accordance  with the  guide-
lines of our university. Tho animal house had artificial light-
ing (from 6 AM to 6  PM). Five ruts were kept per cage. The 
rats had been handled and treated orally three times daily (8 
AM, 2 PM, and 8 PM) with 1 ml of tap water via a gastric tube 
for 6 consecutive days before the experiment. This procedure 
was designed to accustom the rats to the presence of humans 
and to the insertion of tho gastric tube to minimize the effects 
of nonspecific stress, 
Measurements  of  plasma  AVP,  ACTH,  and  corticosterone  
levels  in  response  to ethanol  administration  in the absence or 
presence  of  a  Vj  antagonist.  Each  oxperimontal  group  con-
sisted  of 10 rats.  In  10 groups, 1 ml of 75% ethanol or  1 ml of 
tap water (as control) was administered orally to the animals 
via a gastric tubo.  Zero, 6,16,  30, or 60 min after ethanol or 
water  administration,  tlto  rets  were  killed  by  decapitation  
between  8  and  9  AM,  and  trunk  blood  was  collected  in  
polystyrene  tubes  containing  180 pi  of  1.6 M  EDTA.  Blood  
samples wero kept on ice und centrifuged (3,000 rpm) at 4°C 
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to  obtain  plasma for A VP, ACTH, and  corticosterone  deter-
minations.  A further  10 groups  were  treated  with  a  highly  
selective V t  A VP receptor antagonist  5 min before ethanol  or  
water administration. The V2 receptor antagonist  ll-(J}-mer-
capto-0,|3-cyclopentamethylenepropionic  acid)-2-(0-methyl)-
Tyr,  Arg81VP,  called  Manning  peptide  and  abbreviated  as  
d(CH2)r>Tyr(Me)AVP, was used at a dose of 1.0 (ig/kg body wt 
ip (41). The receptor-antagonist dose was determined  accord-
ing to earlier published data (28,31). The animals were killed 
at  the above different times after ethanol  or water  adminis-
tration, and  their plasma  was  collected  similarly.  
Plasma  AVP  level. Plasma A VP level was determined with  
a  specific RIA system  (25). The extraction was performed on 
RPN  1902-C8 minicolumns (Amprep, Amersham,  UK),  with  
a  recovery  of  >95%.  Synthetic  AVP (Args-vasopressin;  Or-
ganon, Oss, The Netherlands) was used for antibody  produc-
tion, for the preparation  of the tracer, and as a standard.  The 
cross-reactivities  of the AVP antibody used in the  RIA were 
0.03% with vasotocin, <0.01% with oxytocin, and 0.03% with 
ACTHj_24. The sensitivity of the RIA was  1 pg/ml. The intra-
and interassay coefficients of variation proved to be 13.3 and 
16.3%, respectively.  
Plasma  ACTH  level.  A  direct  RIA method was  used  (24).  
Rabbits  were immunized with ACTH1_32  to obtain  an  anti-
body.  The  sensitivity  of  the  method  was  1  pg/ml,  and  the  
intra-  and  interassay  coefficients were  4.7  and  7%,  respec-
tively. The cross-reaction with a-melanotrophic hormone was 
<0.2%. 
Plasma  corticosterone  level  This method was described by 
Mihály et al. (45). Twenty-one-corticosterone-albumin  conju-
gate was used for immunization in rabbits. Endogenous  cor-
ticosteroid-binding globulin was inactivated  with  methanol.  
A direct  RIA was  used. The sensitivity  of the  method was  3  
jjig/dl, and  the intra-  and interassay  coefficients were  9  and  
13.7%,  respectively.  The  cross-reactions  with  progesterone  
and  estrone were 7.3 and  0.1%,  respectively.  
Measurements  of  CRH  content  of  hypothalamus.  After the 
rats'  decapitation,  brains  were  quickly  removed,  and  the  
hypothalamus  was  isolated  on  ice. The  hypothalamus  was  
defined as the tissue within 3 mm of the ventral surface of the 
brain, within the  following borders: optic chiasm,  mamillary  
bodies,  and  lateral  hypothalamic  sulci.  The  whole  stalk-
median  eminence was  included  in  the  hypothalamic  prepa-
rations.  CRH concentration  was  determined  by  a  RIA  tech-
nique  (64).  The  hypothalamus  was  homogenized  with  
ultrasound (Soniprep 150 MSE) in  100 mM HC1 containing  1  
mM  ascorbic  acid,  and  an  aliquot  was  taken  for  protein  
measurements  (38).  The  residual  homogenate  was  centri-
fuged at  6,000 g  for 20 min a t  4°C, and  aliquots were  taken 
and  lyophilized  for  RIA.  The  CRH  antiserum  (P.  Vecsei,  
Heidelberg,  Germany)  was  obtained  from  a  rabbit  immu-
nized with human CRH. The CRH antibody (43) was specific 
for the C-terminal region of the CRH1_«1 molecule because it 
did not  cross-react with the fragments CRH1_20  and  CRH6_  
as. The CRH tracer was prepared with the use  of a modified 
iodogen method to minimize damage to the iodinated peptide 
(35).  The  labeled  material  was  purified  via  two  steps  of  
reverse-phase chromatography (17), a gradient HPLC system 
being applied in the second step. The specific radioactivity  of  
the  purified  tracer  was  1,700-1,900  Ci/mmol.  The  freeze-
dried  residues were »dissolved  in  1 ml  of assay buffer  (50  
mM  phosphate  (Sigma),  pH  7.4,  containing  0.25%  human  
serum albumin (Izinta) and 0.1% Triton X-100 (Reanal)], and 
200-fil aliquots were subjected to RIA. The RIA standard  was  
a  synthetic human/rat  (h/r) CRH preparation  (Bachem,  Bu-
dendorf,  Switzerland).  
The  procedure  involved  «  m>iiu<jui|ibi-(um  hvp"-'"';  a  16-h  
preincubation  of  the  oaml'lei  m  btundui dB with  nntiseruui  
(100  |il,  working  dilution  l:l().()lli»  Wns  followed  by  a  24-h  
incubation with  cortit:otrepin--refossh|g  factor  tracer  (lot)  |il,  
10,000  cpm). The  imimintdofilcnlly  hound  un<l  fre« fractions 
were separated with  n secnud  nnlifo'dy (raised  in our labora-
tory in sheep against  whofo r«tbbll  IBM) and subsequently  by 
polyethylene  glycol  (PEG)  <>,»>1)0 precipitation  (Ferule  Labo-
ratory,  Berlin,  Germany)  by  lbs  donble-mitibody/PEG  
method. The lower limit of as«uiy detection  wtw 7-8  pg/tube.  
The intra-  and  interassay  cnenicisnfo  of  variation  were  4.0  
and  13.8%, respectively. OliH  Inminnoroni'tivity  in hypothal-
amus extracts subjected to Ill'LC  bus been  abmvn to  cochro-
matograph with synthetic ti/rt!KI-l._4,  (04), Thn CKH content 
of  the  hypothalamus  is  expressed  mi  pit-ngrnms  par  milli-
grams protein. Each group consisted  of  it)  rats.  
To determine whether the hypothalamic  C1U1 response to 
ethanol stress  can  be  nscrlbsd  to  Iba  increased  protein  syn-
thesis, rats were treated  with the protein  synthesis-blocking  
compound cycloheximide before orhl ethanel  administration.  
Thirty minutes before ethanol  administration,  un injection of 
0.9% NaCl (Sigma) or  of cycfohexliidtfo (10 or  .'10 mg/kg body 
wt;  Fluka,  Buchs,  Switzerland)  dissolved  in  O.D'J!. NnCl  was  
administered intraperitoneal!!'. The ruts were killed 30 or 60 
min after ethanol administration, and  I lie (!RH content of the 
hypothalamus was  measured.  
Anterior  pituitary  tissue  vulture.  Monolayer  pituitary  ceil  
cultures  of Wistar rats  weighing  j 110-230  g  wore  prepared  
(19). Ten pituitaries wore used  in every tissue culture exper-
iment. The hypophysis was  sterile-removed  immediately  af-
ter decapitation of the rats. The anterior  lolio of the pituitary 
gland was  isolated under  a  preparative  microscope, and  the  
tissue was  digested  in  the  presence  of trypsin,  collngonase,  
deoxyribonuclease  I  and  II,  and  dispase  (GIBCO).  The  dis-
persed  cells  were  placed  in  )I)UBI1C  Collngen-contod  Petri  
dishes and suspended in  Dulbenco's modified Eagle's medium 
supplemented  with  20%  fetal  bovine  Serum  ((111)00).  The  
cultures  were  maintained  at  i)7"0  in  u  humidified  atmo-
sphere  of  10% C0 2  in air  and  washed  every  3 days.  Experi-
ments were performed on 14-day cultures. We performed  the  
standardization  of the  cell  cultures  by  immunoreuctivity  of  
ACTH at the start  and a t the end  of experiments,  determin-
ing the relative  frequency  of immunnroactive ACTH  contain-
ing cells per unit area. If the  relative  frequency  proved to be 
no  more  than  5  to  7%,  the  call  cultures  were  used.  The  
standardized  monolayer  cell cultures  ware  functionally  con-
trolled  with  potassium  (30  mM,  31) min)  ns  n  nonspecific  
releasing agent  Viability was 97-100%. In our experimental 
conditions, the stable equilibrum  in ACTH  release  developed  
after ~90 min. This was the reanon  for tho use  of the  longer  
incubation period. The viability  did  not  change during  incu-
bation.  During  pilot  experiments,  we  tried  several  doses  of  
AVP,  CRH,  and  V,  antagonist,  and  we  used  the  maximal  
effective dose (10"e M) later. The colls were incubatril for.3 h 
with  10  a  M AVP or 10 "° M CR1I (B«cht>m) ftlono or  10  6 M 
AVP +  10'  6 M CRH together, for 3 h with  10  0 M V,  receptor  
antagonist  alone,  and  for  2  h  with  It)'""  M  V,  receptor  
antagonist followed by 1 h with 10"0  M AVP or  10  " M CRH 
alone  or  10  6  M AVP  +  10  "  M CRH  tngother.  During  the  
control  period,  the  incubation  Was  porfi>rmad  without  any  
additions.  The  ACTH  concentrations  from  100-|d  suporna-
tant media  samples were  monsurcd  by  direct. RIA  (24).  The 
method of ACTH determination was tho same as in  the case 
of plasma. The data were  calculated  on  tho  basin  of the  12  
measurements in each  group.  
Statistics.  All  data  are  presented  lis  means  £  gE.  The  
Mann-Whitney's  U test  was  used  for  comparisons  involving  
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Fig.  1.  Effect  of  755P ethanol  administered  orally  (1 ml/rat)  on  the  
plasma  arginine  vasopressin  (AVP)  level.  Vertical  bars  denote  
means  ±  SE; nP  <  0.05 vs.  control  group.  
two groups. The curves were analyzed via the Kruskal-Wallis 
test.  A probability  level  of <0.05 was  accepted  as  indicating  
a  statistically  significant difference. 
RESULTS 
Plasma  AVP  level.  The  oral  administration  of  water  
led to slightly increased plasma AVP levels at  5 and  15  
min,  but  the  AVP  level  later  returned  to  the  normal  
range.  Elevated  AVP levels  were  detected  at  5,  15,  30,  
and  60  min  after  ethanol  administration.  The  maxi-
mum AVP concentration was measured  at  15 min after 
ethanol  (Fig.  1).  
Plasma  ACTH  level.  The baseline  plasma ACTH  and  
corticosterone  levels  are  relatively  high  and  probably  
reflect  the  cumulative  effects  of  fasting  and  the  re-
sponse  to the  control  procedure.  Water  similarly led  to  
increased  plasma  ACTH  levels  at  5  and  15  min,  but  
normalization  had  occurred  by  30  min.  Vx  receptor  
antagonist  injection  before  water  administration  pre-
vented  the  transient  increase  in  ACTH  concentration.  
Ethanol  administration  resulted  in  increased  ACTH  
levels  between  5  and  60  min.  The  ACTH  levels  de-
creased  15 min after every treatment,  possibly  because  
of  the  feedback  action  of  the  increased  corticosterone  
level.  Treatment  with  the  Vx  receptor  antagonist  be-
fore ethanol  administration  significantly  inhibited  the  
ACTH  rise  normally  seen  between  15  and  60  min,  but  
the  normal  range was  not  reached  (Fig.  2).  
Plasma  corticosterone  level.  The  plasma  corticoste-
rone  levels  were  also  higher  between  5  and  15  min  
after water  administration.  Vx  receptor  antagonist  in-
jection  significantly  decreased  the  plasma  corticoste-
rone  level  between  5  and  10 min  after water  adminis-
tration.  Ethanol  yielded  an  elevated  plasma  
corticosterone  level  at  5  min,  and  the  level  remained  
high  up  to  60  min.  receptor  antagonist  injection  
reduced  the  plasma  corticosterone  concentrations  be-
•*--  •Ihiiiol (n-20) 
Fig.  2.  Effect  of  pressor  |V(>  receptor  antagonist  on  the  plasma  
ACTH  level  lifter  75%  ethanol  administration  (1  ml/rat).  Vertical  
bars  denote  moans  ±  SE;  <  U.0B vs.  control  group,  "P  < 0.05  vs.  
group treated  with  ethanol  alone.  
tween  15 and 60 min oftor othnnol administration  (Fig.  
3). 
Hypothalamic  CRH  content.  As  Fig.  4  shows,  water  
administration  through  the gastric tube did not  induce  
any  change  in  the  CRlI  content  of  the  hypothalamus.  
Similar  results  were  observed  after Vx  receptor  antag-
onist  and  water  administrai ion,  Higher  contents  of  
hypothalamic  CRH  wero  measured  at  30  and  60  min  
after  ethanol  administration.  Tho V,  receptor  antago-
nist  injected  5  min  before  ethanol  administration  
blocked  the  rise  in  hypothalamic  CRH  content,  which  
then  remained  within  the  control  range  after  ethanol  
stress. 
Actions  of  cyclohtiximide  on  CRH.  After  cyclohexi-
mide  and  oral  water  administration,  there  was  no  
change  in  the  hypothalamic  CRH  content  (Fig.  5).  
- » -  othnnol  (n-20)  
control  (wator)  (n=15)  
Time  (min)  
Fig. 3.  Effect of V,  receptor antagonist  on tho plnsmn  corticosterone  
level  after  757c  ethanol  administration  (1  ml/rat).  Vertical  bars  
denote means  ±  SE; "P < 0.05 vs.  control  group,  hP  <  0.05 vs.  group 
treated  with  ethanol  ulone,  
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Fig.  4.  Effect of V,  receptor antagonist  on the hypothalamic  cortico-
tropin-releasing  hormone  (CRH)  content  after  75% ethanol  admin-
istration  (1 ml/rat).  Vertical  bars  denote  means  ±  SE;  "P  <  0.05  vs.  
control  group,  hP  <  0.05  vs.  corresponding  group treated  with  etha-
nol  alone.  
Fig.  6.  Effects  of  AVP,  CRH,  and  V,  tarejiMir  nntntfimist  •«>  the  
ACTH  secretion  in  vitro  in  the  anterior  pituitary  lisaiie  culture.  
Vertical bars denote means  ±  SB, where  >, -  I'.I in  PVpry group  *P  <  
0.05 vs.  control  group,  bP  <  0.05  vs.  group tiealiM  with  AVI'  alone,  
"P  <  0.05 vs.  group treated with  CR11 alone,  noil  -.  0,05 vs.  group  
treated  with  AVP  +  CRH.  
Higher  CRH levels were detected  after ethanol  admin-
istration.  Smaller  doses  of  cycloheximide  treatment  
before  ethanol  administration  significantly  inhibited  
the  hypothalamic  CRH  enhancement;  however,  the  
CRH concentration remained above the  control level  at  
both 30 and 60 min after ethanol  administration.  How-
ever, higher doses (30 mg/kg body wt)  of  cycloheximide  
prevented  the  increase  in  the  hypothalamic  CRH  con-
tent  after ethanol  administration.  Inhibition  of protein 
synthesis  with  cycloheximide  dose  dependency  re-
duced the  stress-induced  increase  in  CRH in the  hypo-
thalamus,  as  shown in  Fig.  5.  
ACTH  levels  in  pituitary  tissue  culture.  Increased  
ACTH  levels  were  demonstrated  in  the  anterior  pitu-
itary tissue  culture  media  after the  addition  of 30  mM  
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Fig.  5.  Effect  of the  protein  synthesis  blocker  cycloheximide  on  the  
hypothalamic  CRH  content  after  75%  ethanol  administration  (1  
ml/rat).  Vertical  bars  denote  means  ±  SE;  aP  <  0.05  vs.  control  
group,  hP  < 0.05 vs. corresponding group treated with ethanol  alone.  
K 4  to the  incubation  medium,  dim in  a  depolarization-
induced  ACTH  release  (Fig.  (I).  The  ACTH  concentra-
tion  was  significantly  enhanced  after  the  administra-
tion  of  10~6  M  AVP  or  10  "  M  CRH  alone  A  higher  
ACTH level was  found after the  wdniiniatrnl ion  of AVP 
and  CRH together.  A slightly  ilecroasoil  ACTH  release  
was  observed  after Vx  receptor  antagonist  gdminifltra-
tion  alone.  The  AVP-  or  CRlI-bidui'od,  increased  re-
lease  of ACTH was prevented  l>y the  administration  of  
Vj  receptor  antagonist.  A  modernle  enhancement  of  
ACTH  level  was  detected  when  AVI'  +  CRH  was  ad-
ministered  after the V4  receptor  antagonist  treatment.  
The  data  were  calculated  on  the  basis  of  1"  measure-
ments  in  each  group.  
DISCUSSION 
The  series  of studies  presented  here  shows  that  the  
plasma  AVP,  ACTH,  and  cortlcostorone  levels  and  the  
hypothalamic  CRH  content  are  elevated  nftor  acute  
stress induced by a high concentration  of orally  admin-
istered ethanol,  and these responses can he reversed by 
an AVP  W1 receptor  antagonist.  Those  findings  are  in  
agreement with  previous observations  that, n high  dose  
of  orally  administered  ethunol  causes  AVP  release  in  
humans  and  in  rats  (27,  34).  Those  results,  however,  
are  in  apparent  conflict  with  the  established  finding  
that ethanol in low concentration  inhibits  the release  of  
AVP  (54,  63).  The  paradoxical  nction  of  orally  admin-
istered  ethanol  on  AVP  release  might  pimsibly  reflect  
the  high  dose  of  ethanol  used.  It  is  Known  that,  after  
stress,  CRH  and AVP  are  coreloascd  into  the  primary  
capillaries  of the  portal  circulation  in the  stalk-median  
eminence region  from where  the  blood  carries  the  neu-
ropeptides  to the  anterior  lobe.  This  AVP is unlikely  to  
reach  the  systemic  circulation  In  quantities  high  
enough  to  elevate  the  plasma  AVI'  level.  Instead,  the  
plasma AVP changes probably reflect the activity  of  the 
• •  1 • control  HP)  7  v,  *nt*lmitl«MGItH  
£222  2 - 30 mM K'  B  AVr»0h||  
I  1  3 . AVP  E ®  0  V,  *MO>Uroil«l»AVp.LRH 
fi££S  4  • V,  antagonis t  
I  I  5 - V, antagonist • AVh  a  
fTÏÏTTl 6-CRH 
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magnocellular  neurons  with  terminals  in  the  neural  
lobe,  and  this  AVP may reach the  anterior  lobe only 
after dilution in the general circulation (21). We have 
observed that the AVP elevation is sufficiently high to 
influence the hypothalamic  CRH cells  after  adminis-
tration  of a high dose of ethanol into the  stomach, as 
shown by the  preventive effect of the  receptor  an-
tagonist.  We consider it  likely that stimulation  of the 
CRH/AVP containing parvocellular neurons will be in-
volved in the release of ACTH and corticosterone after 
ethanol  administration.  
Our  experiments  revealed  increased  plasma  AVP  
and hypothalamic CRH contents after ethanol  admin-
istration. There was no elevation of the CRH content in 
the  hypothalamus after ethanol  administration  when  
the Vi receptor antagonist was injected before ethanol 
administration.  This  suggests  that  systemic  AVP  
sends signals via the V! receptors to the hypothalamus 
to  stimulate  either  directly  or  indirectly  the  CRH-
producing  hypothalamic  neurons.  We  suggest  that  
AVP may  act  in  a  dual  manner:  1)  in  the  pituitary  
portal  blood, AVP and  CRH are  cosecreted, and AVP 
potentiates the actions of CRH; and 2) in the systemic 
circulation,  AVP may signal  the  presence  of stress to 
the  hypothalamus  (21).  Many data  in  the  literature  
provide evidence of a physiological synergistic interac-
tion  between  CRH and  AVP at  the  level  of the  pitu-
itary. Exogenously administered  AVP significantly po-
tentiates  CRH-stimulated  ACTH release  in  rats  (12,  
67) and  humans  (26,  37).  Endogenous  AVP can  also  
potentiate  CRH-stimulated  ACTH  secretion  in  hu-
mans; synthetic human  CRH resulted in higher ACTH 
and  Cortisol responses  after a water  restriction  than  
after a water load (69). The role of endogenous AVP in 
the  ACTH response  to stress is  suggested  by the  re-
sults  of Guillaume et al. (13), who found significantly 
reduced ACTH and Cortisol responses to insulin stress 
and  restraint  stress  and  CRH injection in  anti-AVP-
immunized  rams  compared  with  controls.  In  accor-
dance with, our finding, Rivier et al. (58) reported that 
ACTH secretion induced by ether stress, which stimu-
lates CRH secretion, is significantly moderated by pre-
treatment with an AVP antagonist analog. All of these 
data  are  compatible  with  a  dual  role  of  AVP in  the  
regulation  of the  hypothalamic-pituitaiy-adrenocorti-
cal (HPA) axis. 
The increased plasma ACTH and corticosterone lev-
els  in  response to a  high  dose  of orally  administered  
ethanol  relate  to  a  stress  situation  (55-57).  During  
stress, AVP plays an important role in ACTH stimula-
tion. The involvement of AVP in the ACTH response to 
restraint  stress  is  supported  by the  observation  that  
the  ACFH response  is  impaired  in  genetically  AVP-
deficient Brattleboro rats  (5,  11, 22, 44, 70,  71). Fur-
thermore,  the  ACTH  responses  to  ether  stress  and  
adrenalectomy are blunted in Brattleboro homozygous 
rats  (11).  As Brattleboro rats  do not  differ from the 
normal controls with respect to the hypothalamic CRH 
content (22), the impaired ACTH response in these rats 
is  most  probably  explained  by  their  AVP deficiency. 
The role  of endogenous  AVP in stress-induced  ACTH  
release  han  previously  been  demonstrated  in  several  
studies involving the  w*t>  of the passive immunization 
technique with  an  AVP antiserum  or the  administra-
tion of synthetic AVP ant agonists. In tho rat, intraperi-
toneal  administration  of  anti-AVP  immunoglobulins  
reduces  thc.ACTII  rPflPhnBoa to restraint  stress  and  
formalin stress  (36).  The  intracerobroventricular  ad-
ministration of AVP antiserum leads to a moderate but 
significant reduction in plasma ACTH lovel after ether 
stress (50). Vx receptor antagonists attenuate the AVP-
induced increase in plasma  ACTH when administered 
before  AVI* injection  in  the  rat  (4,  18).  Besides  the  
animal observations, we Imvo some human experiences 
(32), i.e., the incidence of human gastroduodenal ulcer-
ation is significantly higher in  the normal  population 
(in whom the release  Of AVP is presumed to be intact) 
than in the AVP-defieient population (control diabetes 
insipidus patients). These findings indicate that endog-
enous AVP plays an aggressive role in the development 
of gastrointestinal  mucosal injury. 
The question arises of how ACTH secretion is influ-
enced by AVP after stress.  We refer here to the mini-
review  by  Kjaor  (21);  the  action  of  AVP  on  ACTH  
release  is  exerted  In  direct  and  indirect  ways.  The  
direct  effect influences  the  ACTH  production  of  the  
anterior  pituitary  gland.  The  principal  effect of  sys-
temic  AVP  on  ACTH  secretion  in  conscious  rats  is  
produced  indirectly  via  the  stimulation  of  hypotha-
lamic CRH. The indirect effect of AVP is probably more 
significant  whon  AVP  is  administered  in  vivo  (47),  
because  it  is  known  to  have  marked  cardiovascular  
effects even in  low concontrationB. Moreover, the pitu-
itary AVP receptor differs from the classical Vx recep-
tor, and the designation Vlb (as opposed to Vla for the 
classical  receptor)  has  been  proposed  (4,  6,  22,  23).  
Under  in  vivo conditions,  however, Vla  receptors  ap-
pear to be involved, because VlH receptor  antagonists  
were  effective in  inhibiting  the  release  of  ACTH  or  
corticosterone  (2,  9,  40,  42,  47,  59, 60,  65) and  be-
cause  the  pressor  activity  of  Vt  recoptor  agonists  
correlated  with  their  ability  to  release  ACTH  and  
corticosterone (2, 47). Our in vivo results fit with the 
above explanation; the ACTH and corticosterone se-
cretions after ethanol stress were considerably inhib-
ited  if  the  ratB  wore  treatod  with  the  Vx  receptor  
antagonist  d(CHa)„Tyr(Me)AVP  immediately  before  
ethanol  administration.  Our  in  vitro  experiments,  
however,  indicate  that  the  ACTH-blocking effect of 
the  Vx  receptor  antagonist  does  not  develop  only  
through tho docrense  of the hypothalamic  CRH con-
tent; in high concentrations, the  compound can also 
directly block the ACTH-increasing effect of AVP in 
the  anterior  tissue  culture.  The  observation  with  
AVP  demonstrates  that  d(CHa)5Tyr(Me)AVP  is  a  
mixed antagonist with direct Vlb receptor antagonist 
character, which ifl in accordance with the findings of 
Jard  et  al.  (18), Antoni  et  al.  (4), and Bernardini et  
al. (8). The latter finding with CRH is rather surpris-
ing,  and  it  might  possibly  relate to a  still  unidenti-
fied interaction  of Vx rccoptor antagonists with CRH 
receptors  on  the  pituitary  ACTH-producing  cell;  
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however, this phenomenon needs further experimen-
tal validation. 
For  clarification  of  the  role  of  CRH  in  the  stress  
reaction  after ethanol  administration,  the  alterations  
in  hypothalamic  CRH content  were  also  determined  
after high doses of orally administered ethanol. Many 
researchers  have  investigated  the  effects of different 
types  of stress  on the  CRH content in the hypothala-
mus (51). Although determination  of the CRH content 
in the hypothalamus  alone is insufficient to establish 
whether the changes in release, storage,  or synthesis 
are responsible, a difference between treated and con-
trol groups clearly reflects the involvement  of CRH in 
the stress situation. Cbappell et al. (10) reported that  
acute  or chronic stress  resulted in  a  50% decrease in 
hypothalamic CRH content. Similar observations were 
published following acute (49,52) or chronic stress (3). 
These reductions are thought to relate to the secretion 
of CRH from the hypothalamus in the acute situation, 
and  to continued  release  in the  chronic stress  condi-
tion, when new CRH synthesis cannot keep pace with 
the  demands  for  higher  secretion.  This  hypothesis,  
however,  has  not  yet  been  proved  convincingly  (51).  
Murakami et  al.  (48) reported  a  fast  increase  in  the  
hypothalamic CRH content,  already observed 2.5 min 
after ether stress.  Moldow et al.  (46) described  a  sig-
nificant decrease in hypothalamic CRH content 15 min 
after the  initiation  of restraint  stress.  This  was  fol-
lowed by an  enhanced hypothalamic  CRH concentra-
tion at  60 min, which  could be  blocked  by cyclohexi-
mide administration before stress, indicating that new 
protein  synthesis  can  explain  the increased  hypotha-
lamic CRH level demonstrated at this time point. Anal-
ogous results were reported by Haas and George (14); a 
significant increase in  hypothalamic  CRH concentra-
tion was observed  24 h after a single 5-min foot shock, 
and when protein  synthesis was eliminated by aniso-
mycin  pretreatment,  it  completely  abolished  the  in-
crease  in  hypothalamic  CRH  content.  A  number  of  
recent  investigations  has  directly  studied  CRH gene 
expression  by  measuring  hypothalamic  CRH  mRNA  
concentrations. Different stressors, which activate the 
hypothalamic-aclrenal  axis,  can  also  influence  CRH  
gene expression.  Swimming, hypertonic  saline,  or re-
straint  stress led  to an  increased  hypothalamic  CRH 
mRNA expression within 4 h,  and the level remained 
elevated  for 24 h  (15,  16,  33).  Similar findings were 
observed after a  2-h immobilization  stress  (39) and  a  
1-h restraint  stress  (20).  In  our  experiments, the  in-
creases in hypothalamic CRH content were blocked by 
cycloheximide pretreatment, which points to a role of 
enhanced protein synthesis in the increased hypotha-
lamic CRH concentration  after ethanol stress  (1, 53). 
Whether  the  overall  increase  in  hypothalamic  CRH  
content, paralleling an  enhanced release in our  stud-
ies, reflects a rapid  increase in  translation  and/or in-
creased processing of the prohormone of CRH requires 
further studies. 
In their review, Owens and Nemeroff (51) presented 
cumulative  evidence that  CRH integrates  the  overall  
physiological  behavioral  responses  of an  organism to  
stress.  The  neuroendocrine  rsspnnnp  to  ntrsss  js  pri-
marily controlled by CR|1 iteui i'nB originating from the 
paraventricular nucleus  of the hypothalamus, hut  the 
AVPergic magnocellulat  neurons presumably also par-
ticipate  in  the  dovolopitmnt.  of a  street* reaction.  Our  
present  results  support  tile  importance  of  tho  liypo-
thalamo-neurohypophyseal  or magnocolhilar  AVP sys-
tem in the development of physiological or pathological 
changes following various stress situations. It also sug-
gests  possible  pharmacological  Strategies  involving  
AVP antagonist agents to prevent  such pathology.  
Perspectives 
Earlier we studied the development  of gastrointesti-
nal stress erosions in different rat. experimental  mod-
els, including mucosal injury provoked  by othanol, in-
domethacin,  cold-restraint  stress,  and  hemorrhagic  
and  endotoxin  shock  (28,  flfl). We  found  that  an  in-
creased  AVP secretion  during  these stress  situations  
has key importance in the initiation  of damage (31). In 
the  present  work,  the  interaction  between  the  HPA  
axis  and  AVP secretion  was  demonstrated  following  
acute ethanol challenge. The lower incidencc of gastro-
intestinal  ulceration  among  AVI'-dcficient  patients  
with central diabetes insipidus gives further support to 
the  pathological  importance  of  endogenous  AVP  re-
lease  in  the  development  of  luuoosul  damage  even  
under clinical circumstances  (3)5),  
Gastrointestinal  mucosal  strcsR  erosions  commonly  
appear among critically ill patients mostly in intensive 
care units after a number  of acute Conditions, such as 
severe trauma, burns, septic or hemorrhagic or cardio-
genic  shock,  or  injury  of the  centre] nervous  system,  
etc.  (62). Once hemorrhage  becomes manifest, the  se-
verity of the condition is reflected in tho mortality rate, 
which  approaches  50% (02).  Although  it  would  be  of  
high  clinical  significance, the  problem  of  how to pre-
vent the  development  of such  mucosal  erosions is not 
solved  (7).  The findings in  earlier  studies  suggested  
that the use of vasopressin pressor receptor (V]) antag-
onists in  clinical practice might have potential  thera-
peutic  benefit  (28,  29,  31,  32),  The  present  results  
revealed that  a vasopressin  pressor  receptor  (Vx) an-
tagonist  could  not  only  prevent  the  vasoconstrictive  
action  of increased  vasopressin  secretion, hut it  could 
also block the  elevation  of the  hypothalamic  CRH re-
sponse  and  ACTH-corticosterono  secretion  following  
acute ethanol challenge. Theso experimental  and"clin-
ical observations lead  us to conclude that  vasopressin  
antagonists might have importance  in the  prevention  
of the generation  of the lifo-threntoning bleeding from 
gastrointestinal stress erosions. 
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Endogenous  bacteria-triggered  inducible  nitric  oxide  synthase  
activation protects  the  ovariectomized  ral  stomach  
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Abstract 
Under  experimental  circumstances,  ovariectomy  attenuates  gastric  mucosal  injury  where  niiric  n\iilr  (N<>)-meili:iiei|  pathways  
are  involved.  In  our  study,  we  have  examined  the  changes  in  constitutive  (cNOSj  and  i ml unfile  NO  synthase  (iNOS)  C I I / V I I I C  
activities (assessed  by the citrulline assay), and  the role of endogenous  bacteria  in overiectomy-pnivokcd  nuico.sal defence. Gastric 
lesions were induced  by indomethacin  (50 mg/kg,  s.c.) over a 4 h period in sham-opera led  ami  nvunecionii'/ed  lem.ile  Wisnir  MIS.  
Groups of animals received the wide-spectrum antibiotic ampicillin  (800 mg/kg/day, p.o.. for 5 ilaysl.  ¡mil others  were injected with 
bacterial  endotoxin  (E. toll,  3 mg/kg,  i.v.,  5 h  before autopsy).  We found that  ovariectomy  increased  iNOS ami  decreased  cNt )S 
activity  (resulting an elevated  total  gastric NO level), and protected  the stomach,  effects were  reversed  l,y  ampicillin  lieaiuieiit.  In  
ovary-intact  rats, administration  of bacterial endotoxin  enhanced gastric iNOS activity and  reduced  lesion-liirmaiioii.  These  results  
suggest that ovariectomy improves gastric mucosal defence by endogenous bacteria-triggered  activation of iNOS. >n 2001 Published 
by Elsevier  Science Ltd.  All  rights  reserved.  
Keywords: Oestrogen; Inducible niiric oxide synthase;  Constitutive niiric oxide: Synthase: Gastric  mucosal defence: finvymc rrmilulinn 
1.  Introduction  
Nitric  oxide  (NO)  is  synthesized  from  u-arginine  by  
three  distinct  isoenzymes  that  can  be  divided  into  two  
functional  classes  based  on  their  sensitivity  to  calcium.  
The  cytokine-  or  bacterial  endotoxin-inducible  iso-
enzyme  (iNOS)  is  expressed  mostly  under  pathological  
conditions,  and  binds  calmodulin  tightly  in  a  calcium-
independent  fashion.  The  constitutive  form  (cNOS)  is  
expressed  continuously  under  physiological  circum-
stances,  and  binds  calmodulin  in  a  reversible  and  cal-
cium-dependent  fashion.  Inhibition  of  cNOS  leads  to  
vasoconstriction,  to  the  aggregation  of  platelets,  to  an  
increase  in  vascular  permeability  and  adhesion  of  neu-
trophils  to  the  vascular  endothelium,  processes,  which  
are  deeply  involved  in  the  development  of  vascular  
endothelial  dysfunction  [9,10].  
In  vitro  observations  suggested  that  the  liberation  of  
NO  from  vascular  tissues  is regulated  by  sex  hormones  
*  Corresponding  author.  Tel.:  +36-62-210-0819.  ext.  150;  fax:  
+  36-62-210-0813.  
E-mail address: laszloffu:koki.hu (E.  Morschl).  
[20],  where  oestrogens  enhance  NO  release  limn  vas-
cular  tissues  [16,20].  In  vivo,  we  recently  confirmed  the  
oestrogen-mediated  up-ivgiilalion  of  cNOS  in  lite  rat  
heart  and  aorta  by  direct  measurement  of  en/yme  
activity  [11],  In  addition,  extensive  evidence  supports  
the  theory  that  sexual  slcroids  are  involved  in  gastro-
intestinal  defensive  mechanisms  [1.4],  where  NO  also  
plays  a  key  role  in  the  maintenance  of  mucosal  integrity  
of  the  gut  [21].  Indeed,  inhibition  of  cNOS  leads  to  
microvascular  dysfunction  during  the  early-compen-
sated  phase  of  sepsis,  at  the  initiation  of  bowel  inflam-
mation  and  in  the  course  of  surgical  intervention  |5  7|.  
Moreover,  decreased  cNOS  activity  and  mucus  level,  
were found  in  the  stontaeh  in  walcr  immersion  restraint  
stress-induced  ulceration,  effects reversed  with  NO  syn-
thase  inhibition  [14].  In  contrast,  in  the  oestrogen  defi-
cient  rat  stomach,  wc  found  an  enhanced  tolal  NO  
synthase  activity  and  mucus  scavlioit,  while  the  gaslric  
mucosa  was  less  susceptible  towards  ulcerogenic  chal-
lenge  [12].  This  had  been  a  result  of  the  increased  NO  
production,  since  the  pharmacological  blockage  of  NO  
synthesis  abolished  ovaricclomy-provoked  elevation  of  
mucus  secretion  and  mucosal  protect ion  |I2|.  
0928-4257/01/$ -  see front matter  ¡JJ  2001 Published  by  Elsevier  Science Ltd.  All  rights  reserved.  
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In  this  present  study,  we  investigated  the  changes  in  
the  ratio  of  cNOS  and  iNOS  activity  in  the  stomach  of  
the  oestrogen-deficient  rat,  in  conjunction  with,  a  pos-
sible  role  of  endogenous  bacteria  in  ovariectomy-pro-
voked  mucosal  defence.  
2.  Materia ls  and  methods  
2.1.  Experimental  protocol  
Female  Wistar  rats  (10-12  weeks-old)  were  used.  
Ovariectomy  and  sham-operation  had  been  performed  
under  ketamine/medetomidine  (75  mg/kg:  0.5  mg,kg)  
narcosis.  The  animals  were  allowed  to  recover  over  1  
month.  Gastric  mucosal  injury  was  induced  by  indo-
mcthacin  (50 mg,kg.  s.c.)  over  a  4  h  period.  Before  any  
experimentation,  the  animals  were  starved  for  24 h,  but  
had  free  access  to  water.  Following  autopsy,  the  extent  
of  lesions  in  the  stomach  was  determined  by  a  digital  
planimeter,  the  ratio  of  injured  parts  was  compared  
with  the  total  mucosal  surface,  and  the  data  were  
expressed  as  a  per  cent.  As  a  pre-treatmcnt.  groups  of  
ovariectomized  animals  received  the  wide-spectrum  
antibiotic,  ampicillin  (800  mg/kg,  p.o.)  48.  24  and  6  h  
before  autopsy,  i.e.  the  latter  2  h  before  indomethacin  
challenge.  Additional  groups  of  ovary-intact  female  rats  
received  exogenous  bacterial  endotoxin  [.E.  coli  lipopo-
lysaccharide  (LPS)  0111:B4,  3  mg/kg,  i.v.]  5  h  before  
autopsy,  i.e.  1 h  before indomethacin  treatment.  
7  7  Measurement  of  nitric  oxide  synthase  enzyme  activity  
N O S  activity  was  determined  as  the  conversion  of  L-
[ l 4C]-arginine  monohydrochloride  to  L-[14C]-citrulline  
based  on  the  method  described  previously  [17.22]  with  
minor  modifications aiming to  detect  mostly  the  activity  
of  cNOS  [2,3,11,20],  We  sacrificed  the  animals  by  
decapitation,  and  immediately  after  autopsy,  we  pre-
pared  the  fresh  tissues  for  NOS  measurements.  Protein  
content  was  estimated  via  spectrophotometric  assay  
(Bio-Rad  Protein  Assay),  and  NOS  activity  was  expres-
sed  as  pmol.min/mg  protein.  Total  NOS  activity  was  
defined  as  citrulline  formation  that  was  abolished  by  
incubation  in  vitro  with  Nc ,-nitro-L-arginine  ( L - N N A ,  1  
niM).  Basal  L-NNA-sensitive  activity  that  was  abol-
ished  by EGTA.  was  taken  as calcium-dependent  cNOS  
activity.  In  addition,  calcium-independent  iNOS  activity  
was  also  determined,  as  the  difference  between  samples  
containing  ImM  F.GTA  and  samples  containing  1 mM 
L - N N A . 
2.3.  Chemicals  and  statistics  
L-[U-14C]-arginine  monohydrochloride  was  obtained  
from  Amersham  International.  All  other  compounds  
were  from  the  Sigma  Chemical  Company.  Data  are  57  
expressed  as  the  mean  J  S.F.M.  of  («)  rats  per  experi-  so  
mental group.  I )ata  were analyzed  w ith one way  A NOVA  59  
followed  by  the  Tuke j  Kramer  Multiple  Comparisons  BO  
test,  where  P -  0.05  was  taken  as  significant.  61  
3.  Results  
In  the  ovariecloniized  rat  stomach,  the  total  NO  syn-
thase  activity  was  enhanced  compared  with  the  ovary-
intact  sham-operated  females  (by  7 3 ± 9 % .  /;  10;  
P<0 .005) .  In  the  gastric  tissues  of  these  oestrogen-deli-
cient  animals,  we  found  a  significant  decrease  in  cNOS  
activity (by  31 ± 8 % ;  n  IX; P<0.05) ,  and  an  increase  in  
iNOS  activity  (by  7193  10%;  /t=-10;  P < 0 . 0 0 l )  as  
shown  in  Fig.  1.  
Administration  of  indomethacin  induced  gastric  
mucosal  lesions  (involving  5 ± 0 . 5 %  of  the  total  gastric  
mucosal  surface,  n ~  10,  / '<0.001) ,  which  were  atte-
nuated  by  ovariectomy  (by  64 ± 4 % ,  « =  5,  P -  0.001).  
Administration  of  ampicillin  reversed  ovariectomy-pro-
voked  gastric  mucosal  defense  after  indomethacin  chal-
lenge  (by  9 4 ±  11 % .  n ~  5,  P<0 .05) ,  and  abolished  the  
increase  in  iNOS  activity  (by  9 9 ± 1 % ,  « =  5,  P<0 .001)  
in  the  ovariectomized  rat.  Data  are  shown  in  Fig.  2.  
During  this  study,  110 change  in  cNOS  activity  could  be  
observed  (data  are  not  shown).  
Administration  of  E.  coli  endotoxin  increased  the  
activity  of  iNOS  (by  491 ± 6 % ,  n ~  5,  PcO.OOl)  and  
decreased  indomethacin-induced  lesion-formation  (by  
6 8 ± 7 % ,  « =  5,  P < 0 . 0 l )  in  (he  stomach  of  ovary-intact  
female  rats.  Data  arc  shown  in  Fig.  3.  We  found  thai  
cNOS  activity  did  not  change  throughout  this  experi-
mental  series  (data  are  not  shown).  
1 2  -1  
S  1 0 -
I  I  Control  
• •  Ovariectomy  
Total cNOS iNOS 
Fig.  1.  Total,  constitutive  and  inducible  nitric  oxide  synthase  (cNOS  
and  iNOS.  respectivelly)  activity  (assessed  by  the  citrulline  assay,  and  
expressed  as  pmol/min/mg  protein)  in  lite  stomach  of  control  and  
ovariectomized  female  rats.  Data  are  shown  as  the  mean±S.F..M..  
where  (11) is at  least  10 measurements  in  a  group,  and  where  statistical  
significance  is  given  as  * f < 0 . 0 5  between  ovariectomized  and  control  
groups. 
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I  I  Control  •  Ovariectomy  Ovariect+Ampici  11 i n 
Fig.  2.  lndomcthacin  (50  mg;kg.  s.c.,  4  hj-induccd  lesion  formation  
(expressed  as  the  per  cent  of  the  total  gastric  mucosal  surface),  and  
inducible  nitric  oxide  synthase  (iNOS) activity  (assessed  by  the  citrul-
line  assay,  and  expressed  as  pmoi/min  mg  protein)  in  the  stomach  of  
control  (ovary-intact),  ovariectomized  and  ampicillin-treated  (800  mg  
kg - 1 ,  p.o.,  3 days)  ovaricctoinizcd  female rats.  Data  arc  shown  as  the  
mean±S.E.M.,  where  (n)  is  at  least  five  rats  in  a  group,  and  where  
statistical  significance  is  given  as  "PcO.OOl  between  ovariectomized  
and  control  groups:  UP<0.05  between  ampicillin-treated  ovar-
ieclomized  and  ovariectomized  groups.  
I  I  Control  LPS-treated 
Fig.  3.  Indomethacin  (50  mg,kg,  s.c.,  4  h)-induced  lesion  formation  
(expressed  as  the  per  cent  of  the  total  gastric  mucosal  surface),  and  
inducible  nitric  oxide  synthase  (iNOS)  activity  (assessed  by  the  citrul-
line  assay,  and  expressed  as  pmol/min  mg protein)  in  the  stomach  of  
control  (ovary-inlact),  and  exogenous  bacterial  endotoxin  (E.  coli  
lipopolysaccharide  (LPS) 0IILB4,  3  nig  kg,  ¡.v.,  5  h)-lrealed.  ovary-
intact  female rats.  Data  are  shown as the mean±S.E.M.,  where  (n)  is  
at  least  five  rats  in  a  group,  and  where  statistical  significance is  given  
as  *P<  0.001  between  I.PS-lrealed  and control  groups.  
4.  Discussion  
Our  present  results  are  in  agreement  with  earlier  
observations,  where  total  NO  synthase  activity  has  
increased  in  the  stomach  following ovariectomy  [12].  In  
these  ocstrogen-dcficient  rats,  the  elevation  of  iNOS  
activity  was  shown  to  be  responsible  for  the  significant  
increase  of  lolal  N<)  m nlltasc  aciivnv,  smo  >>i tin  gas-
tric  tissue,  wc  louinl  a  thcreased  cNOS  activity  which  
corresponds  wiili  our  icccni  linding-.  m  ifi.  heart  ami  
aorta  [11].  Thus,  ocsliogcn-iU'lii  icucy  doiwi-iep.ulales  
cNOS  in  the  stomach,  too  similailv  that  I on ml  by  oth-
ers  in  the  vascular  tissue  |lu.2<>|.  
The  decrease  of  physiological  cNOS  ;u tiviiy  is  known  
to  initiate  an  increase  m  ncnirolil  infiltration  to  Ihr  
vascular  endolhcliuni,  platelet  aggregation,  a"  inipatrcil  
vasodilatation  and  an  elcvalion  ol  vascular  pciinc  
ability,  processes  which  attenuate  blood  supply  towards  
the  gastric  tissue  [9.21].  Moreover,  a  reduction  in  cNOS  
activity  decreases  mucus  level  in  the stomach  |I2.14]  All  
these  processes  attenuate  gastric  defence mechanisms  ll  
is  strongly  suspected  that  this  weaker  defensive  stale  
makes  the  mucosa  more  susceptible  for  the  peneirulion  
of  endogenous  bacteria  towards  the  deepci  layers  of  
gastric  tissues,  which  may  Iriggei  iNOS  activation.  
Indeed,  administration  of  die  wide  spectrum  antibiotic  
ampicillin  blocked  the  expression  of  iNOS.  even  under  
the  control  iNOS  activity  
A  controlled  elevation  m  gastric  NO  level,  originated  
from  an  increased  endogenous  production  or  exogenous  
administration,  defends  Hie  stomach  against  injury  
[8.12,15,18,19,2.1],  In  our  present  study,  we  showed  that  
administration  of  exogenous  bacterial  endotoxin  pro-
tected  the  gastric  mucosa  against  iiulomclhncin-iiuluccd  
ulceration  and  increased  iNOS  activity  in  ovary-intact  
rats,  which  confirms  earlier  observations,  where  diHer-
ein  ulcer  models  were  used  119.23],  Moreover,  other  
investigators  demonstrated  that  neutrophil  depletion  
caused  an  enhanced  generation  of  endogenous  NO.  
which  improved  the  defensive  mechanisms  of  the  sio  
mach  [18].  Finally.  NO  administered  cxogcnously  by  
using  N O  donors,  significantly  ameliorated  gastric  
mucosal  damage  provoked  by  various  ulcerogenic  
agents  [8,13].  The  carliei-dcscnbed  findings  give  furl her 
support  for  the  protective  role  of  an  increased  NO  syn-
thase enzyme  activity  by  the expression  of iNOS. and,  in  
addition,  suggests  that  the  endotoxin  component  ol  
endogenous  gram-negative  bacteria  is  responsible  for  
iNOS  activation  resulting  gastric  mucosal  protection.  
In  summary,  wc  suppose  that  gastric  protection  
against  ulcerogenic  stimuli  following  ovariectomy  is  
mediated  by  an  increased  lolal  NO  synthase  enzyme  
activity,  although  the  reduction  of  cNOS  activity  lias  
been  shown  in  the  stomach.  This  accords  to  the  cardio-
vascular  experience  that  in  the  oestrogen-deficient  state  
the  down-regulation  of  cNOS  develops  [11,20].  How-
ever,  in  the  case  of  the  aorta  and  the  heart.  iNOS  activ-
ity  did  not  change  following  ovariectomy  |l  1,20],  while  
in  the  stomach  wc  demonstrated  an  enhanced  iNOS  
activity.  We  suppose  that  in  the  ocstrogen-dcficient  
state,  endogenous  bacteria  trigger  tile  activation  of  
iNOS,  which  leads  to  increased  NO  production  in  the  
stomach,  a  process  improving  gastric  mucosal  dcfcuce.  
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Abstract 
We studied  the actions of purified Helicobacter pylori endotoxin (3 mg kg - 1 ,  i.v.) on  ral  inti'stiiinl  vascular  pmueahiliiy  (assessed  
by  the  radiolabeled  human  serum  albumin  leakage  technique)  and  on  nitric  oxide  synthase  induction  (assessed  In  the  ciimlliuc  
assay) 4 h later.  We found increased  albumin  leakage and  expression  of the inducible  nitric  oxide synthase  in jeiunuin  and  colon,  
effects reversed  by  a  selective inducible  nitric  oxide synthase  inhibitor  N-(S-(aminomclhyl)heu/.yll-aecluiiudiue  (1-UltiW:  11.3  I  nig  
k g ' s . c . ,  concurrently  with endotoxin).  Thus.  II. pylori  endotoxin seems to  be capablc of provoking  an  inllnninmloiy  response in  
the ral  intestinal  tissue. Transmucosal  invasion or/and surface translocation  of //. pylori  or  its breakdown  products  might  possibly  
attenuate jejunal and colonic mucosal  barrier  function, a process mediated  by the expression  of  the inducible  mine ovjdc synthase. 
'O  2001 Published  by  Elsevier  Science  Ltd. All  rights  reserved.  
Keywords: Helicobacter pviori  endotoxin;  Intestinal  inflammation; Inducible nitric oxide synthase 
1.  Introduction  
Helicobacter  pylori  is  an  acid-resistant  bacterium,  
which  can  grow  only  at  low  pH,  predominantly  in  the  
antral  part  of  the  stomach.  All  over  the  world,  the  inci-
dence  of  H.  pylori  infection  is  high,  e.g.  it  approaches  
50-80%  in  European  adults.  The  pathological  involve-
ment  of  H.  pylori  is  known  in  gastroduodenal  inflam-
mation  and  duodenal  ulceration,  and  it  might  
participate  in  the  generation  of  gastric malignancies  too  
[6].  Although  the  clinical  impact  of  a  better  under-
standing  of  how  H.  pylori  affects  gastrointestinal  
mucosa  is high,  only  a  few investigations  had  been  car-
ried  out  by using  its purified endotoxin  for exploring  its  
local  or/and  systemic  effect.  In  chronic  inflammatory  
diseases of the gut  (e.g.  in inflammatory  bowel  diseases),  
the  overproduction  of  nitric  oxide  (NO)  by  the  expres-
*  Corresponding  author.  Tel.:  +36-1-210  0819 ext.  150; fax:  + 36-
1-210 0813. 
E-maii address: laszloftigkoki.hu (F.  László).  
sion  of  the  inducible  NO  synthase  civ/vnir  (iNOS)  is  
cytotoxic,  and  has  a pathological  impact  |7|.  It  increases  
vascular  permeability,  adhesion  of  neutrophils  to  the  
vascular  endothelium  and  leads  lo  vasocougrsiioii  |  IJ.  
In  the  present  study,  wc  investigated  the  relation  
between  the  expression  of  iNOS  and  intesiinal  inflam-
mation  following  systemic  administration  of  a  purilicd  
H.  pylori  endotoxin  [5].  
2.  Materials  and  methods  
2.1.  Treatments  
We  used  male  Wistai  rats  (230  250  g).  They  were  
fasted  overnight,  but  received  water  ad  libitum.  Under  
transient  ether  anaesthesia,  purilicd  // .  pylori  endotoxin  
(from  Professor  Moron's  laboratory.  Ireland;  3  mg  
k g - 1 )  was  administered  intravenously.  I it  a  separate  
experiment,  we administered  a  bisisolhiourea  derivative  
selective  iNOS  inhibitor  (from  Wellcome  Research  
Laboratories,  N-(8-(aminomclliyl)-bcn7.vl)acr(amidine  
(»928-4257/01/$ -  see from matter  ©  2001 Published  by  Elsevier  Science Ltd.  All  rights  reserved.  
P i t :  S0928-4257(01  )00062-6  
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[ 1400W],  0.2-1  mg  kg"1 ,  s.c.;  [2])  concurrently  with  
endotoxin.  For  the  measurement  of  vascular  perme-
ability  or  iNOS  enzyme  activity,  segments  of  the  jeju-
num  and  colon  were  removed  from  standard  sites  4  h  
following  treatments.  
2.2.  Intestinal  nitric  oxide  synthase  enzyme  activity  
In  this  experiment,  we  used  untreated  (control)  and  
11.  pylori  endotoxin  (3  mg  k g - ' ,  i.v.)-treated  groups  
alone  or  with  1400W  (1 mg kg - 1 ,  s.c., concurrently  with  
endotoxin)  administration.  In  jejunal  and  colonic  tis-
sues.  we  measured  the  calcium-dependent  constitutive  
NO  synthase  (cNOS)  and  the  calcium-independent  
iNOS  activity  by  the  citrulline  assay  as  described  pre-
viously  [1.2],  
2.3.  Intestinal  vascular  permeability  
In  separate  groups  of  rats,  as  a  measure  of  inflamma-
tion.  we  examined  jejunal  and  colonic  vascular  perme-
ability  by  using the  radiolabeled  human  serum  albumin  
leakage  technique  as  has  been  established  in  earlier  
studies  [1].  We  used  H.  pylori  endotoxin  (3  mg  kg - 1 ,  
i.v.)-ireated  groups  alone  or  with  1400W  (0.2-1  mg  
kg"1 ,  s.c.,  concurrently  with  endotoxin)  administration.  
2.4.  Chemicals  
We  obtained  [''Mjluim.m  scrum  albumin  from  
IZINTA  (Budapest,  Hungary)  and  I -[U-IJC']argininc 
monohydrochloride  from  Amcrsham  International  
(UK).  All  other  compounds  were  front  Sigma.  
2.5.  Statistics  
Throughout  our  studies,  the  results  were  expressed  as  
mean±S.E.M.  of  (n)  rats  in  a  group.  Data  were  ana-
lysed  with  the  Tukey-K tamer  multiple  comparisons  
test,  where  /><0.()5  was  taken  as  significant.  
3.  Results  
3.1.  Expression  of  intestinal  inducible  nitric  oxide  synthase  
Administration  of  //.  pylori  endotoxin  led  to  I lie-
expression  of  iNOS  in  the  jejunum  and  colon  (n~  4,  
P<0.001)  4 h  later,  an  effect  which  was  abolished  by  the  
administration  or  I400W  iNOS  (/>-4.  P<().()()I)  in  
both  intestinal  tissues  (Fig.  I).  Basal  cNOS  activities  
remained  unchanged  throughout  the experiments  (n -  4,  
data  are  not  shown).  
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Fig.  I.  F.xpression  of  iNOS  (described  in  pmol  min - '  m g - '  protein  
units)  in  the rat jejunal  and  colonic  tissue  4  h after  the  administration  
of purified  Helicobacter  pylori  endotoxin  (LPS;  3 mg kg - 1 ,  i . V . ) .  and  its  
reversal  by  the  selective iNOS  inhibitor  1400W  (1  mg kg - 1 ,  s.c..  con-
currently with  LPS).  Data  are expressed  as mean±S.E.M.,  where « = 4 
rats  in  a  group.  *P< 0.05  means  significant  increase  in  iNOS  activity-
compared  with  the  untreated  control  (Cont.)  group; "P <0.05  means  
significant  decrease  in  iNOS  activity  compared  to  the  LPS  alone  
group. 
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Fig.  2.  Provocation  of jejunal  and  colonic albumin  leakage  (expressed  
as  pi  albumin g - '  dry  tissue)  by  the administration  of  a  purified  Heli-
cobacter  pylori  endotoxin  (LPS;  3 mg kg  '.  i.v.) 4  h later,  and  its dose-
dependent  attenuation  by  the concurrent  administration  of  a  selective  
iNOS  inhibitor  (1400W,  0.2-1  mg  kg  s.c  ).  Data  are  expressed  as  
mean±S.E.M.,  where  n  -  4—6  rats  in  a  group.  */* --(1.05  means  sig-
nificant  increase  in  albumin  leakage:  hl'<0.05  means  significant  
decrease  in albumin  leakage compared  lo the  LPS alone  group.  
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3.2.  Intestinal vascular permeability 
Administration  of  H.  pylori  endotoxin  (3  mg  kg - 1 ,  
i.v.)  alone  provoked  significant  small  and  large  intest-
inal  albumin  leakage  in  both  tissues  4  h  later  (Fig.  2).  
Concurrent  administration  of  the  selective  inhibitor  of  
iNOS,  1400W  with  II.  pylori  endotoxin  dose-depen-
dcntly  attenuated  jejunal  and  colonic  albumin  leakage  
after  4  h  ( 8 3 ± 5 %  and  9 4 ± 3 %  maximal  protection,  
respectively; « = 4 - 6 ,  P<0 .01) as demonstrated  in Fig.  2.  
4.  Discussion  
Our  present  results  confirm  previous  observations,  
when  a  II.  pylori  extract  was  administered  intrave-
nously, and  the expression of iNOS in the duodenal  part  
of  the  small  intestine and  in  its epithelial  cells  had  been  
found  [3].  The  expression  of  iNOS  correlated  with  epi-
thelial  cell death, and  could  be reversed  by  the  adminis-
tration  of  the  non-selective  iNOS  inhibitor,  
dexamethasone,  and  by  the treatment  with  NG-nitro-L-
arginine  methyl  ester,  a  non-specific  NO  synthase  
blocker at  the  time of  the  expression  of iNOS  [3].  Thus,  
II.  pylori  extract  could damage  the intestinal  mucosa  by  
its  direct  toxic  effect on  epithelial  cells,  which  is  medi-
ated  by  iNOS.  The  vascular  injury  correlating  with  
iNOS  expression,  and  their  reversal  by  the  selective  
iNOS  inhibitor,  1400W  following the challenge  with  H.  
pylori  purified  endotoxin  in  our  study  suggests  that,  
besides  the  damage  of  epithelial  cells,  microcirculatory  
dysfunction  can  also  participate  in  H.  pylori-related  
inflammation.  Morever,  the  induction  of  N O  synthase  
and  microvascular  leakage  in  the  jejunum  and  colon  
might focus the impact  of  H.  pylori  endotoxin-provoked  
mucosal  injury  in  other  parts  of  the  gastrointestinal  
tract. 
In  conclusion,  H.  pylori  endotoxin  seems  to  be  cap-
able  of  provoking  a  inflammatory  response  in  the  rat  
intestinal  tissue.  Transmucosal  invasion  or/and  surface  
translocation  ol  II  pylori  oi  its  hrrakilmvn  inoilucis  
might  attenuate  (In-  mucosal  barrier  tuni-iion  ol  Ilk-
jejunum  and  col""-  This  pioir-ss  is  maliausl  by  iNOS,  
Thus,  the  clinical  hnplicniiiin  ol  M-k-i'liw  mliil»iioi-->  of  
iNOS  might  h a w  poic"l'ul  ilicrapculic  benefit  in  Ilk-
prevention  and  Ircainn'iil  of  II.  /M/»"'/-assoi"ialcul  gas-
trointestinal  mucosal  iultauunaiiou.  
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Abstract 
We have examined  the  effects of  intravenous  administration  of  a  purified  lipopolysaccharide  (LPS)  from  tlelhohafler  pylori  (3 
mg kg-1,  i.v.)  on  rat  vascular  permeability,  assessed  by  the  radiolabeled  human  serum  albumin  leakage  technique  in  the  heart,  
kidney, liver and  lung 4 h after challenge.  An increased  vascular permeability  in cardiac,  renal,  hepatic  »ml  pulmonary  tissues after 
challenge  was  determined.  The  albumin  leakage  observed  in  all  these  organs  could  be  prevented  by  tho  aclei 'ivu  inducible  nitric  
oxide  synthase  inhibitor,  N-(8-(aminomethyl)benzyl)-acetamidine  (1400W; 0.2-1  mg kg-1,  s.c.)  administration  concurrently  with  
LPS. Thus,  H. pylori  LPS  can  provoke  a  microvascular  inflammatory  response  in  the  rat  cardiac,  renal,  hepatic  and  pulmonary  
tissues,  actions  mediated  through  the  activation  of  the  inducible  nitric  oxide  synhase  isoenzyme.  ©  2001  Published  by  Elsevier  
Science Ltd.  All rights  reserved.  
tm,... 
Keywords: Helicobacter pylori  endotoxin;  Heart;  Lung;  Kidney;  Liver;  Inflammation; Inducible  nitric oxide  synthase  
1.  Introduction  .  
j  ";  
t,  |  
Following  the  identification  of  the  Helicobacter  pylori  
organism  [7],  an  acid-resistant  bacterium  growing  pre-
dominantly  in  the antrum  of  the human  stomach,  it  has  
became  clear  that  it  plays  a  role  in  the  development  of  
chronic  atrophic  gastritis,  gastric  malignancies,  espe-
cially  in  mucosa-associated  lymphatic  tissue  (MALT)  
lymphomas,  and  gastroduodenal  ulceration  [1,10].  In  
addition  to  its  gastroduodenal  pathogenic  role,  experi-
mental  and  clinical  data  suggest  that  H.  pylori  infection  
may  play  a  role  in  numerous  diseases  of  organs  in  
addition  to  the  gut  [6,9,11],  although  no  clear-cut  cor-
relation  between  H.  pylori  infection  and  these  disease  
states  have  been  obtained.  
The  purification  of  lipopolysaccharide  (LPS)  from  H.  
pylori  has  allowed  a  better  insight  for  exploring  the  
potential  pathologic  processes  related  to  the  bacterium  
*  Corresponding  author.  Tel.:  +44-20-7882  6176;  fax:  + 44-20-
7882 6177. 
E-mail address: b.j.whittle@mds.qmw.ac.uk  (B.J.R.  Whittle).  
and  its  products  [8],  The  excess  generation  of  nitric  
oxide  (NO)  by  the  activation  of  the  Inducible  NO  syn-
thase  enzyme  (iNOS)  is  triggered  by  bacterial  endotox-
ins.  This  overproduction  of  NO  hns cytotoxic  potential  
and  provokes  microvascular  inflammatory  reactions.  
Recent  studies  have shown  thai  the  LI'S floni  H.  pylori  
can  provoke cytotoxicity  in  rat  duodenal  epithelial  cclls,  
an  effect  involving  the  expression  or  iNOS  and  super-
oxide production,  implicating  a  role  ol  peroxynitritc  [4],  
Therefore,  in  our  present  study,  WC have  investigated  
whether  systemic  administration  of  a  purified  H.  pylori.  
LPS  leads  to  microvascular  dysfunclioh  in  various  
extraintestinal  organs  of  the  rat  and  tile  actions  of  
selective  inhibitors  of  iNOS.  
2.  Materials  and  methods  
2.1.  Treatments  
Male  Wistar  rats  (230-250  g)  were  lasted  overnight,  
but  received  water  ad  libitum.  Under  transient  ether  
0928-4257/01/$  -  see front matter  ©  2001  Published  by  Elsevier  Science  Ltd.  All  rights  reserved.  
PI I:  S0928-4257(01)00035-3  
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anaesthesia,  purified  LPS  from  H.  pylori  (3  mg  kg"1)  
was  administered  intravenously.  In  a  separate  experi-
ment, we administered  a bisisothiourea derivative selective 
iNOS  inhibitor  (GlaxoWellcome,  N-(8-(aminomethyl)-
bcnzyl)acetamidine  [1400W],  0.2-1  mg  kg"1,  s.c.;  [2])  
concurrently  with  the  LPS.  For  the  measurement  of  
vascular  permeability,  segments  of  the  left  ventricle  of  
the  heart,  pulmonary  parenchyma,  liver  and  kidney  
were  removed  from  standardised  sites,  4  h  following  
treatments. 
Vascular  permeability  in  the  heart,  kidney,  liver  and  
lung  was  determined  by  using  the  radiolabeled  human  
serum  albumin  leakage  technique,  established  in  earlier  
studies  [5],  
2.2.  Chemicals  
[125I]human  serum  albumin  was  from  IZINTA  
(Budapest,  Hungary)  and  L-[U-14C]arginine  mono-
hydrochloride  was from Amersham  International  (UK).  
All  other  compounds  were  from  Sigma  Chemical  Com-
pany. 
2.3.  Statistics  I M 
The  results  were  expressed  as  mean±S.E.M.  of  (rip  
rats  in  a  group.  Data  were  analysed  with  the  Tukey-
Kramer  multiple  comparisons  test,  where  P < 0 . 0 J  wis*»/  
taken  as  significant.  
3.  Results  
3.1.  Cardiac,  renal,  hepatic  and pulmonary  vascular  
permeability,  and  their  attenuation  by  the  selective  
inhibition  of  the  inducible  nitric  oxide  synthase  
V  /  
Administration  of  H. pylori  LPS (3 mg kg"1 ,  i.v.) alone 
provoked  significant  cardiac,  renal,  hepatic  and  pul-
monary  albumin  leakage,  determined  4 h later  (Fig.  1).  
Concurrent  administration  of the selective inhibitor  of  
iNOS,  1400W  with  H.  pylori  LPS,  dose-dependently  
attenuated  albumin  leakage  after  4  h  in  the  rat  heart,  
kidney,  liver  and  lung,  with  maximal  inhibition  of  
91 ± 2 % ,  7 3 ± 7 % ,  9 3 ± 6 %  and  9 8 ± %  maximal  pro-
tection,  respectively  (n = 4-6,  P  < 0.01).  The  results  are  
demonstrated  in  Fig.  1.  
4.  Discussion  
In  our  present  study,  we have  found  increased  micro-
vascular  permeability  to  albumin  in  the  rat  heart,  liver,  
kidney  and  lung,  4  h after the administration  of purified 
LPS  from  H.  pylori.  Such  findings  agree  with  earlier  
studies,  where  a  purified  Escherichia  coli  LPS  lead  to  
LPS 0.2  1.0  i  
+1400W (mg  kg-1)  
L P S 
+1400W (mg kg1)  
Fig.EAlbumin  leakage (expressed  us ml albimn g - 1  dry tissue) in  the 
rat  heart,  kidney,  liver  and  lung  4  h  following  the  administration  of  
purified  Helicobacter  pylori  endotoxin  (LPS;  3  mg kg - ' ,  i.v.),  and  its  
reversal  by  the  selective  iNOS  inhibitor  I400W  (0.2-1  mg  kg"',  s.c.,  
concurrently  with  LPS).  Data  are  expressed  us mcaniS.E.M.,  where  
N*4-6  rats  in  a group. *P< 0.05 means  it significant increase  in  albu-
min  leakage; #P<0.05  means  a  significant  decrease  in  albumin  lekage  
compared  to the  LPS group.  
similar  systemic  vascular  inflammatory  actions  under  
comparable  experimental  conditions  [2,5],  In  the  present  
study,  we  have  found  that  the  selective  inhibitor  of  
iNOS,  1400W attenuated  the microvascular  responses  in  
these  tissues  induced  by  H.  pylori  LPS,  which  supports  
the  pathogenic  involvement  of  iNOS.  Previous  studies  
have  shown  that  the  cytotoxic  efTects  on  rat  duodenal  
epithelial  cells  following  challenge  with  this  H.  pylori  
LPS  could  be  abolished  by  1400W  [4],  Likewise,  the  
actions  of  E.  coli  LPS  on  vascular  permeability  could  
also  be  reversed  by  1400W  [2]  or  by  non-selective  NO  
synthase  inhibitors  when  administered  at  the  time  of  
expression  of iNOS  [5].  
In  recent  years,  the  etiological  role  of  infections,  
including  H.  pylori,  has  been  discussed  in  the  patho-
genesis  of  diseases  such  as  atherosclerosis  and  coronary  
heart  disease  [6],  Furthermore,  the  association  of  H.  
pylori  infections  and  chronic  liver  diseases,  including  
cirrhosis  and  chronic cholangitis,  has  been  reported,  but  
no  causal  relationship  has  been  shown  [11].  In  addition,  
H.  pylori  infection  may  be  involved  in  the  etiology  of  
pulmonary  and  renal  MALT  lymphoma  [3,12],  bronch-
iectasia  [13]  and  membranous  nephropathy  [9],  How-
ever,  more  data  are  needed  to  establish  correlation  
between  the  bacterium  and  the  disease.  Our  present  
results  suggest  that  the  purified  LPS  from  H.  pylori  is  
capable  of  provoking  an  iNOS-mediated  systemic  
microvascular  inflammatory  response.  Thus,  transmi-
gration  of  the  bacteria  into  gastro-duodenal  tissue  and  
à 
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liberation  of  its  LPS  into  the  systemic  circulation  may  
provide  one  pathogenic  process  in  these  diseases,  
through  expression  of  iNOS.  
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